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ABSTRACT 
Carnitine palmitoyltransf erases (CPT) I and II are the enzymes 
responsible for enabling activated long chain fatty acids to be 
tranalocated across the mitochondrial impermeable barrier in rat 
liver cells. Carnitine is esterified onto the fatty acid on the 
cytosolic side of the mitochondrial inner membrane, releasing C0A, 
and the activated fatty acid is regenerated on the matrix side, 
releasing free carnitine. The carnitine-fatty acid is translocated 
across the inner membrane by a carnitine acyl-carnitine translocase. 
Once in the mitochondrial matrix, the activated fatty acid is 
available for 3-oxidation. 
The aim of this thesis was to purify both CPT I and II, with a 
view to isolating the nuclear genes which encoded them. This would 
answer questions intrinsic to the CPT system; are the two enzymes 
identical; do they reside on the same membrane; are they encoded by 
one gene; and how are the targeted to two different locations in the 
mitochondrion? 
CPT I was localised in the outer mitochondrial membrane and 
then partially purified. The protein was digested with' 	specific 
peptidases 	and the fragments N-terminally sequenced and used to 
generate ol igonucleot ides for cDNA library screening and polymerase 
chain reaction (PCR). The partially purified protein was also used to 
generate polyclonal antibodies, which were used to screen Xgtll cDNA 
libraries. A positive clone was isolated from the Xgtll cDNA library 
using affinity purified serum. When sequenced, the clone was 
identified as long chain fatty acid C0A synthase. 
CPT II was purified from rat liver mitochondrial inner 
membranes and N-terminally sequenced. The purified protein was used 
to generate polyclonal antibodies. Oligonucleotides were generated to 
the cDNA encoding CPT II reported by Woeltje et al (1990b) and used 
to PCR up a 300 bp fragment, which when cloned and sequenced was 
identified as the C-terminus of CPT II. This fragment was then 
used unsuccessfully to screen XgtlO, Xgtll and Xgtll-stretch cDNA 
libraries, in order to find a full length clone. 
The affinity purified sera was used to show that CPT I and II 
were immunologically distinct and were localised on the rat liver 
mitochondrial outer and inner membranes respectively. Using the 
information generated by this thesis along with other recent 
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publications a possible topology of CPT I in the rat liver 
mitochondrial outer membrane was elucidated. 
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A - adenine 
ATP - adenosine triphosphate 
BSA - bovine serum albumin 
BrP- C0A-bromopalmitoyl-Coenzyme A 
C - cytosine 
cAMP - cyclic adenosine phosphate 
CAT - carnitine 
CHAPS - (acetyltraneferase)3L(3-Cholamido propyl)dimethyl 
-ammonio) -1-propansuiphanate 
CPT I - carnitine palmitoyltransferase I 
CPT II - carnitine palmitoyltransferase II 
C0A - coenzyme A 
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FFA - free fatty acids 
G - guanine 
GIP - general insertion protein 
GPAT - glycerol phosphate acyltransferase 
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HMG-00A - hydroxy-3-methylglutaryl-coenzyme A 
HSP - heat shock protein 
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LDL - low density lipoproteins 
LSB - Laemmli sample buffer 
MAO - monoamine oxidase 
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MPP - mitochondrial processing peptidase 
NAD+ - nicotinainide adenine dinucleotide 
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OD - optical density 
OG - octyl g].ucoside 
PEG - polyethylene glycol 
PEP - processing erihancingprOteifl 
PCR - polymerase chain reaction 
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Pi - inorganic phosphate 
R - purine 
RNA - ribonucleic acid 
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T - thymine 
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1 General introduction 
The uptake of activated long chain fatty acids into the 
mitochondrion prior to 13-oxidation, is facilitated by a transport 
system involving the membrane bound proteins; carnitine 
palmitoyltransf erases (CPT) I & II, and a carnitine-acylcarnitine 
translocase protein. There has been growing interest in the CPT step 
as a potential target for pharmacological intervention in diabetes 
therapy (Tutwiler et al, 1985; Wolf and Engel, 1985). CPT II has also 
been identified as a site of inherited mutations, some with severe 
consequences (Declerq et al, 1985). Such developments have promoted 
renewed efforts to explore the CPT system at a molecular level. 
1.1 Energy storage within the eukaryotic cell 
Within higher eukaryotes there is a considerable diversity of 
function at the cellular level. These observed physiological 
differences are reflected in biochemical differences such as the 
choice of fuel substrate in different cell types. Adipocytes (fat 
cells) have, as their name suggests, the purpose of storing energy in 
the form of fat, mainly triacylglycerols, as a reserve for the body 
in times of starvation. Up to 90% of the body's energy reserve is 
stored in the form of triacyiglycerols. The hydrophobic nature of 
triacylglycerols enables them to be stored almost completely 
dehydrated hence devoid of excess weight due to water. 
The other main store of energy within the body is glycogen 
which is stored in the liver and the skeletal muscle. The 
mobilisation of glycogen reserves releases glucose-6-phosphate which 
is either converted into glucose, which is released into the blood 
stream by tissues that contain glucose-6-phosphatase (e.g. liver) or 
intracellularly converted into pyruvate. However, glycogen storage is 
limited due to the hydrated nature of the glycogen. The mass of 
glycogen trebles when hydrated and therefore stores less potential 
energy than an equal weight of triacylglyceride. Nevertheless, a 
degree of glycogen storage is necessary for the maintenance of blood 
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glucose levels and the provision of energy under anaerobic conditions 
(e.g. for fast muscle contraction). 
1.2 Role of fatty acids in energy metabolism 
With a few exceptions (brain and red blood cells) most tissues 
have the ability to oxidise fatty acids. Usually, these tissues will 
use a mixture of glucose and fatty acids, the ratio of which is 
determined by the physiological state. 
Apart from their physiological importance as a fuel substrate, 
fatty acids are also used in the synthesis of complex lipids, such as 
phospholipids and triacylglycerols. They are also responsible for the 
storage and transport of the fat soluble vitamins A, D, E and K. 
The oxidation of fatty acids is aerobic since the reducing 
equivalents formed during fatty acid oxidation can only be oxidised 
through the electron transport chain. Therefore fatty acid oxidation 
requires a constant delivery of fatty acids and oxygen. The products 
of complete oxidation of fatty acids are ATP, H20 and CO2. which can 
never be used as a carbon source for the synthesis of either 
carbohydrate or protein. Incomplete oxidation of fatty acids gives 
rise to ketone bodies. This process occurs primarily in the liver 
which metabolises fatty acids not only for energy, but also for the 
production of ketone bodies. These substitute for glucose in most 
tissues including some tissues that are unable to metabolise fatty 
acids (e.g. brain). The liver uses fatty acids for triacylglycerol 
synthesis. These are secreted within very low density lipoproteins 
(VLDL) which are responsible for the transport of triacylglycerols to 
peripheral tissues such as heart, skeletal muscle and adipose tissue. 
The fatty acids released through VLDL triacylglycerols, are either 
oxidised or used for synthesis of triacyiglycerols at the periphery. 
1.3 Conditions determining substrate selection by 
tissues 
The supply of glucose, fatty acids (lipoproteins) and ketones 
are controlled by the physiological state of the animal, which is 
governed by a variety of factors. In a normal state the diet of the 
animal supplies both glucose and fatty acids which are metabolised in 
the liver to triacylglycerols, and are transported by VLDL to both 
adipose tissue for storage and other tissues such as heart and muscle 
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for metabolism. The liver does not produce ketone bodies in this 
state. In this normal state the level of the hormones insulin and 
glucagon are high and low respectively, (high insulin/glucagon 
ratio). 
In 	a glucose deficient 	animal, 	e.g. 	starved, 	the 
insulth/glucagon ratio is low. Tissues such as heart, diaphragm and 
red skeletal muscle, must therefore metabolise fatty acids. These can 
either come directly from their own stores, from fatty acids 
delivered by VLDL secreted by the liver, or from fatty acids 
complexed to albumin delivered directly by the circulation after 
release from adipose tissue. They also metabolise ketone bodies which 
are produced in the liver. In humans the metabolism of ketone bodies 
is not only the result of a prolonged glucose deficiency, but can 
also be the result of longer than normal overnight fast. 
1.4 The role of insulin and glucagon 
Insulin stimulates the uptake of glucose by binding to specific 
receptors on the plasma membrane of cells. This activates a protein 
phosphorylation cascade system. If the level of blood glucose becomes 
too low, then glucagon is released from the a-cells of the pancreatic 
islets. Glucagon receptors on the cell membrane are coupled to the 
activation of sensitive adenylate cyclase. So receptor occupation 
results in increased levels of intracellular cAMP. This second 
messenger mainly acts by its activating cAMP dependent protein 
kinases. One of these cAMP-dependent kinases hydrolyses glycogen 
reserves to form glucose-6-phosphate. In the liver glucose-6-
phosphate is hydrolysed to glucose which is released into the blood 
stream. cAMP also stimulates gluconeogenesis in the liver such that 
glucose can be synthesised from precursors such as lactate and 
alanine. 
The uptake of glucose by the brain is not insulin dependent and 
therefore is proportional to the blood glucose level. This is one of 
the main reasons why blood glucose levels must be strictly controlled 
at all times, regardless of the physiological state of the animal. 
This control is referred to as glucose homeostasis. 
Insulin and glucagon also play an important role in the control 
of fatty acid metabolism. They generally have opposite effects on 
lipolysis. In adipose tissue insulin decreases lipolysis, and 
glucagon increases lipolysis. They also have opposite effects on 
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liver ketogenesis, again with insulin decreasing ketogenesis and 
glucagon increasing ketogenesis. 
Although glucagon supports lipolysie in adipose tissue, it does 
not support lipolysis in other tissues such as heart or skeletal 
muscle. This is a vital selective mechanism to ensure that the 
immediate fatty acid reserves of the organs are not mobilised during 
starvation, and are therefore left for use by the organ. Therefore, 
during glucose deficiency an animal will utilise not only the 
lipolysed stored fatty acids from the adipose tissue, but also the 
non-lipolysed fatty acids stores in the other tissues (heart, 
diaphragm red skeletal muscle etc.). 
1.5 Types of absolute or relative glucose deficiency 
There are two main categories of deficiency. Firstly true 
glucose deficiency, which is caused either by starvation or by 
insufficient food intake to satisfy the glucose demand of bodily 
functions. The second is a relative deficiency, such as in 
uncontrolled diabetes. In this condition there are very high blood 
glucose levels but no glucose uptake by the cells, due to either 
insulin deficiency or insulin resistance. 
Diabetes is the general name for a group of glucose metabolism 
disorders that prevents glucose uptake by tissues. The result of such 
a disorder is a lack of adequate glycogen in the muscle cells and, 
unless controlled, a high glucose level in the blood stream. The main 
symptoms of diabetes, associated with hyperglycaemia, are thirst, 
weakness, weight loss and polyuria. In extreme cases, the rate of 
production of ketone bodies in the liver is markedly increased 
resulting in ketoacidosis. If the blood glucose level is left 
unattended it would result in coma and ultimately give rise to brain 
damage and death. There are two types of diabetes mellitus which 
require different methods of control. Type I is referred to as an 
absolute insulin deficiency due to non-functional P-cells, whereas 
type II is due to a relative insulin deficiency. In this state, 
insulin secretion and/or insulin action may be deficient. 
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1.5.1 Starvation 
During prolonged physical exercise or a period of starvation 
the animal's glycogen reserves are depleted before its 
triacylglyceride reserves. During starvation this readily available 
energy source will last for only a short time in the liver, after 
which the animal is totally reliant on fatty acid catabolism. Fatty 
acid reserves can last for a much longer period depending on the 
physiological state of the animal before starvation. After the 
depletion of the fat reserves, the animal will start to degrade its 
protein to generate amino acids which can be used, via glucogenesia, 
to generate glucose in the liver. In the final stages of starvation 
protein catabolism will serve as the only source of energy. 
1.5.2 Diabetes mellitus type I 
Diabetes mellitus type I is caused by an inability of an animal 
to produce insulin. In humans the defect usually becomes symptomatic 
during the first 25 years of life. It is caused by either damage to 
and loss of the j-cells of the pancreatic islets of Langerhans with 
resulting loss of insulin production. The agent that damages the 
islets is not known. Two main factors which have been implicated are 
virus infection and autoimmunity. The latter has been implicated 
because complement fixing islet cell antibodies can be found in 
genetically predisposed individuals. It should be noted, however, 
that not all of these genetically predisposed individuals develop 
diabetes. 
The treatment for the majority of cases involves the 
administration of exogenous insulin. The intravenous method is 
usually used during stabilisation of an individual or when the blood 
contains life-threateningly high glucose levels. Intramuscular 
insulin injections are the normal method of control for insulin 
dependent diabetics. There are many modified forms of insulin 
available (isophane, protamine, zinc and lente etc.) each having a 
characteristic onset time, peak effect and duration time. These forms 
of insulin fall into three categories of fast, medium and slow acting 
insulin. A normal scenario would be a diabetic who would inject twice 
a day (morning and evening) with a mixture of fast and slow acting 
insulin. This would be injected usually 30 minutes before meals and 
would cover two meals from each injection. This method is very 
6 
effective after the diabetic has been stabilised. However care must 
always be taken with the calorific value of the meals. The key 
element however is the stabilisation of individuals. Stabilisation, 
on an individual basis, can be very easily obtained or almost 
impossible for reasons which are not yet understood. In cases where 
stabilisation is difficult the individuals are referred to as 
'brittle' diabetics. In order to avoid either hyper- (section 1.4) or 
hypo-glycaemia, brittle diabetics must pay great attention to their 
blood and urine glucose levels at all times. Hypoglycaemia is a 
frequent and serious problem, which is caused by the blood sugar 
falling below 5 mM. In many cases the symptoms are undetectable to 
the sufferer and can manifest themselves as severe character 
alterations. These include confusion, blurred vision, drowsiness and 
aggression. The patient will then slip into unconsciousness and 
convulsions, leading ultimately to coma, brain damage and death. Most 
type I deaths occur at night due presumably to hypoglycaemia, 
although post mortem blood glucose levels are not accurate enough to 
provide proof. 
Even in stabilised individuals problems arise when the 
treatment has been continued over a number of years as is the case in 
most sufferers. Eye deterioration, although preventable, is common in 
long term juvenile onset diabetic individuals. This is thought 
perhaps to be caused by fluctuating glucose levels in the blood 
stream which cause alterations in the' refraction of the lens. This 
can cause cataracts and in extreme cases haemorrhaging. Ulcerations 
of the foot are also a common problem along with limb nerve damage 
which prevents sensations such as touch and pain being experienced 
from the hands and feet. 
Recently molecular biological techniques have been developed to 
produce human recombinant insulin. This has proved very effective in 
90% of sufferers and hopefully should not cause side effects to the 
same extent as its porcine counterpart. In the remaining cases a more 
serious problem has been encountered. In these cases stabilisation 
is unobtainable with the recombinant human insulin, and violent side 
effects resulting in frequent comas are common. Signs of oncoming 
hypoglycaemia, which were detectable in people treated with the 
porcine insulin, are no longer detectable. The cause of such effects 
is not known, and the reason why they should happen to a greater 
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extent with human recombinant insulin and not porcine insulin is 
confusing. 
1.5.3 Diabetes mellitus type II 
Maturity onset diabetes (mellitus type II) is a rather 
different scenario, and is sometimes referred to as non-insulin 
dependent diabetes. Individuals must be genetically predisposed to 
the disorder but need not necessarily develop the condition. The 
individual is usually in the latter part of life (50 plus) and has a 
history of obesity. Non-insulin dependent diabetic patients can 
secrete insulin, but their serum insulin concentrations may be 
diminished, normal, or even elevated. The problem lies with the 
receptors on the cells to which the insulin binds. The insulin 
receptors in the cell membrane are either blocked or desensitised. 
The cell therefore can not respond to insulin, and hence glucose 
cannot be transported into the cells. This is referred to as insulin 
resistance. The usual treatment for insulin resistant diabetics is 
dietary control. The patients must eat only enough to maintain hour 
by hour functions, and must strictly avoid simple carbohydrates of 
any kind as this would almost certainly result in hyperglycaemia. If 
dietary control is not sufficient to keep the blood sugar normal, 
then there is a wide spectrum of oral drugs available. Most of the 
drugs available fall into two categories. The sulphonylurea group act 
chiefly by stimulating insulin release from the /3-cells of the 
pancreatic islets, and the biguanides act by decreasing hepatic 
glucose reduction. The drugs can be used individually or in 
combinations with each other. Problems arise if the drugs are taken 
in conjunction with other drugs such as alcohol, beta-blockers and 
aspirin, which cause hypoglycaemia, or corticosteroids which cause 
hyperglycaemia. In the type II disorder a more attractive cure is one 
of prevention. Even if the individuals are genetically predisposed, 
they will never develop the condition if they eat a normal diet, 
avoiding simple carbohydrates and obesity. 
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1.6 Fatty acid metabolism 
Fatty acids have an important role in the metabolism of the 
cell (section 1.1), and are oxidised in a manner unaffected by either 
insulin deficiency or insulin resistance. Therefore, theoretically, 
the energy produced from fatty acid oxidation could be used to 
alleviate the effects-of diabetes. 
1.6.1 Activation of fatty acids 
Once in the cell the fatty acids are activated, before being 
transported into the mitochondria or the peroxisomee prior to #- 
oxidation. This activation of the fatty acids is catalysed by carbon 
chain length dependent fatty acyl-00A synthases (or fatty acid 
thiokinases). These enzymes are widespread through the cell and are 
usually associated with the membranes of several organelles. The 
reaction occurs in two stages. Firstly the carboxyl group of the 
fatty acid binds to the a-phosphoryl group of adenosine triphosphate 
(ATP) to form an acyl adenylate and releasing pyrophosphate (PPi) as 
a by-product. The PPi is hydrolysed by pyrophosphatase. 
0 
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Secondly the sulphydryl group of C0A attacks the acyl 





R--AMP + HS-00A 	 R--S-CoA + AMP 
Acyl adenylate 	 Acyl-00A 
It is interesting to note that the partial reactions are freely 
reversible and the equilibrium constant is close to one. The reaction 
is actually driven forward by hydrolysis of pyrophosphate by 
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pyrophosphatase. This makes the overall reaction irreversible since 
two high energy bonds are broken, but only one is formed. Long chain 
acyl-CoA synthase from rat is a very interesting protein because it 
has no typical targeting sequence as deduced from its cDNA sequence 
(Suzuki et al, 1990). Also there is no difference in the size of the 
mature protein and the precursor which is synthesised free in the 
cytoplasm. This feature is common in mitochondrial outer membrane 
proteins. The authors also reported that the enzyme could be purified 
not only from mitochondrial outer membrane, but also from microsomes 
and peroxisomal membrane. In each case the proteins have an identical 
molecular weight and an immunogenic similarity. If these results were 
to be believed then this would be the only known enzyme to be 
distributed in three different organelles. The absence of a classical 
targeting sequence to either mitochondria, peroxisomes or endoplasmic 
reticulum is unusual, especially as the enzyme is so widely targeted. 
Doubts must therefore be cast as to the reliability of the 
subcellular fractionations used during the isolation of the enzyme 
from the different organelles. In such procedures contamination from 
fraction to fraction is a common problem (Parsons et al, 1966). 
1.6.2 a-oxidation of long chain saturated fatty acids 
f3-Oxidation, in eukaryotes, takes place both in the peroxisomes 
and in the mitochondrial matrix. The process is carried out by four 
reactions which sequentially remove two carbon units from the 
activated fatty acid in a cyclic manner. The reactions are (i) 
oxidation linked to flavin adenine dinucleotide (FAD), (ii) 
hydration, (iii) oxidation linked to nicotinamide adenine 
dinucleotide (NAD), and (iv) thiolysis by C0A (Fig 1.1). The 
principal reactions involved in the degradation of saturated fatty 
acyl-CoA produce reduced flavin adenine dinucleotide (FADH 2) , reduced 
nicotinaxnide adenine dinucleotide (NADH), and acetyl-CoA. The first 
reaction in each cycle of the 13-oxidation is the oxidation of acyl-
C0A by an acyl-CoA dehydrogenase to give an enol-CoA with a trans 
double bond between C-2 and C-3. The next step is the hydration of 
this double bond by enol-CoA hydratase. This reaction is 
stereospecific and only the L-isomer of 3-hydroxyacyl-coA is formed 
when the trans- 2  double bond is hydrated. The second oxidation then 
takes place converting the hydroxyl group at C-3 into a keto group, 
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Fig 1.1 n-oxidation of medium to long chain saturated fatty acids 
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generating NADH. This oxidation is catalysed by the enzyme L-3-
hydroxyacyl-CoA dehydrogenase, which is absolutely specific for the 
L-isomer of the hydroxyacyl substrate. The final step is the cleavage 
of 3-ketoacyl-00A by the thiol group of a second molecule of C0A, 
which yields acetyl-00A and an acyl-00A shortened by two carbon 
atoms. This thiolytic cleavage is catalysed by 13-ketothiolase. The 
shortened acyl-00A then goes through further cycles of degradation 
using the same enzymes (since they are not specific to chain length) 
until, on the last cleavage the acyl-00A remaining is either also 
acetyl-00A (in the case of even numbered fatty acids) or propionyl-
C0A (in the case of the less common odd numbered fatty acids). In 
such cases the propionyl-00A is converted into succinyl-00A, firstly 
by carboxylation to yield D-methylmalonyl-00A at the expense of one 
ATP, (catalysed by propionyl-CoA carboxylase). The D-isomer is then 
racemised to the L-isomer of methylmalonyl-CoA, which is the 
substrate for the methylmalonyl-00A mutase enzyme which converts it 
into succinyl-00A. The succinyl-00A is then ready to enter the citric 
acid cycle. 
The number of ATP molecules obtained from the complete 
oxidation of a typical long chain fatty acid such as palmitate (a C-
16 saturated fatty acid) can be calculated. The complete degradation 
of palmitate requires seven reaction cycles yielding 8 molecules of 
acetyl-00A. Three molecules of ATP are generated for each NADH that 
is oxidised, two for each FADH2 and 12 for each acetyl-00A being 
completely oxidised by the citric acid cycle. Hence the total yield 
of ATP, calculated from the stoichiometric equation of oxidation, is 
131 molecules of ATP per molecule of palmitate. 
Palmitoyl-00A + 7 FAD + 7 NAD + 7 C0A + 7 H20 	--I- 
8  acetyl-00A + 7 FADH2 + 7 NADH +7 H+ 
However during the activation of palmitate two high energy 
bonds are used up so the net gain of ATP from the complete oxidation 
of palmitate is 129. 
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1.6.3 a-oxidation of long chain unsaturated fatty acids 
The oxidation of unsaturated fatty acids requires two 
additional enzymes. The first is an isomerase which converts a double 
bond in the cis configuration to a trans configuration by 










Trans- 2 -Enol-CoA 
This reaction occurs prior to hydration by enoyl-CoA hydratase 
(section 1.6.2). This means that after hydration both L- and D-
isomers will exist since the enzyme also hydrates a cis-1 2 double 
bond, but the product then is the D-isomer which is not a substrate 
for the next enzyme. An epimerase must therefore be used to change 
the D-isomer to the L-isomer which, as indicated above is the only 
substrate of the L-3-hydroxyacyl-00A dehydrogenase. 
H 	H 	0 
H3C- (CH2 ) 7-C=C-CH2-C-CH2-C-S-00A 
OH 




HH 	OH 	0 
H3C- (CH2 ) 7-CC-CH2--CH2-C-S-CoA 
H 
L-3--Hydroxy-cis-i 5 --enol-CoA 
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1.6.4 By-products of a-oxidation of fatty acids 
Acetyl-CoA, formed by the oxidation of the fatty acids, is 
oxidised by entering the citric acid cycle. It can only do this when 
carbohydrates are also being metabolised. This is because its entry 
into the citric acid cycle depends on the availability of 
oxaloacetate for the formation of citrate. 
In states of fasting, diabetes or extreme exertion, 
oxaloacetate is also used for gluconeogenesis and is therefore 
unavailable for condensation with acetyl-coA. 
Acetyl-00A is indirectly responsible for the activation of the 
enzyme pyruvate carboxylase. This enzyme catalyses the first reaction 
in the glucogenic pathway ie the formation of oxaloacetate from 
pyruvate. Pyruvate carboxylase has biotin as a prosthetic group, 
which must first be carboxylated before it can catalyse the reaction. 
Biotin can only be carboxylated when acetyl-00A is associated with 
the enzyme, although acetyl-00A plays no further part in the 
formation of oxaloacetate. Therefore when acetyl-00A is abundant in 
the liver the glucogenesis will be activated. 
Under such conditions acetyl-CoA is diverted to the formation 
of ketone bodies (acetoacetate, D-3-hydroxybutyrate). Acetoacetate is 
formed from acetyl-CoA in three steps. Firstly two molecules of 
acetyl-00A condense to form acetoacetyl-00A. 
Thiolase 
0 	 0 -. 	0 	0 
H3C-3-S-CoA + H3C--S-CoA ------H3C--CH2--S-CoA + C0A 
Acetyl-00A 	Acetyl-00A 	 Acetoacetyl-CoA 
This reaction, which is catalysed by thiolase, is a reversal of 
the thiolysis step in the oxidation of fatty acids (Fig 1.1). 
Acetoacetyl-CoA then reacts with acetyl-CoA and water to give 3-




H3C--S-CoA + H20 	C0A 
q 	o 	 -0 	 CH3 





The unfavourable equilibrium in the formation of acetoacetyl-
CoA is overcome by the favourable equilibrium of this reaction, which 
is due to the hydrolysis of a thioester linkage. 3-Hydroxy-3-
methylglutaryl-00A is then cleaved to acetyl-CoA and acetoacetate. 3-
Hydroxybutyrate is formed by the reduction of acetoacetate in the 
mitochondrial matrix and is dependent on the NADH/NAD+ ratio inside 
the mitochondrion. The acetoacetate also undergoes slow but 
spontaneous decarboxylation to acetone. 
CH3 	0 
II 
00C-CH2 -COH-CH 2 -C-S-00A 
3-hydroxy-3- 
methylglutaryl-coA 
H 	 H+ + 











D-3-Hydroxybutyrate 	Acetoacetate 	 Acetone 
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1.6.5 control of fatty acid 3-oxidation 
The simplified pathway for the oxidation of fatty acids in the 
liver has three expected control points. 
Fatty acid -. acyl-00A -- -0 /3-oxidation —a ketone bodies 
The first point of control is at the partitioning of acyl-CoA 
between esterification to glycerol and esterification to carnitine 
outside the mitochondrial perrneabil1y barrier. This step is 
controlled by the activity of overt carnitine palmitoyltranaferase I 
(CPT I). The second branchpoint is at the level of acetyl-00A. 
Acetyl-00A can either form citrate or acetoacetyl-00A. Citrate can 
either be used in the Krebs cycle or efflux to the cytosol. Under 
conditions of high flux, CO2 production in the citric acid cycle from 
fatty acid oxidation accounts for only about 5% of total acetyl-00A. 
The third point of control is at the intermediate between 
acetoacetyl-CoA and acetoacetate, 3-hydroxy-3-methylglutaryl-CoA 
(HMG-CoA). HMG-00A synthase can undergo 1 reversible inhibition by 
succinylation, but this is likely to have a small influence on flux 
20%). 
The main control point of fatty acid 13-oxidation is at the CPT 
step. This step is catalysed by two enzymes, carnitine 
palmitoyltransferases (CPT) I and II. It is CPT I which is 
responsible for the control of the transport of medium to long chain 
fatty acids into the mitochondrial matrix. 
As discussed earlier, the oxidation of medium to long chain 
fatty acids takes place within the mitochondrial matrix (section 
1.6.2). Free fatty acids in the cytosol are readily activated to 
their C0A esters on the mitochondrial outer membrane surface by long 
chain fatty acid C0A synthase (section 1.6.1). The mitochondrial 
outer membrane is permeable to molecules of molecular weight less 
than or equal to 10000 (section 1.11.1), and is therefore permeable 
to activated fatty acids. The inner membrane however, is not 
permeable to activated fatty acids and a method of transport is 
required. This is facilitated via an acyl-carnitine/carnitine 
translocase. The acyl group is cleaved from the C0A and 




0 	 I 	I 
R--S-CoA + H3C-N-CH2-C-CH2-COO 










The acyl-carnitine is then translocated into the mitochondrial 
matrix via the carnitine-acylcarnitine translocase. The reaction is 
then reversed by carnitine palmitoyltransferase II (CPT II), 
resulting in reformation of activated fatty acid and in so doing the 
releasing of free carnitine. 
Factors governing the activity of CPT I include the 
availabilities of carnitthe, glycerol-phosphate and the relative 
affinities of the two pathways for carnitine. 
Acyl-glycerol-phosphate production is catalysed by the enzyme 
glycerol phosphate acyltransferase (GPAT). It occurs, in different 
isoforms, as mitochondrial and microsomal enzymes, that are reliant 
on the level of glycerol phosphate present. This can either be 
supplied from glycerol in the blood or synthesised from glucose-6-
phosphate. The affinity of GPAT for acyl-00A is not as high as the 
affinity of carnitine for acyl-00A. Therefore when acyl-00A is 
abundant, the carnitine system (if not inhibited) has preferential 
choice of the acyl-CoA over the GPAT system. 
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1.6.6 Control of CPT I 
The activity of CPT I is governed by four factors. The amount 
of CPT I present; the amount of carnitine present; the Vmax of CPT I; 
and whether or not there are activators or inhibitors affecting its 
activity. 
McGarry and Foster (1977) reported the potent inhibitory affect 
of malonyl-00A on CPT I as a key component in the regulation of 
hepatic fatty acid oxidation and ketogenesis. The characteristics of 
this inhibition are of a competitive nature with respect to 
palmitoyl-00A. This competitive inhibition is however not straight 
forward since malonyl-CoA and palmitoyl-00A appear to bind to 
different active sites. Rather than sterically inhibiting the binding 
of each other, they seem to change the kinetics of binding via a 
conformational change in the protein. 
The physiological importance of such inhibition can be related 
to changes in CPT I activity during different physiological states 
(section 1.3). During carbohydrate feeding (high insulin; low 
glucagon/insulin ratio) adipose tissue lipolysis is suppressed and 
plasma free fatty acids (FFA) are low. Within the liver carbon flow 
through acetyl-00A carboxylase is brisk, resulting in an elevated 
concentration of malonyl-00A and a high rate of lipogenesis. Because 
of the inhibitory effect of malonyl-00A on CPT I, newly formed long 
chain acyl-CoAs are prevented from entering the mitochondria for 3-
oxidation, and are instead directed into triacylglycerol synthesis 
and VLDL formation. A futile cycle involving the simultaneous 
oxidation and synthesis of fatty acids is thus avoided. 
Conversely, 	in 	ketotic 	states 	(low 	insulin; 	high 
glucagon/insulin ratio) lipolysis in adipose tissue is stimulated and 
plasma FFA levels rise. Simultaneously, because of cAMP mediated 
interruption of carbon traffic through glycolysis and acetyl-00A 
carboxylase in liver, the tissue concentration of malonyl-CoA falls 
dramatically and fatty acid synthesis is much diminished. Such 
conditions allow for the de-repression.of CPT I, accelerated fatty acid 
oxidation and a marked increase in the production of acetoacetate and 
0-hydroxybutyric acid. Once the ketogenic machinery of the liver is 
activated the output of ketone bodies is governed principally by 
delivery of fatty acids to the liver. 
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1.7 Ketone bodies are energy sources within peripheral 
tissues 
Acetoacetate and 3-hydroxybutyrate are major fuels in the body 
for respiration and are quantitatively important as a source of 
energy (section 1.2). Indeed heart muscle and the renal cortex prefer 
acetoacetate to glucose, and during starvation the brain (which in 
the normal, fed state utilises glucose) can adapt to using 
acetoacetate for 75% of its energy requirements. During starvation, 
extreme exertion or diabetes the ketone bodies are released into the 
blood stream to reach the major tissues that require energy. 
Interestingly the intermediates 3-hydroxy-3-methylglutaryl-00A 
(in cholesterol synthesis) and malonyl-00A (in fatty acid synthesis) 
are products formed from acetyl-00A on its reconstitution once 
outside of the mitochondrion. Obviously in times of starvation 
neither fats or cholesterol would be synthesised to any great extent 
so ketone bodies would be produced. 
1.8 Synthesis of fatty acids, cholesterol and isoprenol 
from acetyl-00A 
When the cell requires acetyl-00A for biosynthetic purposes, it 
combines with oxaloacetate in the mitochondrial matrix to form 
citrate which can efflux from the mitochondrion on the tricarboxylate 
carrier. 
In the cytosol, acetyl-00A is again formed by the action of 
citrate lyase. Both fatty acids and cholesterol can then be 
synthesised. The carboxylation of acetyl-00A to malonyl-00A by 
acetyl-00A carboxylase is an irreversible reaction and a committed 
step to long chain fatty acid synthesis. 
Acetyl-00A 
carboxylase- 
0 	 HCO3 	 0 
if ii 
H3C-C-S-00A + ATP ----k 00C-CH2-C-S-00A + ADP + Pi + H 
Acetyl-00A 	 Malonyl-00A 
The synthesis of long chain fatty acids is carried out by 
sequential additions of malonyl-00A. The enzyme responsible for the 
elongation of the fatty acid is fatty acid synthase. In mammals this 
consists of two polypeptide chains each of which has several enzymic 
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activities (multifunctional proteins). One subunit has covalently 
attached pantothenic acid as a prosthetic group. This compound is a 
constituent of C0A, and contains a aulphydryl group to which the 
fatty acids combine as thioesters. This is unlike the enzymes 
responsible for the oxidation of the fatty acids which show no enzyme 
complex formation. The first committed step towards cholesterol and 
isoprenol synthesis is the formation of mevalonate from 3-hydroxy-3-
methylglutaryl-00A. 
HMG-00A 
CH3 0 	Reductase 	 CH 
I 	 II ' 
00C-CH2 -C-CH2-C-S-CoA -------- -' 00C-CH2-C-CH2 -CH2OH 
oH 	 OH 
3-hydroxy-3- 	 Mevalonate 
methylglutaryl-00A 
The enzyme responsible for this reaction is 3-hydroxy-3-
methylglutaryl-00A reductase (HMG-00A reductase). It is a 97 kDa 
integral membrane protein, that contains seven hydrophobic membrane 
spanning regions and a binding site for cholesterol. The accomodation 
of cholesterol in the binding site causes end product inhibition by 
making the enzyme more susceptible to degradation rather than 
directly inhibiting the activity of the enzyme. Another level of 
control of HMG-00A reductase is effected by insulin and glucagon 
(insulin being the more dominant). This is thought to be via 
phosphorylat ion-dephosphorylat ion of the enzyme causing deactivation 
and activation respectively. 
1.9 Protein targeting 
The structure within the eukaryotic cell is highly organised, 
and contains many highly specialised organelles, each of which is 
separated from the cytosol by at least one phospholipid membrane 
bilayer. The vast majority of polypeptides are synthesised on 
polysomes in the cytosol. This creates a two fold problem for protein 
targeting within the cell. Firstly, newly synthesised proteins must 
be localised to their specific destination and not elsewhere within 
the cell, creating the need for a highly specific and efficient 
address system on the protein. Secondly, organelle proteins have to 
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be translocated into or across biological membranes by processes 
which are poorly understood. Several different targeting pathways 
coexist within eukaryotic cells. The biogenesis of many organelles, 
such as vacuoles, Golgi bodies and the plasma membrane, depends upon 
delivery of proteins via branches of the secretory pathway and in 
these cases the initial targeting steps occur at the endoplasmic 
reticulum (von Heijne, 1986). Transport of proteins into other 
organelles including mitochondria, peroxisomes and the nucleus, 
occurs directly from the cytoplasm and therefore requires a vast 
range of different primary targeting sequences incorporated within 
the precursor protein. 
1.9.1 Cytosolic protein targeting to the nuclear 
envelope 
Targeting sequences that direct proteins to the nucleus have 
been reported by Silver (1991) to consist of short sequences rich in 
basic amino acids. The nuclear targeting sequence is present in the 
mature protein, which depicts a fundamental difference in its 
targeting pathway compared to other targeting pathways. This property 
can be rationalised by observing that, during mitosis, the nuclear 
membrane of many organisms breaks down into vesicles with the result 
that the soluble components of the nucleus are released into the 
cytosol. These components are reabsorbed via their targeting pathways 
after reformation of the nuclear envelope. 
1.9.2 Cytosolic protein targeting to the peroxisomes 
Peroxisomes are vesicular organelles which belong to the 
microbody family, and contain a varying array of oxidative enzymes. 
Peroxisomes are found universally in eukaryotes although in many 
cases their biological role is unclear. They are particularly 
abundant in the methylotrophic yeasts such as Hansenula polymorpha. 
When this yeast is grown with methanol as a sole carbon source, it 
undergoes a massive induction of methanol oxidase which forms 
crystalline arrays in enlarged peroxisomes. Proteins are imported 
into peroxisomes directly from the cytosol. Many of these proteins in 
higher eukaryotes have been found to contain a C-terminal tripeptide 
targeting signal, serine-lysine-leucine (Ser-Lys-Leu), or a closely 
related sequence (Gould et al, 1989). It has also been shown by Gould 
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et a.Z (1990), that firefly luciferase, an insect peroxisomal protein, 
is efficiently targeted to peroxisomee when expressed in the yeasts 
H. polymorpha and Saccharomyces cerevisiae, indicating that targeting 
to peroxisomes has been well conserved throughout eukaryotic 
evolution. 
1.9.3 Cytosolic protein targeting to the aitochondria 
(For review Glover and Lindsay, 1992) 
Within the mammalian cell targeting of proteins to mitochondria 
is made complicated by the complexity of the organelle. The 
mitochondria are comprised of two membranes an inter-membrane space 
and a matrix, all of which require specific proteins to be targeted 
accurately (Fig. 1.2). The mitochondrial targeting sequence is 
located at the N-terminus of a protein and is usually 20 - 25 amino 
acids long. Mitochondrial targeting sequences are characterised by a 
lack of acidic amino acids and a predominance of basic amino acids, 
and are predicted under biological conditions to form alpha helices. 
The targeting sequence is usually removed by a protease in the 
mitochondrial matrix. By following the behaviour of fusion proteins 
the targeting sequences have in several cases been shown to target 
proteins which are normally extramitochondrial. For example it was 
shown by Walker et al, (1990) that the mouse cytosolic protein 
dihydrofolate reductase (DHFR) could be targeted to mitochondria by a 
fusion with the first 15 amino acid residues of the j-subunit of 
mitochondrial AT? synthase. The authors also reported that when a 
larger leader peptide was fused from the AT? synthase (35 amino 
acids) to DHFR, proteolytic processing was also observed. 
1.10 Mitochondrial biogenesis 
The mitochondria are generally thought to have originated from 
a symbiotic prokaryote. This prokaryote allowed the earliest 
eukaryotes, otherwise anaerobes, to utilise oxygen. The mitochondrial 
genome is still replicated independently of nuclear chromosomes and 
is inherited maternally in all mammals. Over 90% of DNA contained 
within the mitochondrion has, during the passage of time, either been 
translocated to, or copied into the nucleus of the cell, making the 
mitochondrial version redundant. 
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The nuclear encoded mitochondrial proteins are synthesised on 
cytosolic polysomes as precursor proteins, and are then translocated 
to their functional destination in one of the four mitochondrial 
compartments. 
1.11 Translocation of precursor proteins into 
itochondria 
Translocation of precursor proteins into mitochondria is a 
multi-step process. This has been shown by accumulating translocation 
intermediates at different stages of the import pathway into 
mitochondria. This approach has allowed the identification of 
distinct functional steps in protein import. 
1.11.1 ATP dependent unfolding of precursor proteins 
Precursor protein was accumulated in contact sites (section 
1.11.3) in a two membrane spanning manner by Schleyer and Neupert 
(1985). They reported that the amino terminus of the precursor 
protein had entered the mitochondrial matrix where it was processed 
by a processing peptidase. They also demonstrated that the carboxyl 
terminus was still outside the mitochondrion by its susceptibility to 
proteolytic cleavage. The protein they used in their experiments was 
F1-ATPase j3-subunit which in a mature form has a diameter far smaller 
that the distance between the two membranes. This suggests that the 
precursor protein must have been incompletely folded, to enable it to 
span both membranes. It was also shown that depletion in vitro of 
NTPs (AT? and GTP) prevents protein import and that re-addition of 
NTP8 restores import (Pfanner and Neupert, 1986; Pfanner et al, 
1987a; Chen and Douglas, 1987; Eilers et al, 1987). The requirement 
for NTPs was shown to be independent of membrane potential by the 
import of the mitochondrial protein porin which requires NTPs but 
does not require a membrane potential (Kleene et al, 1987). Porin 
does not require a membrane potential because it does not cross the 
inner mitochondrial membrane during its translocation. It has also 
been shown that precursor protein treated with small quantities of 
protease, in the absence of mitochondria, was more sensitive to 
digestion in the presence of NTPs. This is possibly because they are 
more loosely folded than their non-protease treated counterparts and 
do not need to be further unfolded (Pfanner et al, 1987a). Different 
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lengths of precursor protein, with the same targeting sequence, have 
been shown to require differing quantities of NTPs. However once the 
precursor protein has been inserted into the mitochondrial outer 
membrane it no longer requires NTPg. The authors suggested that NTPs 
are required in the unfolding of precursor proteins possibly via a 
NTP dependent unfoldase resident in the cytoplasm or associated with 
the mitochondria. Precursor proteins once in an unfolded state must 
remain so until translocation has been completed. The unfolded or 
loose conformation is thought to be maintained by a group of proteins 
called molecular chaperones which are contained in the cytosol, 
(including heat shock protein 70 (HSP70)J which bind to the precursor 
polypeptide. When the precursor proteins appear in the mitochondrial 
matrix they become associated with mitochondrial Hsp70 proteins (Kang 
et al, 1990; Scherer et al, 1990). It is suggested that this 
interaction provides the main driving force for transport subsequent 
to the translocation initiation event mediated by the targeting 
sequence (Fig 1.3). The precursor protein is then passed on to HSP60 
proteins in the mitochondrial matrix which are thought to assist in 
the correct folding of the mature protein. ATP hydrolysis is 
associated with the release of polypeptides from each of these heat-
shock proteins. It has also been suggested that this model may have 
relevance in the transport of polypeptides across other eukaryotic 
membranes. Substantiating this claim are reports that heat-shock 
proteins have also been implicated in other transport pathways, 
although their exact function has not been elucidated. 
1.11.2 Specific recognition of precursor proteins 
The mitochondrial outer membrane contains receptor proteins 
which are thought to bind mitochondrial targeting sequences. It has 
been known for some time that mild pre-treatment of mitochondria with 
protease prevented the import of precursor, (for review see Pfariner 
and Neupert, 1987a). Recently, the binding of ADP/ATP carrier to 
mitochondria has been resolved into two sequential steps (Pfanner and 
Neupert, 1987b; Pfanner et al, 1987a; Söllner et al, 1988). The 
precursor first reacts with protease sensitive receptors on the 
mitochondrial surface where it remains accessible to externally added 
proteases or antibodies. 
OR 
-S. 
Fig. 1.3 Trans].ocation of precursor protein across the mitochondrial 







Precursor proteins initially" bind to a receptor in the outer membrane. 
Translocation is then initiated by -dependent insertion of the N-
terminus through contact sites between the outer and inner membrane. The 
precursor proteins are maintained in a 'loose' unfolded state by 
interaction of HSP 70 proteins. Mitochondria HSP 70 (mHSP 70) bind the 
precursor protein as it appears in the mitochondrion matrix. Neupert et 
al (1990) suggested that the binding of mHSP 70 proteins provides the 
driving force for translocation after the initial Acc-dependent 
insertion. 
26 
The precursor then inserts into a protease protected site in the 
outer membrane which are sometimes referred to as general insertion 
proteins (GIP). Pfanner et al, (1988), calculated the number of 
receptor sites to be approximately 0.25 pmol/mg mitochondrial protein 
and the number of GIP sites to be around 2.5 pmol/mg mitochondrial 
protein. They also reported that although other proteins such as 
porin, ADP/ATP carrier, the bc1 and iron sulphur (Fe-S) complex of 
the respiratory chain had different receptor proteins, they were all 
inserted by the same GIP protein. The only protein that did not 
require GIP for insertion was cytochrome C which seemed to use a 
completely separate insertion pathway. More recently a number of 
proteins have been identified in the mitochondrial protein 
translocation pathway both in S. cereviaiae and Neurospora crassa 
(Baker and Schatz, 1991; Pfanner et al, 1991) These proteins seem to 
function as a complex of 400-600 kDa (Kiebler et al, 1990). This 
complex includes the receptor proteins M0M72 and MOM19 (Söllner et al 
1989), an integral transport protein M0M38 (ISP 42) and an outer 
membrane polypeptide M0M22. A possible mechanism for translocation 
was suggested by Neupert et al, (1990), whereby precursor 
polypeptides synthesised in the cytosol are recognised by receptors 
on the mitochondrial surface. Translocation is initiated by insertion 
of the N-terminal targeting sequence of these polypeptides into the 
outer membrane of the mitochondrion. In response to the transmembrane 
potential difference, generated by the respiratory chain, the N-
terminus crosses the inner membrane, resulting in the unfolding of 
the membrane spanning domain. 
1.11.3 Import of precursor proteins via translocation 
contact sites 
The accumulation of precursor proteins in contact sites between 
both mitochondrial membranes was reported by Schleyer and Neupert 
(1985). Their experimental evidence showed sites of close contact 
between both mitochondrial membranes. A role for co.tact sites had 
first been proposed by Kellems et al, (1975). Three distinct methods 
were used to produce translocation intermediates spanning both 
membranes; import of precursor proteins at low temperature; pre 
binding of antibodies to the carboxyl terminus of precursor proteins; 
and import of precursor proteins at low levels of NTPs. The arrested 
27 
trans].ocation 	intermediates were then examined 	for their 
accessibility to the matrix processing protease, to externally added 
proteases and to antibodies in order to show that the precursor 
protein had in fact partly traversed both mitochondrial membranes. 
Thus even when precursor unfolding was taken into consideration, the 
two membranes had to be in very close proximity to each other. These 
points of close proximity are referred to as contact sites. 
1.11.4 The insertion of precursor protein into 
translocation sites requires a membrane potential 
The completion of precursor translocation into the inner 
membrane or matrix is independent of membrane potential (Schleyer and 
Neupert, 1985; Pfanner et al, 1987b). As described in section 1.11.3, 
binding of precursor protein and insertion are independent of 
membrane potential, suggesting that the only step of translocation 
which requires a membrane potential is the initial insertion of the 
precursor protein into the inner membrane. This step usually requires 
a positively charged pre-sequence which is a targeting leader 
peptide. However it has been shown by Pfanner and Neupert (1985) that 
only the electrical component of the total protonmotive force () 
and not the chemical component (pH), is required for protein import. 
The authors concluded from this that the membrane potential across 
the inner membrane (negative inside) exerts an electrophoretic effect 
on positively charged regions of the precursor proteins thereby 
triggering the initial entrance of precursor into the inner membrane. 
1.11.5 Conservative sorting of precursor proteins 
In the mitochondrial matrix the amino-terminal presequence of 
the precursor protein is proteolytically removed by the matrix-
processing peptidase (MPP), a soluble 57 kDa protein. A 52 kDa inner 
mitochondrial membrane associated protein, the processing enhancing 
protein (PEP), greatly enhances processing of the precursors. It is 
thought that PEP binds the precursor and presents it for processing 
in the correct orientation for the peptidase. Several proteins are 
processed in two steps. The first step has been described as a 
cleavage of presequence by the MPP. The second cleavage may also be 
performed by this peptidase (Schmidt et al, 1984) or by the 
processing activities located in the intermembrane space (Hartl et 
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al, 1987). For example cytochrome C1, cytochrome c peroxidase and 
cytochrome b2 undergo a second cleavage in the intermembrane space. 
These precursor proteins contain an uncharged stretch of around 20 
amino acids in the second part of their presequences, which is 
involved in the intramitochondrial sorting of the precursor. Two 
models have been proposed for the function of these interinembrane 
space targeting sequences. Firstly they could act as atop transfer 
sequences that allow only the N-terminus of the precursor to cross 
the inner membrane, leaving the majority of the protein ie. the 
mature protein, in its functional location outside the inner membrane 
(Reid et al 1982). Alternatively it may act, as suggested by Hartl et 
al,(1987) in a manner depicted in Fig 1.4. The precursor proteins are 
imported through a hydrophilic membrane environment via translocation 
sites into the mitochondrial matrix. The positively charged first 
half of the presequence is then removed by the MPP. The protein 
together with the hydrophobic second part of the presequence is then 
redirected back across the inner membrane. On the outer surface of 
the inner membrane the second proteolytic cleavage is performed. 
Cytochrome b2 is then released as a soluble protein into the 
intermembrane space, whereas cytochrome c1 is anchored to the inner 
membrane via a hydrophobic sequence at the extreme C-terminus of the 
mature protein. These results can be rationalised in terms of the 
endosymbiotic origin of the mitochondria. In the prokaryotic 
ancestor, periplasmic proteins were synthesised in the cytoplasm, 
which corresponded to the mitochondrial matrix. These proteins had a 
signal sequence similar to the hydrophobic second half of the 
mitochondrial presequence. When the genes of the endosymbiont were 
transferred to the nucleus of the host after the endosymbiotic event, 
proteins requiring to be translocated into the endosymbiotic 
organelle were endowed with a hydrophilic targeting signal. This 
enabled import via contact sites into the organelle matrix. 
Precursors that were therefore translocated into the organelle matrix 
could then follow their ancestral sorting and assembly pathways. It 
is for this reason that this type of import and sorting has been 
named conservative sorting (Hart 1 and Neupert, 1990). 
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After translocation (Section 1.11.4) of the precursor protein into 
the mitochondrial matrix, the N-terminal mitochondrial targeting 
sequence is cleaved by a matrix processing peptidase (MPP). This 
leaves a second sequence that targets the precursor protein to the 
intermembrane space. A second peptidase then proteolytically removes 
the second sequence leaving the mature protein either free in the 
interniembrane space or anchored to the inner membrane. 
30 
1.12 Protein topology within membranes 
Membrane-spanning domains are usually considered to consist of an 
uninterrupted series of 22-26 hydrophobic amino acids (Gierasch, 
1989). The yeast mitochondrial outer membrane protein 0MM 70 (MAS70) 
was shown by Gierasch (1989) to contain a uninterrupted stretch of 29 
hydrophobic amino acids in the first 38 amino acids of its N-terminal 
sequence. 
Li and Shore (1992) however reported that only the first 19 
amino acids of this hydrophobic stretch were required for 
transmembrane orientation of the protein. The orientation of 0MM 70 
in the mitochondrial outer membrane has its N-terminus exposed to the 
intermembrane space and its C-terminus exposed to the cytoplasm (Nj-
Ccyt). 
A hybrid protein was constructed by Li and Shore (1992) where 
the N-terminal amino acids (1 through 29) of OHM 70 were fused, in-
frame, to a cytosolic reporter protein DHFR. The fusion protein was 
targeted to the mitochondrion and was translocated into the outer 
membrane. However, the 19 amino acid membrane spanning domain was 
reversed in its topology (NcytCin ). 
Typically, tranemembrane sequences are flanked by highly 
charged stretches of amino acids (von Heijne, 1985; von Heijne, 
1986). These stretches are usually 10 to 15 residues long, and 
generally the more positive of the two flanking portions faces the 
cytosol. Where there is more than one transmembrane sequerice, the 
orientation of them all is determined by the most N-terminal one 
(Hartmann et al, 1989). 
Parks and Lamb (1991) reported that the removal of positive 
charges from the N-terminal side of the membrane spanning domain of a 
Ncyt-C n protein changes the topology to NinCc yt. Addition of 
positive charges at the C-terminal side however had little effect. 
The authors concluded from this that eukaryotic membrane protein 
topology is governed by the presence or absence of a N-terminal 
signal for retention in the cytoplasm that is composed in part with 
positive charges. 
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1.13 Common genes for proteins located in different 
compartments within the cell 
The existence of single genes that encode two (or more) 
polypeptide products has been documented in yeast (Penman and 
Halverson, 1981), mammals (Suzuki et al, 1989) and viruses (Kozak, 
1986). For example the SUC2 gene, described by Penman and Halverson 
(1981), encodes distinct yeast invertase mRNAe for secreted and 
cytoplasmic invertase. Until recently similarly functioning proteins 
in different compartments were thought to be encoded by different 
genes. This conclusion was based on the biochemical properties or 
electrophoretic mobility of the proteins. It should be noted however 
that proteins which are translocated across organelle membranes often 
undergo modifications which could account for differences in the 
mature proteins. In addition, further evidence for the existence of 
more than one message being encoded for by a single gene is 
accumulating. The existence of genes containing more than one 
transcription initiation site, multiple translation starts or single 
mRNAs that under go RNA processing such as splicing have now been 
documented. Thus one gene can produce two proteins that differ in 
location, molecular weight, electrophoretic mobility and other 
properties. 
1.13.1 RNA processing (splicing) 
Alt et al, (1980) reported that B lymphocyte tumour cells 
directed the synthesis of two forms of i heavy chain, one with a 
molecular weight of 67 kDa and one of 64 kDa. When the B cells were 
converted into 1gM secreting cells it was shown that membrane bound 
1gM contained the 67 kDa heavy chain (A-m) and secreted 1gM contained 
the 64 kDa heavy chain (A-s). The authors reported that cells which 
produced both proteins did so via two mRNAs with different 3 ends. 
Rodgers et al, (1980) reported that during differentiation B 
lymphocytes underwent a shift from membrane bound 1gM synthesis to 
secretory 1gM synthesis. They also reported the presence of splicing 
sites at the 3 end of the fourth constant region of the i gene (C4) 
where the z-m and -s cDNAs diverge, suggesting that the two species 
of mRNA were manufactured from the same transcript by differential 
RNA splicing. Early et al, (1980) reported that the only splicing 
that occurs in the C4 boundary is in the -m mRNA. The authors 
32 
presumed that the role of this splicing reaction was to introduce a 
membrane binding sequence which would anchor the 1A chain to the B 
lymphocyte membrane. The system would presumably operate by an 
inducible positive (or negative) regulator molecule that would 
facilitate the shift from p-m to s-s. This control of antibody 
secretion is probably not unique to 1gM, and is possibly conserved 
throughout a wide spectrum of lymphocyte secretion of antibody. 
Indeed a similar method of control was reported for 1gB by Yaoita et 
al, (1982) involving RNA splicing and possibly a DNA rearrangement. 
1.13.2 Double start Bites at the transcriptional level 
Wu and Tzagoloff, (1987) reported that disruption of the 
chromosomal copy of the FUM1 gene in S. cerevisiae, caused a 
respiratory defect, due to an absence of fumarase in the 
mitochondria, and an absence of cytoplasmicfumarase. The authors 
concluded that the FUM1 gene encoded both mitochondrial and 
cytoplasmic fumarase. Sequencing of the FUM1 gene revealed multiple 
start codons (ATG8), some of which were in the coding region of the 
gene. Two mRNAs were also found which differed in length by several 
hundred nucleotides. However, only the more abundant, longer 
transcript was detected by a probe from the 5' end of the gene. Given 
this evidence the authors suggested that the shorter transcript was 
transcribed further downstream from the initial ATG and translation 
initiated from other ATG sites. This was in accord with the 
translation product from the longer transcript being targeted to the 
mitochondria, since the sequence of amino acids encoded by the 5' end 
of the gene were generally basic (3 arginine, 3 lysine), hydroxylated 
(3 serine, 2 threonine) and lacked any acidic residues. This is in 
accordance with classical mitochondrial targeting sequences. 
Another example of double transcriptional start sites, was 
described by Natsoulis et al, (1986). They reported that both 
cytoplasmic and mitochondrial histidine-tRNA synthetases were encoded 
by a single gene, HTS1. In this case, as with the fumarase from S. 
cerevisiae, the two proteins are encoded by different length mRNAs. 
The shorter mRNA encodes the cytoplasmic protein and the longer mRNA 
encodes the mitochondrial counterpart. The translation initiation 
sites of the two transcripts are located 60 base pairs (bp) apart 
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resulting in a 20 amino acid leader peptide on the mitochondrial 
protein which is basic in nature. 
1.13.3 Multiple translational initiation sites 
tRNA-modification enzymes in yeast have been shown to be common 
to mitochondria, cytoplasm and nucleus. This suggestion was based on 
indirect data obtained by studying the effect of nuclear mutations in 
the trml gene in activating the first enzyme in both mitochondria and 
cytoplasm, and in the trm2 gene causing the damage of the second 
enzyme in both cellular compartments (Hopper et al, 1982). The sante 
conclusion may be true for the mod5 gene, which controls the 
isoprenylation of both cytoplasmic and mitochondrial yeast tRNA 
(Martin et al, 1982; Dihanich et al, 1987). Recently the genes for 
the yeast tRNA modifying enzymes have been cloned confirming that 
both the mitochondrial and cytoplasmic enzymes are encoded by the 
same genes (Dihanich et al, 1987; Najarian et al, 1987). Najarian et 
al (1987) also reported that the mod5 gene may encode two proteins, 
one of which is a mitochondrial form with an amino terminal extension 
of basic charge. Although mRNAs of heterogeneous size are transcribed 
from this gene, all of them initiate upstream of the first ATG codon 
of the open reading frame. It was therefore suggested by the authors 
that mod5 transcripts generated two proteins through differental 
translation. This would mean that initiation at the first ATG would 
generate a protein with a basic N-terminal extension, whereas 
initiation at the second in-frame ATG located ten codons downstream 
would give rise to the cytoplasmic-nuclear form of the same enzyme. 
It was reported by Suzuki et al (1989) that rat liver 
mitochondrial and cytosolic fumarate hydratase which are almost 
equally distributed between the two compartments were encoded by the 
same gene, similarly to yeast fumarase (Wü and Tzagoloff, 1987). 
However under northern blot analysis only one species of mRNA could 
be found. This gave rise to two possibilities. Either the two 
fumerases were encoded by different mRNAS of the same length, or one 
mRNA gave rise to both proteins. The second theory is more 
interesting since there is a second AUG just upstream of GCA, which 
is the codon of the N-terminal alanine of both mature proteins. If 
this second AUG codon does initiate translation then both fumarases 
would be encoded by the same mRNA by differential translation. 
34 
1.14 Carnitine palmitoyltransferases I and II 
As discussed in section 1.6.5 the CPT system is the pivotal 
role in fatty acid metabolism. It has been known for some time that 
both CPT I and II are synthesised in the cytosol and are therefore 
targeted to the mitochondria, and translocated to either side of the 
mitochondrial inner membrane (Brady et al, 1986). 
The exact position of the two enzymes has been the subject of 
great conjecture for many years. However most evidence now points 
towards a CPT system which operates as depicted in Fig 1.5. 
The reactions of the CPT enzymes are freely reversible, and the 
direction of the reaction is dictated by the environment of the 
enzyme. CPT II would appear to be more easily solubilised than CPT I, 
which is therefore presumed perhaps to be an integral membrane 
protein. 
There are many more questions that can be asked about these two 
proteins. For example, are CPT I and CPT II identical proteins; are 
they encoded for by the same gene; and if so, how are they targeted 
to the different locations in the mitochondrion. The answers would be 
an important asset in the understanding of the complex mitochondrial 
targeting system. 
Elucidation of the CPT system would also be of benefit to 
diabetes research. It has been known for some time now that CPT holds 
a pivotal role in the control of fatty acid oxidation (McGarry and 
Foster, 1980). Both starvation and ketotic diabetes have been shown 
to cause a two fold increase in CPT I active protein (Brady and 
Brady, 1987). Along with this increase of CPT I active protein, is a 
desensitisation of CPT to inhibitors, such as malonyl-CoA (Grantham 
and Zammit, 1988; Kolodziej and Zammit, 1990a) This is thought to be 
related to membrane fluidity, which is altered by a decrease of 
cholesterol incorporation into the membranes. 
1.15 Aims of this project 
The aim of this study was to examine the CPT system in order to 
elucidate the connection or distinction between the two rat liver 
mitochondrial CPT enzymes. The enzymes would have to be extracted 
from their membrane environments, purified, and then used to clone 
the gene (or genes) encoding them. 
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CoA-SH 
Fig. 1.5 	The uptake of long chain length fatty acids by the 
nitochondrjon for fl-oxidation 
acyl-CoA 
acyl-CoA 
Activated fatty acids are permeable through the outer mitochondrial 
membrane. Carnitine palmitoyltransferase I (CPT I) then catalyses the 
esterification of carnitine to the fatty acid with the release of 
CoASH. The acyl-carnitine is then translocated through the inner 
membrane by a antiport translocase. Carnitine palmitoyltransferase II 
(CPT II) then reverses the previous reaction reforming the activated 
fatty acid and releasing carnitine to be translocated back out of the 
matrix. The activated fatty acid is then ready to be oxidised in the 
mitochondrial matrix (Murthy and Pandy 1987a & b). 
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One of the main objectives of this study to elucidate which of 
the mitochondrial membranes contained CPT. Comparisons of rat liver 
mitochondrial CPT I, CPT II and other known acyl-transferases could, 
be made in order to establish relationships, and possible ancestral 
roles of the system involved in fatty acid oxidation within 
eukaryotes. 
Inhibition studies on the two enzymes could be carried out and 
when compared to other acyl-transf erases would gradually build up a 
more complete picture of the CPT system in rat liver mitochondria. 
Finally a mechanism for the uptake of long chain fatty acids by 
rat liver mitochondria could be more correctly conceptualised. 
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CHAPTER 2 
MATERIALS AND METHODS 
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CHAPTER 2 
Materials and Methods 
2.1 MEDIA 
2.1.1 Media for Escherichia coli 
Luria broth; Dif Co Bacto tryptone, 10 g; Difco Bacto yeast extract, .5 
g; NaCl, 5 g; MgSO4, 6 g; per litre. 
Luria agarAs luria broth with 15 g Difco Bacto agar per litre. 
Luria top agar, A8 luria broth with S g Difco Bacto agar per litre. 
Ampicillin, kanamycin and tetracycline, were added to the media 
immediately prior to use, to final concentrations of 100, 25, and 25 
ig/ml respectively. 
2.1.2 Media for Saccharomyces cerevisiae 
YPD Yeast extract 10 g; peptone 20 g; glucose 20 g per litre. Plates 
were made by adding Difco Bacto agar (20 g/L) to above media. 
2.2 SOLUTIONS 
2.2.1 Sucrose solution (300 mM) 
300 mM Sucrose 	 102.60 g 
5 mM Tris.Cl 	 0.605 g 
1 MM EGTA 	 0.38 g 
Per Litre 
The solution was adjusted to pH 7.4 at 0 °C. 
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2.2.2 S14-Phage buffer 
NaCl 	 5.8 g 
MgSO4.7H20 	 2-4 g 
1 M Trie.HC1(pH 7.5) 	 50 ml 
2% gelatin 	 5 ml 
per litre 
2.2.3 TE buffer 
Tria.HC1 	 10 MM 
EDTA 	 1 MM 
2.2.4 10 x TBE 
Trio base 	 108 g 
Boric acid 	 55 g 
0.5M EDTA pH8.0 	40 ml 
per litre 
2.2.5 10 x Loading buffer 
0.25% Bromophenol blue 
15% Ficoll 400 
2.2.6 Prehybridisation solution 
20x SSC 	 7.5 ml 
100 x Denhardts 	1.25 ml 
10% SDS 	 1.25 ml 




2.2.8 2 X Laemmli sample buffer (LSB) 
1 N Tris.HC1 pH 6.8 	 3.13 ml 
SDS 	 2g 
Glycerol 	 9 ml 
2- mercaptoethanol 	 5 ml 
1% bromophenol blue 	 1 ml 
Distilled water 	 80 ml 
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2.2.9 Solutions for polyacrylamide gel electrophoresis (PAGE) 
4 X resolving buffer 	per litre 	4 x stacking buffer 	per 500 ml 
Tris.base 181.6 g Tris.base 30.28 g 
SDS 4.0 g SDS 2.0 
20 600 ml dH20 450.0 ml 
conc.HC1 10 ml conc.HC1 15.0 ml 
pH to 8.8 pH to 6.8 
10 X running buffer 	 per litre 
Tris.base 	 60.56 g 
glycine 	 288.5 g 
SDS 	 20.0 g 
dH20 to 1 litre 
2.2.10 lox Transfer buffer 
250mM Tris.HC1 pH 8.3; 1.5M Glycine 
2.2.11 Tris-buffered saline (TBS) 
lOml 1M Tris.HC1 pH 7.5, 37.5m1 4M NaCl, 952.5m1 water 
2.2.12 90% Percoll 
Percoll 	 900 ml 
Sucrose 2.5 M 	 100 ml 
Per Litre 
The solution was adjusted to pH 7.4 at 0 °C. 
2.2.13 Potassium phosphate (KPi) 
KPi 20 mM 	 400 ml 
Bovine Serum Albumin (BSA) 0.2% 	0.8 g 
EGTA 1 mM 	 0.16 g 
The solution was adjusted to pH7.4 at 0 °C. 
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2.2.14 Magnesium AT? (MgATP) 
ATP 	 1.79 g 
M9C12 	 0.161 g 
Made up to a final volume of 15 ml with KC1 and adjusted to pH7.4 
with solid Tris.base. The solution was then devided into 2 ml 
aliquots and stored at -20 °C. 
2.2.15 Potassium chloride (ICC1) 
KC1 150 MM 
	
11.18 g 





Adjusted to pH 7.4 at 0 °C. 
2.3  DETERGENTS 
Octyl Glucoeide (OG) 
3L ( 3-Cholamido propyl ) dimethyl 
-ammonio J -1-propansuiphanate. (CHAPS) 
Octanoyl-N-methyl glutamide(MEGA 8) 
Decanoyl-N-methyl glutamide(MEGA 10) 
(Detergents were obtained from Sigma) 
2.4 SUPPLIERS 
2.4.1 Enzymes 
T4 DNA ligase, restriction endonucleases and Kienow fragment of 
DNA polymerase were obtained from Gibco-BRL, Paisley, UK. Pyruvate 
kinase was obtained from Boehringer Mannheim (BCL), Lewes, Sussex. 
Pancreatic ribonuclease A was obtained from Sigma, and was boiled for 
10 minutes to remove any DNase activity before use. Sequenase® was 
obtained from United States Biochemical Corporation, Cleveland, Ohio. 
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2.4.2 Antisera 
Antibodies against CPT I and CPT II were raised in sheep at 
Hannah Research Institute, Ayr. HRP-conjugated anti-rabbit IgG was 
obtained from Bio-Rad Laboratories, Richmond, California, USA. HRP-
conjugated anti-sheep/goat IgG was obtained from Scottish Antibody 
Production Unit. 
2.4.3 Isotopes - Amersham International 
2.4.4 General laboratory chemicals - Sigma chemical company, Poole, 
Dorset or, BDH, Poole, Dorset. 
2.4.5 Proteinase inhibitors 
Antipain, Leupeptin & Pepstatin were obtained from Sigma 
2.5 BACTERIAL STOCKS 
Name 
	
Genotype 	 Reference 
E.coli Y1090 	 AlacU169, 	A+, ilon, 
araD139, strA, supF 
[trpC22::TnlO] (pMC9 = 
pBR322) 
E.coli Y1088 	 AlacU169,92pE, supF, 
hsdR, fl. _dl4, metB, trpR, 
A21, [proC::Tn5] 
(pmC9 = pBR322) 
E.coli TG1 	 2.UpE, hsd5, thi, L(lac- 
9AB), F', trat36, 
R9AB, laqjq, lacZ.M15 
Young and Davis, 
1983b 


























Young and Davis, 1983a 
Huynh et al, 1985 
Young and Davis, 1983a 
Meselson, 1964 
Vieira and Messing, 1987 
Description and use 	Reference 
phagemid cloning vectors 	Rokeach et al, 1988 
2.8 OLIGONUCLEOTIDES 
N = (A,G,C or T); 	R = A or G; 	Y = C or T. 


















• CPT I sense 
• CPT I antisense 
b CPT I sense 
b CPT I antisense 
• CPT I sense 
• CPT I antisense 
d CPT I sense 
d CPT I antisense 
el CPT II - Brady 
e2 CPT II - Brady 
f CPT II 
g CPT II 
h CPT II 
i CPT II 
j CPT II 
k CPT II 
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2 • 9 SUCROSE STEP GRADIENTS 
The layers were added to the tubes in reverse order: 
Top layer 	: 	Sucrose 0.76 M (26% sucrose), Tris.HCI. 5 mM, 
EGTA 1 mM. 
Middle layer: 	Sucrose 1.0 M (34% sucrose), Tris.HC]. 5 mM, 
EGTA 1 MM, 
Bottom layer: 	Sucrose 1.17 M (40% sucrose), Tris.HC1 5 mM, 
EGTA 1 MM 
The pH of all three layers was adjusted to 7.4 at 0 °C. 
Depending on availabilty, two centrifuges were used. The volumes of 
each layer were as follows: 
Combi swing out 
	
Prepspin swing out 
tubes (10 ml) 	 tubes (20 ml) 
Top layer: 	 3 ml 
	
7 ml 
Middle layer: 	 3 ml 
	
6 ml 
Bottom layer: 	 1.5 ml 
	
6 ml 
2.10 PREPARATION OF CYANOGEN-BROMIDE-SEPOSE 
CYTOCHROME C 
15g of cyanogen-bromide-sepharose (CNBr-sepharose) was swollen 
in 500ml of dH20 for 2 hours then stored overnight at 4°C. The 
suspension was then washed sequentially with the following: 
1 litre dH20 
1 litre 1 mM HC1 (15 minutes) 
1 litre dH20 
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The CNBr-sepharose was then suspended in 30 ml of NaHc03 (pH 
8.0). 360 mg of cytochrome c (equine SIGMA C2506) were added along 
with 30 ml of NaHCO3. This was then incubated at room temperature 
(RT) for 1.5 - 2 hours with occasional stirring. The "slurry" was 
then washed with the following solutions: 
0.1)4 Na acetate 	 pH 5.0 	200m1 
1.0)4 XCI. + 1% Lubro]. 	 200m1 
0.1)4 NaHCO3 	 pH 8.0 	200m1 
This cycle of washes was repeated three times before the 
"slurry" was washed with 1 litre of dH20. In order to fully oxidise 
the cytochrome c, 1 litre of 1mM K3Fe(CN)6 was added and left for 15 
minutes. The "slurry" was then washed with 1 litre of dH20 before 
being washed (equilibrated) with sucrose 0.25M ; Tris.HC1 10mM ; EDTA 
1mM (all at pH 7.4). It was then divided into three aliquots and 
stored in sucrose buffer (as above) at 0 °C. 
2.11  PREPARATION OF RAT LIVER )4ITOCHONDRIAL OUTER 
MEMBRANE FRAGMENTS 
(Parsons et al, 1966) 
Six rats were starved in wire bottomed cages for 48 hours and 
killed by cervical fracture. The livers were removed from the rats 
and immediately placed in ice cold sucrose solution. The livers were 
then finely minced (still on ice), transferred to a teflon-glass 
potter homogeniser and homogenised carefully by hand. The homogenate 
was then centrifuged at 500 X g (.SorvallSS-34 rotor) for 10 minutes 
and decelerated with the brake on. The supernatant was decanted and 
centrifuged at 9000 X g (sorvallSS-34 rotor) for 10 minutes (brake 
on). The fat at the top of the tube was removed with a tissue, and 
the supernatant decanted. After the pellets had been resuspended in 
ice cold sucrose solution by gentle homogenisation, the volume was 
made up to 135 ml with ice cold sucrose solution. 75 ml of 90% 
Percoll solution (4 °C) was added and the mixture was split evenly 
into 8 x 35 ml Oakridge tubes. The tubes were then centrifuged at 
35000 X g (OTD-Combi ) for 20 minutes at 4 °C. At this point the KPi 
solution was prepared (section 2.2.13). 
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The tubes were decanted almost down to the mitochondrial layer, 
visible as a pale fibrous layer almost at the bottom of the tube. 
The mitochondria were carefully pipetted into a homogeniser. Care 
was taken not to collect any of the red blood cells that were still 
present at the very bottom of the tube. 
The mitochondria were gently resuspended in 300 mM sucrose 
solution (section 2.2.1) and then centrifuged at 18000 X g (Servall 
SS-34 rotor) for 15 minutes (brake off). The pellets were .then 
resuspended in 160 ml of KPj medium (section 2.2.13), transferred to 
a 200m1 beaker and left on ice for 20 minutes. This had the effect of 
swelling the mitochondria by osmosis. 
2 ml of 200 mM MgATP solution were then added. This resulted 
in the sudden shrinking of the mitochondrial inner membranes. After 
5 minutes the suspension was centrifuged at 35000 X g (OTD-Combi) for 
20 minutes (4 °C). 
These pellets were resuspended in KPi and homogenised 
vigorously creating large shearing forces to disrupt the 
mitochondria. This suspension was then centrifuged at 2000 X g 
(Sorva].1 SS-34 rotor) for 20 minutes. 
The supernatant was then harvested and put in a 100 ml 
measuring cylinder. 0.1 x the volume of the supernatant of 1.5 M KC1 
was then added and mixed thoroughly in order that the 150 mM 
concentration of KC]. was obtained. The resultant solution was then 
centrifuged at 45000 X g (OTD-.Combi) for 20 minutes (4 °C) to pellet 
the outer membrane fragments. The sucrose step gradients were 
prepared at this point (section 2.9). 
The pellets were resuspended by washing with 150 mM KC1 
solution and homogenising vigorously. The total volume of the 
suspension was kept to less than 4m1, which was layered on top of the 
sucrose step gradients. These gradients were centrifuged at 40000 X 
g (OTD-Combj) for 2.5 hours at 4 °C in swing out rotor. The 
mitochondrjal layer was collected with a bent Pasteur pipette and 
either; extracted with Tween 20, before being frozen in liquid 
nitrogen and stored at -70 °C; or put in a 50 ml measuring cylinder 
and made up to 25 ml with dH20. 
An aliquot of activated...sepharose (section 2.10) was then added 
to the measuring cylinder, and incubated for 20 minutes at 35 °C while 
being constantly mixed. The SepFiaroe was centrifuged out at 200 x g 
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(Sorva11 SS-34 rotor) for 10 minutes (4 0C). The supernatant was then 
filtered through Pasteur pipettes filled with glass wool in order to 
remove the reacted .Sepharose. The Sepharose was resuspended in 
sucrose solution and the process was repeated. 
Both filtered supernatants were then centrifuged at 45000 X g 
(OTD-Combi) for 45 minutes (4 °C). The pellets were resuspended in 
dH20 (volume variable) and frozen in liquid nitrogen before being 
stored at -70 °C. 
2.12 RAT LIVER MITOCHONDRIAL ENZYME ASSAYS 
2.12.1 Cytochrome c oxidase assay 
(Smith , 1955) 
The assay buffer was prepared as follows: 
K2HPO4/KH2PO4 (pH 7.2 at 22 °C) 	 70 mM 
EDTA 	 5 mM 
1.8 ml cytochrome c oxidase assay buffer was added to a cuvette 
along with 50 Al of cytochrome C type II (20 mg/ml) (Sigma C2506). A 
few crystals of sodium dithionite were added to give 90% reduction. 
The samples to be assayed were diluted with 5 volumes sample 
and 1 volume sample buffer (EDTA 10 mM; NaHCO 3 10 mM; 1% Triton X-
100) and incubated for 5 minutes before being assayed. 
The optical density (OD) at 550 nm of the assay buffer (30 °C) 
was adjusted to an OD of 1.000. The recorder speed was set to an 
appropriate speed (dependent on sample) and the sample was added very 
quickly on a stirring rod. The decrease in OD550nm was recorded 
continuously from 0 - 30 seconds, during which time the change in OD 
was linear. The gradient (right to left) of the slope obtained and 
the molar extinction coefficient, E = 19200 1mo1 1cm 1 , were used to 
calculate the amount of cytochrome oxidase that was present in the 
sample. 
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2.12.2 Monoamine oxidase(MAO) assay 
(Schnaitman et al, 1967) 
The assay buffer was prepared as follows: 
K2HPO4/KH2PO4 (pH 7.2 at 22 °C) 	 70 mM 
EDTA 	 5 mm 
1.9 ml assay buffer was added to a cuvette along with Triton x-
100 (20Al) and fresh 1 H benzylarnine-HC1 (10l). The assay buffer 
was then left for 20 minutes before the sample was added. 
2 ml of the assay buffer (30 °C) was added to 10 jul of fresh 
benzylamine (1 H) and 10 Al of 10% (w/v) Triton X-100. The 
spectrophotometer was then set to an OD around 1.000 and 20 #1 of 
sample was added. The decrease in absorbance at 250 nm was recorded 
continuously for about 3 minutes during which time the change in 
absorbance was linear. The amount of monoamine oxIdase present was 
then calculated using the gradient of the slope and the molar 
extinction coeficient of benzaldehyde (E = 13000 lmolcm). 
2.12.3 Colorimetric CPT assay 
CPT was assayed at 25 °C in a final volume of lml. Reactions 
were initiated by the addition Of 0.4 mM L-carnitine to a reaction 
mix of 150 mM sucrose; 60mM KC1, 25 mM Tris.HC1 (pH 6.8), 1mM EDTA, 
0.1 mM 4,4'-dithiodipyridine, BSA (1.3mg/ml), and 40 AM palmitoyl 
C0A. The reaction was monitored at 324 nm. (Ghadiminejad and 
Saggerson, 1991). 
2.12.4 Radiochemical CPT assay 
Carnitine 	palmitoyltransferase 	activity 	was 	assayed 
radiochemically by measuring the incorporation of [ 3H] or [ 14C]-
carnitine into palmitoylcarnitine in the presence of palmitoyl C0A. 
The acylcarnitine formed was extracted into butanol which was washed 
three times with butanol-saturated water. 
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The reaction mixture was as follows: 
KC1 	 150 mM 
EGTA 	 1 MM 
Tris.HC1 	5 mM 
DDT 	 1 m 
BSA 	 10 mg/mi 
The pH of this mixture was then adjusted to 7.4 at 37 °C and 2 
9/ml of.rotenone/actinornycin A in ethanol were added. Each assay was 
2 ml in final volume. The substrates used were 50l of palmitoyl-00A 
(5.3 mM) and 50 Al of [ 3H] or ( 14C) Carnitine (20.8 mM), which were 
added to start the reaction. The reaction was then run for 2 minutes 
before being stopped by the addition of 300 Al of concentrated HC1. 
Water saturated butanol (4.5 ml) was then added to the reaction mix 
which was then shaken well and centrifuged at 3000 X g on a MSE bench 
top centrifuge. The butanol layer was removed to a clean tube, to 
which 3 ml of butanol saturated water was added. The tubes were 
mixed well and centrifuged as before. The water was then removed and 
the previous step repeated twice more. After the three butanol 
saturated water washes 3 ml of the butanol layer were transferred 
into 10 ml of Opti-fluor 12 and counted against palmitoyl-CoA blanks 
in a scintillation counter. 
2.13 PROTEIN TECHNIQUES 
2.13.1 Estimation of proteins 
All protein standards for the protein calibration curves were 
obtained by dissolving BSA (obtained from Sigma) in the buffer used 
to store the samples. Care was taken during all estimations that 
standards were measured in identical conditions as the samples, 
especially where detergents were used. 
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2.13.1.1 Lowry method 
Protein was estimated using the method described by Lowry et 
al, (1951). 
Solution A- 2% Na2CO3, 1.6% Na tartrate, 0.4% NaOH, 1% SDS 
Solution B- 1 ml 4% CuSO4 and 100 ml solution A 
Folin reagent- diluted 1:1 with dH20 
The sample to be assayed was diluted in dH20 to a volume of 1 
ml, as were standards of BSA (0-100 g/ml). To these, 3 ml of 
solution B was added. After 30 minutes, 1 ml of diluted Folin reagent 
was added, and the absorbance at 660 nm was read after a further 30 
minutes. The concentration of the sample was then calculated from a 
standard curve. 
2.13.1.2 Bradford method 
(Bradford, 1976) 
Bradford reagent was obtained from BDH. Reagent (2.5 ml) was 
added per 0.5 ml of sample, and the absorbance at 595 nm was measured 
against a reagent blank within one hour. The concentration of the 
sample was then calculated from a standard curve. 
2.13.2 Enzymatic digestion of proteins 
2.13.2.1 Digestion of proteins by endoproteinase Asp-N 
Protein samples (40 mg/ml) were diluted in the same volume of 1 
M sodium phosphate (pH8). The sample was concentrated for one hour in 
a speed vacuum. 25 Al of endoproteinase Asp-N was then added and the 
mixture incubated for varying amounts of time at 22-37 °c. 
2.13.2.2 Succinylation and clostripain digestion of 
proteins 
In order to limit clostripain to the digestion of arginine 
residues, succinylation of the lysine residues was first performed. 
This was carried out by mixing together in a microfuge tube 0.1 ml of 
2 M Tris.base and 0.1 ml of concentrated protein solution (1-10 
mg/ml). A couple of flakes of succinic anhydride were the added every 
n 
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30 minutes for 2-4 hours. The succinylated protein was then dialysed 
against 1% ammonium bicarbonate for 2 hours. 
Clostripain was activated by pre-incubating the enzyme at a 
concentration of 2 mg/ml in 1 mM calcium acetate and 2mM 
dithiothreitol (DTT) over night at 4 °C. 
0.5-0.05 mg of succinylated protein (100 Al of dialysed sample) 
were mixed in an Eppendorf tube with 10 Al of 75 mM DTT solution in 
1% ammonium bicarbonate. Activated clostripain was then added 
(protein/ciostripain ratio of 50:1), and incubated at 37 °C for 2-4 
hours. The sample was then dried in a speed vacuum. 
2.13.3 Chemical cleavage of protein by cyanogen bromide 
All glassware to be used in this procedure was first washed 
thoroughly with concentrated nitric acid and rinsed with dH20 before 
use. The sample of protein to be cleaved was treated with 5% 2-
mercaptoethanol (pH8) for 24 hours. The protein was separated from 
the thiol by dialysis for a minimum of 4 hours at 4 °C, before freeze 
drying. 
The sample was dissolved in 70% (v/v) aqueous formic acid to a 
concentration of 5 mg/ml at room temperature. A spatula tip of 
cyanogen bromide was added with constant stirring. The mixture was 
then incubated in the dark under oxygen—free nitrogen at 20-25 °C for 
16-24 hours. 
The mixture was twice diluted with 15 volumes of water and 
freeze dried. 
2.13.4 Separation of peptides in preparation for 
N-terminal. sequencing 
Peptide samples were separated in two ways. They were either 
separated by polyacrylamide gel electrophoresis, as described in 
section 2.28, or by reverse phase chromatography using the RP-300 
Aquipore 250 X 1 mm column (Amersham). Such samples were first 
dissolved in 0.1%trif1uozocetjc acid 
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2 • 14 DETERGENT TREATMENT OF RAT LIVER MITOCHONDRIAL 
OUTER MEMBRANES 
2.14.1 Effect of detergents on CPT 1 activity 
All detergents were dissolved in 500 mM KC1. 	In order to 
examine the effect on the activity of CPT I by the detergents that 
might be used for solubilisation, 200 #1 of outer membrane 
preparation were centrifuged at 100000 X g for 10 minutes (Beckman 
Air-fuge), before the resultant pellet was resuspended in an 
appropriate volume of 10 mM; 20 mM; and 40 mM detergents. The 
membrane 	concentrations were calculated to give protein 
concentrations of 2.5 - 3.0 mg/mi. 	Protease inhibitors antipain, 
leupeptin and pepetatin were added to a final concentration of 100 ,i 
g/ml, 4 ig/ml, and 100 &g/ml respectively. Care was taken to avoid 
frothing of the detergent as this can damage proteins. The 
suspensions were then left on ice for 30 minutes before being assayed 
for CPT activity. 
2.14.2 Solubilisation of CPT active protein in outer 
membranes by detergents 
So].ubiljsation of CPT I was carried out in a similar fashion to 
that described by Murthy & Pande (1987). Mitochondrial outer 
membranes (800 l) were centrifuged at 100000 X g (Beckman Air-fuge), 
for 10 minutes The pellet was then resuspended in an appropriate 
volume of detergent and proteinase inhibitors were added as before. 
The suspension was stirred periodically on ice for 30 minutes and 
centrifuged at 100000 X g (Beckman Air-fuge), for 1 hour. The 
supernatant was removed and either assayed for activity or counted 
(when radioactive markers had been used). The pellet was then 
resuspended in the same volume of detergent containing protease 
inhibitors as before and measured for CPT activity in the same way as 
the supernatant. Double solubilisation experiments were carried out 
by resolubilising the pellet obtained after the first soiLbilisation. 
The second supernatant was either measured separately or combined 
with the first. Any pellet obtained was measured as before. All work 
was carried out at 4 °C. 
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2.15 ACTION OF INHIBITORS ON CPT ACTIVITY 
2.15.1 Inhibition of CPT I by bromopaliuitoyl-CoA 
Bromopalmitoyl-00A (BrPC0A), is an inhibitory substrate 
analogue of CPT where a bromine atom is subsituted onto the a-carbon 
of palmitoyl-00A. BrP-CoA was tested for inhibition of CPT using the 
following method. A pellet obtained by centrifugation at 100000 X g 
(Beckman Air-fuge) of 200 Al of outer membranes, was dissolved in an 
appropriate volume of 300 mM KC1 to give a protein concentration of 
2.5 - 3.0 mg/mi. 1.25 mM "Cold" carnitine (10 Ml) was then added 
along with 5 Al of 10 MM BrPC0A. This mixture was then incubated at 
25 °C for 45 minutes before being spun at 100000 X g (Beckman Air-
fuge) for 10 minutes. A control was run where the BrP-00A was 
replaced with 100 mM KC1. The pellets were then assayed for CPT 
activity as described in section 2.12.4. 
2.15.2 Inhibition of CPT I by malonyl-CoA 
Assay Conditions 
Malonyl-00A 	100 MM 
BSA 	 1% 
Palmitoyl-00A 	132 MM 
Carnitine 	 0.5 mM 
KC1 	 150 mM 
EGTA 	 1 mm 
Tris.HC1 	 3 mM 
DTT 	 1 1mgl 
Malonyl-00A inhibition of CPT I was used to determine the 
effect of Tween 20 on the membranes. This was done by solubilising 
200 Al of a rat liver mitochondrial outer membrane preparation, as 
described before. After solubilisation the pellet and supernatant 
were assayed for CPT activity in the presence and absence of 20 Ag/ml 
malonyl-CoA. The effect of 1% Tween 20 (w/v) on the outer membrane 
preparation (3 mg protein/ml) was also examined against a control 
where dH20 was used instead of Tween 20. 
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2.15.3 Binding of radiolabelled carnitine by rat liver outer 
membranes in the presense of BrP-CoA 
The effect of BrP-00A on the binding of carnitine to the rat 
liver mitochondrial outer membrane preparation was examined by the 
following method (Declerq et al, 1987). [ 3H]-carnitine (0.15 nmol 
with specific activity 75 Ci/mmol) was dissolved in the appropriate 
volume of 500 mM KC1 to give an outer membrane protein concentration 
of 25 - 3.0 mg/ml when added to the pellet obtained from spinning 
down 200 il of outer membrane preparation. 1.25 mM "Cold" carnitine 
(10 Al) was added along with 3 Al of 10 LM BrP-00A. This mixture was 
incubated at 25 °C for 45 minutes before being spun at 100000 X g 
(Beckman Air-fuge) for 10 minutes. A control was prepared whereby 
the BrP-CoA was replaced with 500 mM KC1. Both control and reaction 
were washed 4 times in 10% BSA in 100 mM KC1 and then counted in 10 
ml Opti-fluor 12 in a scintillation counter. 
2.16 DESIGN OF MICRO-DIALYSER 
In order to dialyse small volumes (10-100 Al) a new method had 
to be developed. This was accomplished by altering Eppendorf tubes. 
An Eppendorf tube, with its cap removed, had its coned bottom sliced 
off with a sharp scalpel, leaving a cylindrical tube. The centre of 
the removed cap was then hollowed out carefully and the lip, used to 
open the Eppendorf cap, carved to a circular shape. 
Boiled dialysis tubing was then sliced into a sheet and 
stretched over the cap. The sheet was then pulled tight, and threaded 
through the cylindrical Eppendorf body. This procedure pulled the 
Viskingsheet tightly over the cap at the same time as securing the 
cap onto the Eppendorf body. 
Excess visking tubing was removed from the inside of the 
Eppendorf with a sharp scalpel. A paper clip was shaped into a handle 
and attached to the top of the inverted Eppendorf tube. 
Shallow containers, filled with buffer, were used during the 
dialysis. The solution to be dialysed was added carefully into the 
Eppendorf onto the viscing material. The Eppendorf was then placed 
into the buffer and dialysed by gentle agitation, ensuring that the 
Eppendorf remained vertical and inverted at all times. 
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2.17 PURIFICATION OF CPT II 
2.17.1 Solubilisation of CPT II 
Total heavy mitochondria were prepared as in section 2.11 up to 
and including the Percoli gradients. This ensured that only heavy 
mitochondria were present since light mitochondria are known to 
contain peroxisomal contamination. The mitochondria used were free 
from peroxisomes to 5% as measured by catalase activity. The 
mitochondria were solubilised in 4% (v/v) Tween-20 in the presence of 
1 14 KC1, 0.1mM DMSO and 0.5 mM dithiothreitol. Solubilisation was 
carried out by gentle stirring for 15 minutes at 0 °C, with sonication 
every 2 minutes (5 bursts of 15 seconds). The mixture was centrifuged 
at 30000 X g (OTD-Combi) for 20 minutes. Both supernatant and pellet 
were assayed for CPT activity (described in section 2.12.3) to 
determine the percentage solubilisation. 
2.17.2 POlyethylene glycol (PEG) precipitation 
PEG 6000 was added 'very slowly' with constant stirring to the 
crude protein preparation suspended in 500mM potassium phosphate 
buffer (pH7.2) containing PMSF 0.1 mg/ml and 0.5% (v/v) Tween-20. 
Once added to the required percentage of PEG, the preparation was 
centrifuged at 30000 X g (OTD-Combi) for 30 mm. Both supernatant and 
pellet were then assayed for CPT activity (section 2.12.3) and the 
percentage of PEG altered in order to further eliminate the 
precipitation of unwanted proteins on subsequent cuts. 
2.17.3 Ammonium sulphate (NH4)2504 precipitation 
(NH4)2SO4 was added 'very slowly' to a 40% saturation and then 
left on ice for 1 hour, before centrifugation at 30000 X g (OTD-
Combi) for 30 minutes. The supernatant was decanted and filtered 
through butter muslin gauze (three layers) and increased to 50% 
saturation with (NH4)2SO4 . After standing in ice for 1 hour the 
precipitate of CPT II was collected by centrifugation as above, 
dissolved in 500mM potassium phosphate buffer (pH7.2) containing PMSF 
(0.1 mg/ml) and 0.5% (v/v) Tween-20 then desalted and equilibrated 
with 20mM bis-Tris-propane buffer (pH7.0) containing 0.5% (v/v) 
Tween-20 by applying the sample to a Sephadex G-25 column 
(Pharmacia). The mixture was then concentrated by Amicon 
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Ultrafiltration with a low molecular weight cut-off point of 30000 
Daltons. 
2.17.4 Mono Q ion exchange 
A Mono Q 10/10 column (Pharnacia), pre-equilibrated with 20 MM 
bis-Tr is -propane buffer (pH7.0) containing 0.5% (v/v) Tween-20 was 
used to purify CPT II after the second (NH4)2SO4 cut. Once applied to 
the column, the enzyme was eluted with a shallow linear gradient of 
0.01-0.15 M NaCl dissolved in the same buffer. Most of the CPT 
activity eluted between 0.05-0.1 M NaCl. All fractions containing 
activity were pooled, desalted and concentrated by ultrafiltration. 
2.17.5 Mono P chromatofocusing 
Chromatofocusing produces a pH gradient on an ion exchanger by 
taking advantage of the buffering action of the charged group of the 
ion exchanger. Polybuffer 96 (Pharmacia) was adjusted to pH8 and run 
through a Mono P chromatofocusing column (Pharmacia) as described by 
Brady and Brady (1986) except that 0.5% (v/v) Tween-20 was 
incorporated into the buffers instead of octyl glucoside. The column 
was pre-equilibrated with polybuffer 94 adjusted to pH5.5 before the 
proteins were loaded and the gradient applied. CPT II activity was 
eluted from the column between pH6.5-6.0. 
2.18  GROWTH AND MAINTENANCE OF R. C011 
2.18.1 Growth of E.coli bacterial cultures 
Liquid cultures of E.coli were grown in Luria broth by 
inoculating a given volume of broth with a single colony using a 
sterile inoculating loop. Cells were shaken at 37 °C for an 
appropriate length of time. 
2.18.2 storage of H.coli bacterial cultures 
For long term storage 1 ml of fresh overnight culture of 
bacteria, grown in Luria broth supplemented with antibiotics as 
appropriate, was mixed with 1 ml of 100% sterile glycerol, and stored 
in a sterile vial at -80 °C. Upon recovery, vials were thawed quickly 
at 37 °C and the culture streaked Out on Luria broth agar plates, with 
antibiotics if required. TG1 was streaked out onto minimal agar 
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plates to maintain the F plasmid. After overnight incubation at 37 ° 
C, a single colony was picked to propagate a fresh bacterial culture. 
For short term storage (4 - 6 weeks), bacteria were stored on agar 
plates at 4 °C. 
2.19 TRANSFORMATION PROCEDURES 
2.19.1 Preparation of competent cells 
1-litre--of Lüria broth was inoculated with lOmi of an overnight 
culture and shaken at 37 °C until an 0D600 of 0.3 was reached. Cells 
were placed on ice for 10 minutes to arrest growth, then pelleted by 
centrifugation in 4 x 250 ml sterile Sorvall pots at 5000 X g for 15 
(Sorvall SS-34 rotor) minutes at 4 °C. The pellets were resuspended in 
125m1 of fresh 100 mM calcium chloride. After 30 min on ice, the 
cells were pelleted at 9000 X g (Sorvall SS-34 rotor) for 10 minutes 
at 4 °C. Each pellet was resuspended in 25 ml of 100 mM calcium 
chloride, and combined in one of the pots. Glycerol (20 ml) was added 
(final concentration of 17%) then the cells were devided into lml 
aliquotes, frozen in liquid nitrogen and stored at -80 °C. 
2.19.2 Transformation of E.coli 
Supercoiled plasmid DNA (5 to 10 ng), or half of a ligation 
reaction, were added to 100 jul of competent TG1 cells in a 1.5 ml 
microcentrifuge tube and left on ice for 40 minutes. The cells were 
then heat shocked at 42 °C for 3 mm. Luria broth (1 ml), containing 
ampicillin, was added to the cells, which were then incubated at 37 °C 
for 1 hour. The cells were then pelleted in a microfuge and 
resuspended in 100 Al of luria broth containing anipicillin. Aliquots 
(25 Al and 75 Al) were spread onto luria agar petri dishes containing 
100 Ag/ml ampicillin. The plates were incubated overnight at 37 °C. 
2.20 ISOLATION OF NUCLEIC ACIDS 
2.20.1 Isolation of plasmid DNA from E.coli 
Plasmid DNA was isolated from E. coli using the alkaline lysis 
method essentially as described by Birnboim and Doly (1979). 
58 
2.20.1.1 Small scale isolation of plasmid DNA from E.coli 
Luria broth (3 ml), supplemented with arnpicillin to a final 
concentration of 100 g/ml, was inoculated with a single colony of 
the plasmid carrying strain and incubated at 37 °C overnight with 
shaking. Half of the culture (1.5 ml) was pelleted by centrifugation 
in a microfuge and resuspended in 100 Al of 25 mM Tris.HC1 (pH8), 10 
mM EDTA, 50 mM glucose (TEG). Lysis buffer (200 Al of 0.2 N NaOH, 1% 
SDS) was added and after gentle mixing, placed on ice for 5 mm. 
Following the lysis 150 Al of 3 M sodium acetate (pH5) was added to 
precipitate chromosomal DNA, SDS and proteins. After a further 
incubation on ice for 5 minutes the precipitate was removed by 
centrifugation in a microfuge for 10 minutes. Absolute ethanol (1 ml) 
was added to the supernatant, mixed, and immediately centrifuged in a 
microfuge to pellet the plasmid DNA. The DNA was washed with 70% 
ethanol, dried under vacuum, and resuspended in 50 Al of TE buffer. 
Plasmid IminiprepI DNA was stored at 4 °C. 
2.20.1.2 Large scale isolation of plasmid DNA from H.coli 
A 250 ml culture of bacteria carrying the desired plasmid was 
incubated overnight at 37 °C with vigorous shaking in Luria broth 
supplemented with 100 Aglml of ampicillin. The cells were pelleted by 
centrifugation at 9000 X g (Sorvall GSA rotor) and resuspended in 4 
ml of 25 mM Tris.HC1 (pH8), 10 mM EDTA, 50 mM glucose (TEG). Cells 
were lysed on ice by adding 8m1 of 02 M NaOH, 1% SDS and left on ice 
for 20 mm. Addition of 6 ml of 3 M sodium acetate (pH5) precipitated 
chromosomal DNA, SDS and proteins which were spun down at 17000 X g 
(Sorvall SS-34 rotor) for 15 minutes at 4 °C. Isopropanol (11 ml) was 
added to the supernatant and left at room temperature for 30 min to 
precipitate plasmid DNA. The DNA was pelleted by centrifugation at 
20000 X g (Servall SS-34 rotor) for 20 minutes at 4 °C. The pellet was 
washed in 70% ethanol, dried under vacuum, resuspended in 10 ml TE 
buffer containing 10 gg/ml RNase and incubated at 37 °C for 30 
minutes. Plasmid DNA (9.4 ml) was transferred to a fresh tube to 
which 100 Al of lOmg/ml ethidium bromide and 9.02g of CsC1 were 
added, giving a density of 1.55 g/ml. The DNA was banded by 
centrifugation at 40000 X g (Beckman TI-100; TLA-100.3 rotor) for 12 
hours at 20 °C. DNA was visualised by side illumination with a UV 
light. The lower band containing supercoiled plasmid DNA was removed 
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by puncturing the tube with a 19 gauge needle and syringe. A second 
19 gauge needle was inserted at the top of the tube to allow pressure 
release. The ethidium bromide was removed by extraction several times 
with butanol, and the CsCl was removed by dialysis against 2 litres 
of TE buffer for 8 to 15 hours at room temperature. The TE buffer was 
changed 3 to 4 times during dialysis. The DNA was then stored at 4 °C 
for up to 12 months or under ethanol at -70 °C for long term storage. 
2.20.2 Isolation of single stranded DNA from E.coli 
Single stranded DNA from plasmids with the Fl origin of 
replication (phagemids) were prepared from H. coli using M13K07 
helper phage. This method yielded approximately 1 ig single stranded 
DNA which was suitable for use in sequencing reactions. 
A single colony of E. coli host containing the phagemid was 
grown in 2 ml selective medium to mid-log phase (0D600 of 0.5). 
M13K07 helper phage was added to this, giving a multiplicity of 
infection of 10, and the culture was shaken vigorously. After 1 hour, 
400 jL1 of infected cells were mixed with 10 ml of selective medium, 
to which kanarnycin was added at a final concentration of 70 Ag/ml to 
select for the phage. The culture was grown over night, with vigorous 
shaking to give good aeration. 
Cells were removed from the culture supernatant by centrifuging 
1.5 ml of the overnight culture at 12000 x g for 5 minutes. To 
precipitate the phage, 1.2 ml of the supernatant was added to 0.3 ml 
of NaC1/PEG solution (2.5M NaCl, 20% polyethylene glycol 6000), and 
left at room temperature for 15 minutes. The phage were pelleted at 
12000 x g for 5 minutes. After removing all NaC1/PEG solution, the 
phage were resuspended in 100 Al TE. Phenol (50Al) was added to the 
phage. The suspension was vortexed and centrifuged for 1 minute. DNA, 
which was located in the aqueous layer, was removed and cleaned by 
Genec leanTM. 
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2.20.3 Preparation of rat liver nucleic acid 
All equipment and solutions were pre-treated with diethyl pyro-
carbonate (DEPC) when RNA was being prepared. 
Preparation of CsC1 Density Gradients; 
Guanidinium isothiocyanate (GIT). 
GIT 	 100.0 g 
dH20 	 100.0 ml 
Tris.HC1 1 H (pH 7.6) 	10.6 ml 
EDTA 0.2 H 	 10.6 ml 
This solution was stirred for 30 min at 4 °C. Then 21.2 ml of 
20% sarkosyl (sodium lauryl sarcosinate) were added and the resultant 
solution was filtered through a Nalgene (0.45'Lrn) filter. Finally 21 
ml of fi-mercaptoethanol was added before the GIT was aliquoted and 
stored at -20 °C. 
Caesium Chloride (CsC1). 
Per litre 
Cad 	5.7 M 
EDTA 	0.1 H 
The CaC1 was autoclaved and filtered before use. 
A liver was removed from a rat and immediately frozen in liquid 
nitrogen (N2). It was then broken up into 1 g quantities and stored 
at -70 °C until required. Rat liver (1 g) was ground to a fine powder 
in liquid N2 using a mortar and pestle. The powder was transferred 
(as a slurry in N2) to thaw. The thawed homogenate was passed 
through a 19 gauge needle and then through a 23 gauge needle (5 to 6 
times each), in order to disperse small clumps of tissue and shear 
genomic DNA. Solid Cad (lg per 2.5m1) was added to the homogenate 
which was then layered on top of a "cushion" of 1.2m1 of 57M CsCl in 
a 5ml swing out centrifuge tube. The tubes were filled up with GIT, 
balanced and centrifuged at 30000 X g (OTD Combi) for 30 hours at 20 ° 
C. After centrifugation the tube contained three visible bands. A 
top band of fat, a middle band of protein and a bottom band of DNA. 
There was also a transparent gelatinous pellet of RNA. 
61 
2.20.3.1 Preparation of rat liver DNA 
The gradient was removed from the Corex tubes (section 2.20.3) 
to just above the DNA band which in turn was collected down to the 
interface with the cushion and transferred to a 30 ml Corex tube. 
The DNA sample was then diluted to 15 ml with TE buffer, extracted 
with phenol-chloroform and precipitated with ethanol as in section 
2.20.5. 
2.20.3.2 Preparation of rat liver RNA 
After removal of most of the gradient by a pasteur pipette, the 
corex tubes (section 2.20.3) were drained by inversion leaving only 
the gelatinous RNA pellet. The tubes were stored on ice after the 
sides had been dried carefully with clean tissue. The pellet was 
resuspended in 0.5 ml of sterile H20 and transferred to a 15 ml 
falcon tube. An equal volume of a mixture of chloroform and butanol 
(4:1) was added. After vigorous shaking, the mixture was centifuged 
in a MSE bench top centrifuge at 5500 X g for 5 minutes at 0 °C. The 
aqueous layer was then trasfered to a Corex tube and the organic 
layer was re-extracted. The aqueous layers were pooled and then 
precipitated as described in section 2.20.5. The RNA was recovered by 
centifuging at 15000 X g (.Sorvall SS-34 rotor), for 20 minutes at 40 
C. The RNA was dissolved in TE buffer and stored at -80 °C. 
2.20.4 Extraction of proteins from nucleic acid by phenol and 
chloroform 
Distilled phenol was equilibrated with buffer at p118 for 
extraction of proteins from DNA, by mixing with an equal volume of 1M 
Tris.HC1 (pH8). The phases were allowed to separate and the upper 
aqueous phase was discarded. This process was repeated until the pH 
of the phenol reached 8. The Tris.HC1 layer was then replaced with TE 
buffer. Extraction of proteins from RNA required phenol to remain 
acidic (pH5-6). Phenol was therefore equilibrated as above except 
Tris was replaced with distilled water. The nucleic acid to be 
extracted was mixed thoroughly with 0.4 to 1 X the volume of phenol 
then centrifuged at 2000 X g (Sorvall SS-34 rotor) for 2 - 5 minutes. 
The upper aqueous phase was removed into a fresh tube, taking care 
not to collect any proteins located at the interface, and re-
extracted with phenol if necessary. Instead of, or following phenol 
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extraction, DNA or RNA was extracted with phenol-chloroform. The 
aqueous phase was then extracted with an equal volume of chloroform 
to remove any remaining phenol. After centrifugation as above, the 
upper aqueous phase was transferred to a fresh tube. 
2.20.5 Precipitation of nucleic acid with ethanol 
Nucleic acid was precipitated from solution by addition of 0.1 
volumes of 3 M sodium acetate (pH5) and 3 volumes of absolute ethanol 
at room temperature. The solution was mixed thoroughly and allowed to 
stand at room temperature for 10 minutes, -20 °C for 20 minutes, or - 
70 °C for 15 minutes depending on the DNA concentration. DNA was 
pelleted by centrifugation at 5000 X g (Servall SS-34 rotor) for 15 
to 30 minutes. The supernatant was discarded and the pellet was 
washed with 70% ethanol and centrifuged as above for 2 minutes. The 
supernatant was discarded and the pellet dried under vacuum until no 
visible traces of ethanol remained (2 to 5 mm). The DNA was 
dissolved in sterile distilled water or TE buffer. Precipitation of 
RNA from solution with ethanol was identical except that 0.033 
volumes of 3M potassium acetate (pH5) and 0.5 volumes of ethanol were 
added. Alternatively, RNA was precipitated by adding 2 volumes of 3 M 
LiC1 and left over night at 4 °C before centrifugation, washing and 
drying. 
2.21 GEL ELECTROPHORESIS OF DNA 
2.21.1 Agarose gel electrophoresis of DNA 
DNA was separated in 0.7 - 2% (w/v) agarose BRL electrophoresis 
grade with 0.5 ug/ml ethidium bromide in 1 X TBE (for Southern 
blotting), or 1 X TAE (for routine gels). Prior to loading, DNA 
samples were mixed with 0.1 X volume of loading buffer (20% glycerol; 
EDTA; 0.1% bromophenol blue). Electrophoresis was carried out 
horizontally across a potential difference of 1-10 V/cm. 
Bacteriophage Xc1857 DNA cut with Hindill was used as size markers. 
DNA was visualised by UV illumination and photographed. 
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2.21.2 Recovery of DNA from agarose gels 
DNA was electrophoresed through 1% agarose BRL in 1 X TAE, 
containing 0.5 jig/ml ethidium bromide. The desired fragment was 
visualised by uv illumination, cut out, and extracted from the 
agarose using GenecleanTM. The agarose was weighed and 2 - 3 volumes 
of 6M Nal were added per mg agarose. The agarose was dissolved by 
heating to 55 0c for 5 minutes with occasional mixing, and then cooled 
on ice for 5 minutes. The molten agarose was treated with 5111 of 
'glass milk' (a silica matrix suspended in water), and left for 5 
minutes on ice with occasional mixing to allow the DNA to bind to the 
silica matrix. The 'glass milk' was pelleted by centrifugation at 
15000 X g (microfuge) for 1 minute. The supernatant was discarded and 
the pellet washed three times with 500 Al of 'NEW wash' 
(NaC1 /ethanol /water mix). After a final spin all the NEW wash was 
discarded and the DNA was eluted from the 'glass milk' in 5-20 Al of 
TE buffer or water at 55 °C. The mixture was spun in a microfuge, and 
the supernatant containing the DNA, transferred to a fresh microfuge 
tube and stored at -20 °C. Recovery of DNA fragments of 500 base pairs 
or greater was usually around 80%. 
2.21.3 Recovery of DNA fragments of 300 bp or less from agarose gels 
The DNA was electrophoresed through a 1-2% low melting point 
agarose gel (LMP Agarose; BDH) in 1 X TAE containing ethidium 
bromide. The required DNA fragment was visualised with UV, as 
described before, and excised from the gel into an microfuge tube.-To 
ever  fo.lg of agarose, 200 Al water, 1 jg glycogen, and SDS to final 
concentration of 0.1% were added. The agarose was dissolved at 55 °C 
for 20 minutes until all the agarose had dissolved. The DNA was then 
separated from the agarose by phenol /chloroform extraction followed 
by ethanol precipitation. 
2.21.4 Agarose gel electrophoresis of RNA 
RNA isolated from rat livers was separated on agarose gels 
prior to Northern blotting using the method of McMaster and 
Carmichael (1977). A 1.5% agarose gel was prepared with DEPC treated 
water and 10 mM sodium phosphate (to a final concentration of 10 AM. 
The RNA sample was prepared by mixing 5 jLl of RNA with 20 Al of 
glyoxal mix, [100 Al glyoxal (30%) pH6; 250 Al formamide pH7; 10 Al 
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0.5 N sodium phosphate; 40 Al water], and incubated at 50 °C for 30 
minutes. The running buffer used for the gel was 500 mM sodium 
phosphate buffer (pH7). The RNA was electrophoresed into the gel 
before adding more buffer to submerge the gel. Electrophoresis was 
carried out at 200 mA for 2 hours, recirculating the buffer every 10 
mm. 
2.21.5 Polyacrylaaide gel electrophoresis of DNA 
To separate DNA fragments less than 400 base pairs long, 
electrophoresis was carried out with a vertical gel of 6 - 10% 
polyacrylamide (40:1 acrylamide : bis-acrylarnide) in 1 X TBE buffer 
at 10 - 70 v/cm. 
2.22 DNA MANIPULATION TECHNIQUES 
2.22.1 cleavage of DNA with restriction enzymes 
All restriction enzyme digests were performed using BRL enzymes 
and buffers. DNA (0.1 to 20 gig) was cut in 10 - 200 ul of 1 X 
appropriate 'React' buffer for 2 - 8 hours at the appropriate 
temperature. For double digests involving enzymes with different 
recommended buffers, the buffers were checked individually in double 
digests to determine which gave the most efficient digestion. 
2.22.2 Filling in of protruding 5' ends of fragments 
Protruding 5' ends were filled in using the DNA polymerase 
activity of the Klenow fragment of DNA polymerase 1 from E.coli. The 
fragment of DNA (1 g) in 21.5 il of distilled water was added to 2.5 
Al of 10 X Nick Translation buffer (0.5 M Tris.HC1 pH7.5; 0.1 N 
MgSO4; 10 mM DTT; 500 ig/ml BSA) and 1l of a 2mM solution of all 4 
dNTPs. Kienow fragment (2 units) was added and the reaction mixture 
was incubated at 22 °C for 30 minutes. The Kienow fragment was 
inactivated by heating to 70 °C for 5 minutes. 
2.22.3 Ligation of DNA ends 
50-100 ng of vector (cut with the appropriate restriction 
enzyme) was incubated with a four-fold molar excess of fragment in 1 
X ligation buffer (10 mM Tris.HC1 pH 7.2; 1 mM EDTA; 10 mM MgCl2; 10 
mM DTT; 1 mM ATP) with 10 units of T4 ligase. The reaction was made 
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up to a final volume of 10 Al and incubated for 12 to 48 hours at 16 ° 
C . 
2.22.4 Polymerase chain reaction 
All reaction were carried out on a Techne Programmable Dryblock 
(PHC-2). The amplification strategy was based on that of Scharf et al 
(1986), reviewed by Mullis and Faloona (1987). Primers were designed 
such that they shared 15-25 nucleotide homology to the template and 
where appropriate a 6 base restriction enzyme site at their 5' end. 
Where amino acid sequence had been used to elucidate primer sequence, 
either primers containing total heterogeneity or 'guessmers' using 
selective heterogeneity were made. In the latter case care was taken 
to ensure that the 3' end was always complementary. Template DNA (100 
pg - 1 ig) was mixed with 10 Al of 10 X amplification buffer (100 mm 
Tris.HC1 p118.3; 500 mM KC1; 15 mM MgCl2; 0.1% gelatin(w/v); 0.1% 
Tween 20 (v/v); 0.1% NP40 (v/v)), 2 Al of 10 mM dNTPs, 1-2 Ag of each 
primer, and 2.5 units of Taq polymerase (Cetus, Perkin Elmer), and 
made up to a volume of 100 Al with DEPC treated water then submerged 
under 100 Al of mineral oil (Sigma). One initial 95 °C 5 minutes 
denaturation cycle preceded all amplifications from either single or 
double stranded DNA. Where RNA/DNA duplex was used as a template the 
initial denaturation step was at 99 °C for 10 minutes. After this 
initial step all cycling was identical where the annealing of the 
primers to the template was carried out at 37-55 °C for 1 minute, 
polymerisation at 72 °C for 2 - 5 minutes and further denaturation 
steps at 94 °C for 1 minute. The number of cycles used varied 
according to the abundance of the target DNA, but was usually between 
25 and 55 cycles. Following the final cycle a further period of 10 
minutes at 72 °C was carried out to ensure that all products were full 
length. PCR products were checked by polyacrylamide gel 
electrophoresis and excess primers were removed by first removing the 
oil by addition of 0.5 ml of chloroform, and then phenol and 
chloroform extraction of the DNA, followed by ethanol precipitation. 
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2.23 SEQUENCING OF SINGLE STRANDED DNA 
Sequencing of DNA was carried out using the SequenaseTM Version 
2.0 kit (United States Biochemicals). The dideoxy chain termination 
method was used. 
Appropriate sequencing primer (1 Al of 3 ng/gil) was annealed to 
7 Al of template DNA (approximately 1 gig DNA) in 2 Al of 5 X reaction 
buffer (200 m14 Tris.HCI pH7.5; 100 mM MgC12; 250 mM NaCl) by heating 
to 65 °C for 2 minutes then cooled slowly to below 37 °C. Extension 
from the annealed primer was done by adding 1 Al 0.1 N DTT, 2 Al dGTP 
label mix (a 1 in 4 dilution of 7.5 giN dGTP, dCTP, dATP and dTTP), 
0.5 Al a-( 35S)-dCTP (400 Ci/mmole) and 2 Al diluted sequenaseTM(a 1 
in 8 dilution of sequenase at 13 U/gil in 10 mM Tris.HC1 pH7.5; 5 mM 
DTT; 0.5 mg/ml BSA). The extension mixture was left at room 
temperature for 2 - 5 mm. Further extension and termination was done 
by dispensing 3.5 gil of extension mix into four tubes preheated to 37 
°C containing 2.5 Al of one of the four termination mixes: 
ddGTP mix - 80 giN dNTPs; 8 giN ddGTP; 50 mM NaCl 
ddATP mix - 80 giN dNTP5; 8 giM ddATP; 50 mM NaCl 
ddCTP mix - 80 giN dNTP8; 8 AM ddCTP; 50 mM NaCl 
ddTTP mix - 80 giN dNTPs; 8 giN ddTTP; 50 mM NaCl 
The termination reaction was allowed to proceed at 37 °C for 5 
minutes and the reaction was stopped by the addition of 4 Al of stop 
solution (95% formamide; 20 mM EDTA; 0.05% bromophenot blue). 
Extension products were separated by electrophoresis through a 6% 
denaturing polyacrylamide gel made up by mixing 25.2 g of urea, 6 ml 
10 X TBE, 12.5 ml Protogel (30% acrylamide (30:1 acrylamide: bis-
acrylamide)) made up to a final volume of 60m1 with water. 
Polymerisation of the acrylamide was achieved by adding 140 Al of 10% 
ammonium persuiphate and 140 ml of TEMED immediately prior to pouring 
the gel. Sequencing reaction were heat denatured at 75 °C for 3 
minutes, loaded onto the gel and electrophoresed in 1 X TBE buffer at 
65 watts for 1 hour 45 minutes to 6 hours. The gel was fixed in 10% 
acetic acid (v/v) 1 washed with water and then dried under vacuum at 
80 °C for 45 minutes. The gel was then autoradiographed at room 
temperature overnight. 
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2.24 NUCLEIC ACID HYBRIDISATION TECHNIQUES 
In order to detect specific sequences in either DNA or RNA, the 
nucleic acid was separated in an agarose gel and transferred to a 
nylon membrane before hybridisation with a DNA probe. 
2.24.1 Transfer of nucleic acids to filters 
The capillary blotting method used for transfer was essentially 
that described by Southern (1975), and as detailed below for the 
transfer of DNA (Southern transfer) or RNA (Northern transfer). 
2.24.1.1 Southern transfer 
Discs and sheets of both nitrocellulose (Hybond-C) and nylon 
(Hybond-N) were obtained from Amersham International. Chromosomal DNA 
was digested with the restriction endonucleases Hindlil, EcoRl, 
BamHl, and a mixture of all three. The digests were then separated 
on a 0.8% agarose gel by electrophoresing in 1 X TBE. The gel was 
placed in denaturing solution (1.5 M NaCl; 0.5 M NaOH) for 30 mm, 
and then in neutralising solution [1.5 N NaCl; 0.5 M Tris.HC1 (pH 
7.2), 0.001 N Na2EDTA) for 30 minutes. The gel was placed upside 
down on a piece of 3 MM filter paper, the ends of which were resting 
in a reservoir of 20 X SSC (3 N NaCl; 0.3 N sodium citrate). A sheet 
of nylon membrane (Hybond-N) was cut to the size of the gel and 
placed on top. Care was taken to avoid any air bubbles forming 
between the gel and the membrane as they would prevent migration of 
the DNA. Three layers of presoaked filter papers were placed on top 
of the membrane followed by a 10 cm stack of absorbent paper towels, 
and a glass plate with a weight placed on top of it to ensure even 
transfer. Transfer was allowed to proceed overnight, after which the 
filter was removed and washed in 2 X SSC. The filter was then 
allowed almost to dry on a piece of filter paper before being wrapped 
in Saran wrap and placed upside down on a UV trans illuminator for 5 
mm. This procedure covalently bonded the DNA to the nylon membrane. 
2.24.1.2 Northern transfer 
The RNA sample was electrophoresed in a denaturing agarose gel. 
Transfer of RNA to the nylon membrane was essentially as described 
for Southern Transfer above, using the method described by Thomas 
(1980) except that the membrane was baked for 2 hours at 80 °C after 
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transfer to reverse glyoxylation and to therefore allow the 
subsequent hybridisation steps to take place efficiently. 
2.24.2 Detection using radioactive probes 
2.24.2.1 5 end labelling 
Probing mixture: 
2 l (20iCi )132P-ATP (3000Ci/mmol ;Amersham P810168) 
3 Al 1 N Tris.HC1, pH8.0 
1.5 Al 0.1 N DTT 
1 Al 0.3 H MgC12 
20 pmol oligonucleotide 
H20 to 30 Al 
0.5 Al (5 units) polynucleotide kinase 
This reaction mixture was incubated at 37 °C for 1 hour before 
the enzyme was inactivated by incubation at 68 °C for 10 minutes. 
Incorporation of the ( 32P] into the ol igonucleot ides was checked by 
electrophoresing 2il of the completed digests on a 10% polyacrylamide 
gel. An autoradiograph was then taken of the gel. A 20 minute 
exposure of the gel was sufficient to see incorporation. The probes 
made were 20 and 17 oligomers. They were obtained by interpretation 
of the amino acid sequence of the amino terminus of CPT II, and 
constructed in the Orwell DNA synthesis unit, Department of 
Chemistry, University of Edinburgh. 
2.24.2.2 Random-primed labelling of DNA 
(Feinberg and Vogelstein, 1983) 
Linear DNA (50-100 ng) in a total volume of 35 z1 was heat 
denatured by boiling. After snap cooling on ice the DNA was mixed 
with 30 ACi a[ 32 P)-dCTP (3000 mCi/mmol), 10 Ag BSA, 10 jul 5 X OLB 
(0.05 H /-mercaptoethanol; 1 M HEPES pH 6.6; 0.03 U pd(N)6; 0.26 H 
Tris.HC1 pH8; 0.26M MgCl2; 0.1mM dATP, dTTP and dGTP) and 1 Al of 
Klenow fragment (5 U/al) from E.coli DNA polymerase 1. The reaction 
took place at room temperature over a 5-12 hour period. The 
radiolabelled DNA was separated from unincorporated nucleotides by 
firstly making the total volume of the reaction mixture to 200 Al 
with 4 X SSC (final concentration of 3 X SSC), then passing the 
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mixture through a 1 ml Sephadex G-50 column (made up in 3 X SSC), 
(modified from Haniatis et al, 1989). 
2.24.2.3 Incorporation of [ 32PJ by PCR techniques 
Linear DNA (50-100 ng) was used in a PCR reaction (normal 
conditions, see section 2.22.4) along with 50 iCi a( 32P3-dCTP (3000 
mCi/mmol). The radiolabelled DNA was then separated from 
unincorporated nucleotides (section 2.24.2.2). 
2.24.3 Hybridisation conditions 
The nylon membrane to which the DNA was bound was placed in a 
heat sealable bag with 0.2 ml of prehybridisation solution per cm2 of 
membrane. The bag was sealed and then incubated at 50 °C for >3 hours 
with constant shaking. Hybridisation was then carried out by adding 
50 ng of denatured labelled probe to the bag, resealing it and 
incubating it at 37 °C for > 6 hours with shaking. Care was taken 
during both prehybridisation and hybridisation to avoid air bubbles 
in the heat sealed bags. After hybridisation the membranes were 
washed with increasing stringency of temperature until all the 
background radiation had been washed off. The membranes were then 
allowed to dry before being autoradiographed at -70 °C. 
2.25 EXTRACTION OF TOTAL CELL PROTEIN FROM E.coli 
A single colony of E.coli. was grown in LB broth, supplemented 
with ampicillin, to stationary phase before being harvested by 
centrifugation at 9000 X g (Sorvall SS-34 rotor). The pelleted cells 
were resuspended in 1 ml of ice cold 10% TCA and transferred to an 
Eppendorf tube. Approximately 2 ml of glass beads (0.45 - 0.5, 40 
mesh) were added in order to fill the tube to just below the meniscus 
of the cell suspension. The tubes were then vortexed at full speed 
for 2 minutes. 10% TCA (1 ml) was added and the tubes which were 
vortexed again. The liquid was then removed to a fresh tube and 
combined with 2 X 1 ml 10% TCA washes of the beads. The precipitated 
protein was pelleted by centrifugation at 20000 X g (Sorvall SS-34 
rotor) for 5 minutes and was washed twice in cold ethanol to remove 
residual TCA. The protein pellet was dried and resuspended in 200 Al 
of 2 X LSB. Protein concentrations of these samples were estimated 
by spotting 2 Al dilutions of the cell extract onto a piece of filter 
paper, alongside 2 Al standards of 
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bovine serum albumin (1 &g/ml) and staining with Page Blue 83 
'Electran (BDR) solution made up in 20% methanol and 5% acetic acid. 
The amount of protein present could then be estimated by the 
comparative intensity of the blue spots. 
2.26  EXTRACTION OF TOTAL CELL PROTEIN FROM THE YEAST Saccharomyces 
cervisiae 
A single colony of S.cervisiae was grown in yeast extract broth 
to an 0D600 of 0.7. Cells were then harvested by centrifugation, 
washed in distilled water and resuspended in imi of ice-cold 10% TCA. 
The preparation of the protein was then carried out identically to 
the procedure for E.coli protein preparation. 
2.27 EXTRACTION OF TOTAL CELL PROTEIN FROM RAT LIVER 
Rat liver (1 g) was finely minced and homogenised in 3 ml of 
sucrose solution to form a thin emulsion. A sample was taken (0.5 g) 
and the rest was centrifuged at 1000 rpm (Servall SS-34 rotor) to 
remove cell debris. The supernatant was then centrifuged at 7000 rpm 
( Sorvall SS-34 rotor) to spin out mitochondria. This pellet was 
resuspended in sucrose solution as in section 2.11. This pellet of 
crude mitochondria was taken as the second sample. To each of the two 
samples an equal volume of 2% (v/v) Triton X 100 was added. The 
samples were then left on ice (with occasional stirring)' for 30 
minutes. The samples were then centrifuged at 9000 X g (Sorvall SS-
34 rotor) for 20 minutes at 4 °C. An equal volume of 20% PEG was 
added to the supernatant and the samples were then left on ice for a 
further 30 minutes. The protein-PEG precipitate was then pelleted at 
10000g for 20 minutes (4 0C). Care was taken to remove all of the PEG 
before resuspending the protein pellet in SDS sample buffer. The 
protein suspensions were boiled for 3 minutes and then centrifuged at 
9000 X g (Sorvall SS-34 rotor) for 3 minutes. The supernatant was 
transferred to Eppendorfs and frozen at -20 °C until required. The 
approximate concentration of the protein solution was estimated 
(section 2.13.1.1). 
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2.28 ONE DIMENSIONAL SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS OF 
PROTEINS 
This technique was used to separate proteins according to their 
molecular weight, (Laemmli, 1970). The polyacrylamide gel was 
prepared in two phases, a resolving gel for the separation of the 
protein samples and a stacking gel for the concentration of the 
protein samples before separation. The resolving gel was prepared by 
mixing the following solutions in the following order: 
30% Acrylamide : 0.8% bis-acrylamide 	 10.0 ml 
4 X Resolving Buffer 	 7.5 ml 
dH20 	 12.3 ml 
TEMED 	 30.0 Al 
10% Ammonium Persulphate (APS) 	 190.0 Al 
The gel was mixed well, poured between two glass plates and 
overlaid with water saturated butanol. It was then left to 
polymerise for 1 hour. Once the resolving gel had polymerised the 
water saturated butanol was rinsed off with distilled water and a 
stacking gel was prepared by mixing the following solutions in the 
following order: 
30% Acrylamide : 0.8% bis-acrylamide 	 1.6 ml 
4 X Stacking Buffer 	 2.5 ml 
dH20 	 5.86 ml 
TEMED 	 10.0 Al 
10% Ammonium Persulphate (APS) 	 30.01 
The stacking gel was mixed well and then poured on top of the 
resolving gel. A comb was then inserted into the top of the stacking 
gel and the gel was allowed to polymerise for 30 minutes. Once 
polymerised the gel was clamped into a vertical electrophoresis tank 
filled with 1 x running buffer. The comb was then carefully removed 
and the protein samples (in 2 X LSB) were loaded into the wells. The 
gel was then run at 10 volts per cm for 4 - 5 hours. The gels were 
stained with 1% PAGE Blue Electran in 20% (v/v) methanol, 5% (v/v) 
acetic acid. 
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2 • 29 ELECTOPHORETIC TRANSFER OF PROTEIN TO MEMBRANES BY WESTERN 
BLOTTING 
In order that specific proteins could be detected from a cell 
extract, the proteins were firstly electrophoresed and then 
transferred to a nylon membrane (Hybond-N) or a nitrocellulose 
membrane (Hybond-C). Once run the gel was soaked in 1 X transfer 
buffer for two minutes. It was then assembled into a "sandwich" with 
the gel adjacent to a piece of nylon membrane (Hybond-N) placed 
between 2 x 2 layers of 3 MM filter paper and foam sponge, (all pre-
soaked in 1 X transfer buffer). The proteins were then transferred 
onto the membrane, by immersing the sandwich in a tank containing 1 X 
transfer buffer and passing a current of 1 Amp through it for 2 
hours. The membrane was on the positive electrode side of the gel, 
since proteins migrate towards the positive electrode. The membrane 
was then dried or used immediately for immunodetection. 
2.30 METHODS OF BLOCKING THE UNFILLED SITES ON THE MEMBRANE FILTERS 
Agents used to block the unbound sites of the membrane were BSA 
and skimmed milk. These blocking agents were tried at various 
concentrations for both blocking and antibody incubation (both in the 
presense and absense of Tween 20) in order to find the most sensitive 
detection system. All blocking agents were made up in TBS, and once 
antibody was introduced, were stored at -20 °C and used up to 5-8 
times. Both nylon (}iybond-N) and nitrocellulose (Hybond-C) were used 
in the comparisons. 
2.30.1 Filters blocked with BSA 
The filters were blocked for 6 hours in 2% BSA made in TBS. 
First antibody incubations were carried out (individually) on each 
filter over night at R.T. in 2% BSA, 0.05% Tween 20 made in TBS. The 
filters were then washed extensively in 2% BSA, 0.05% Tween 20 in TBS 
before the second antibody or antibody affinity protein, was added to 
the filters. Incubations were again carried out in 2% BSA, 0.05% 
Tween 20, TBS, for 4 hours. The filters were then washed extensively 
before developing. 
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2.30.2 Filters blocked with skimmed milk proteins 
The filters were blocked for 6 hours in 2%,5%, and 20% (w/v) 
skimmed milk powder in TBS, at 25 °C overnight. The solution was then 
replaced with 20 ml of 0.5%, 2% and 5% respectively, skimmed milk 
powder in TBS. Antibody (30 l) was added and the membranes/ filters 
incubated at 25 °C for 5 hours. The antibody solution was stored at - 
20°C and was reused many times. After incubation with the antibody 
the membrane was washed in 100 ml of TBS, four times for 5 minutes. 
The membrane was then placed in fresh skimmed milk powder in TBS (at 
the same relative concentration) and second antibody or antibody 
affinity protein, was added. After incubation for 4 - 5 hours the 
membrane was washed as before and then developed. 
2.31 PREPARATION OF SERUM 
2.31.1 Removal of H. coli proteins from antibody serum 
A culture of a Xgtll lysogen of Y1090 was grown at 30 °C until 
an 0D650 of 0.5 was obtained. The culture was induced into lysis by 
incubation at 42 °C (shaking at 300 rpm) for 20 minutes. The culture 
was then incubated at 37 °C for 3 hours until total lysis had 
occurred. Chloroform was added to the culture if total lysis had not 
occurred at the end of 3 hours, and incubation continued for a 
further 15 minutes. After this the culture became clear. Membranes 
(82 mm Hybond-C) were then added to the culture and left to absorb 
E.coli proteins. 	These membranes were then incubated with the 
antibody serum at RT for 4 hours. 	Approximately 10 of these 
membranes were required to mop up all the antibodies against E. coli 
proteins present in the serum. 
2.31.2 Affinity purification of antibody 
Two thin strips were cut from each side of a (pre blocked) 
Western blot of partially purified proteins containg the main protein 
to which the antibodies were raised. These strips were then incubated 
with the serum and then with second antibody and developed (section 
2.32.1).. The position of the desired protein was then be accurately 
excised from the remaining undeveloped blot. The excised horizontal 
strips were then incubated with the impure IgG serum. Bound antibody 
was eluted with 0.2 M glycine (pH2.8), at 15 °C for 2 hours. The 
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eluted antibody was neutralised with sodium hydroxide, containing 1 
mg/ml soyabean trypsin inhibitor and dialysed against three changes 
of TBS containing 10% (v/v) glycerol, for three hours at 4 °C. BSA (2% 
w/v) was added and the purified antibody was stored at -70 °C. 
2.32  DETECTION SYSTEMS 
2.32.1 Horse radish peroxidase 
Horse radish peroxidase-conjugated anti-rabbit IgG (Biorad) and 
anti-sheep/goat IgG (Scottish Antibody Production Unit) were used as 
second antibodies. Antibody (10-20 Al) was added to a small volume of 
the diluted blocking agent and incubated with the washed membranes at 
25 °C for 2 hours. The membranes were then washed thoroughly and 
developed by shaking the membrane in 10 ml of developing solution 
(0.5 ml of 5 mg/mi dianisidine, 1 ml of 0.1 N imidazole (pH 7.4), 0.1 
ml. of 30% H202 and 8.4 ml of water) until a pink band appeared. Where 
larger membranes were used the volumes were scaled up accordingly. 
The reaction was stopped by rinsing the membrane in distilled water 
and the membrane left to dry. The developed membrane was 
photographed since the colour tended to fade with time. 
3.32.2 [ 125 1J-Protein 0 
( 125 1)-Protein G was also used as a detection system for 
sheep/goat antibodies. The method was as above but after incubation 
with protein G (5 ACi1l00 ml) the membranes were autoradiographed at 
-80 °C for 40 - 70 hours. 
2.33 TECHNIQUES INVOLVING BACTERIOPHAGE X 
2.33.1 Preparation of X libraries for screening 
Mid log phase bacteria were prepared making a 1:10 dilution of 
an overnight culture of E.coli. This was grown to mid-exponential 
phase (3 hours) and was then spun down at 9000 X g (sorvall SS-34 
rotor) for 10 minutes. The pelleted cells were suspended in 1 mM 
MgSO4 and aliquoted into 100 Al quantities directly before use. The 
MgSO4 Suspension could be stored at 4 °C for up to 3 days. Confluent 
plaques were obtained by incubating 100 Al of plating cells with 100 
Al of the appropriate dilution of the bacteriophage X at 37 °C for 20 
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- 45 minutes. The mixture was then poured onto fresh ainpicillin 
supplemented LB plates along with 3 ml of LB ampicillin supplemented 
top agar. The plates were then incubated at 37 °C for 8 to 12 hours. 
2.33.2 A DNA small scale preparation 
Individual plaques were picked and placed in 1 ml of SM buffer 
with 10 il of chloroform. The phage were allowed to elute into the 
buffer (kept at 4 °C) for 5 hours before being titred by drop 
inoculation on a lawn of E.coli Y1088, From this titre the volume of 
SM/Phage stock required to cause 10 X confluent lysis was plated out 
as in section 2.33.1. After incubation, 5 ml of SM buffer was added 
to the plates of confluent lysis and left shaking at 25 °C for 5 
hours. 	The sM-phage was harvested and centrifuged at 9000 X g 
(Sorvall SS-34 rotor) for 10 minuz.es. 	The supernatant was then 
incubated with DNase and RNase (50 Ag/ml) for 30 minutes at 37 °C. An 
equal volume of polyethylene glycol (20% PEG 6000;2 M NaCl; 10 mM 
MgSO4) was added to the buffer which was then kept in a slush of ice 
and water for 1 hour. The buffer was then centrifuged at 17000 X g 
(Sorvall SS-34 rotor) for 20 minutes at 4 °C to precipitate the phage. 
The phage pellet was then resuspended in 10mM MgSO4 (0.25-0.5ml) with 
vortexing. The phage were then centrifuged (Sorvall SS-34 rotor) at 
9000 x g to clarify the solution. To the supernatant 5il of 10% SDS 
and 5M1  of 0.5M EDTA were added per 0.5ml of resuspension volume. 
This solution was then incubated at 68 °C for 15 minutes. The phage 
DNA was then extracted twice with phenol : chloroform and then 
ethanol precipitated. The phage DNA was then precipitated by 
centrifugation at 20000 X g (Sorvall SS-34 rotor) for 20 minutes (4 ° 
C). The DNA pellet was then resuspended in TE buffer. 
2.33.3 Screening cDNA library contained in Xgtll 
and XgtlO 
The percentage of recombinants in the libraries was checked in 
two ways. Firstly by adding 50 i1 of X-gal (20 mg/ml) and 50 Al of 
IPTG (20 mg/ml) to 3 ml of top agar and plating out 1000 pfu. The 
plaques which were blue in colour were non recombinants, whereas 
recombinant plaques would be colourless. 
Secondly, prepared X DNA from confluent plates was digested (in 
T.E. buffer) with the restriction enzyme EcoRl (1-2 U), and 
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electrophoresed in a 0.8% agarose gel. Both the insert size and 
abundance were then visualised under UV light. 
2.33.4 Plaque lifts using nylon and nitrocellulose membranes (Hybond-
N and Hybond-C respectively) for DNA detection systems 
In order to increase the efficiency of transfer of the DNA to 
the membrane, the discs were pre-wet by placing on a blank agar 
plate. This also stopped the discs from slipping on the agar surface 
during lifting. Hybond-N discs however did not require to be pre-wet 
since they are hydrophilic. The discs were then placed on plates 
containing lawns of plaques to be screened and orientated with three 
pins. The discs were removed from the plates, washed in 2 X SSC and 
placed on a filter paper which had been pre-soakéd in denaturing 
solution (1.5 M NaCl; 0.5 N NaOH). The discs were left for 7 mm, 
before being placed, face up, on a filter paper which had been pre-
soaked in neutralising solution (1.5 M NaCl; 3.0 M sodium citrate) 
for 6 minutes. The soaked filter paper being renewed after 3 minutes. 
The transferred DNA was then covalently bound to the discs by UV 
illumination for the Hybond-N and baking in a vacuum oven (80 °C for 2 
hours) for the Hybond-C. The filters were then ready for 
prehybridisation (section 2.24.2). 
2.33.5 Xgtll plaque lifts for screening with antibodies 
(Young and Davis, 1983a&b) 
Lawns of plaques (10,000 pfu per 82 mm plate) were grown on 
plates of E.coli Y1090 at 42 °C for 4 hours. The plates were then 
overlaid with dry membranes (Hybond-C) that had been presoaked in 
50mM IPTG. The plates complete with membranes were then incubated at 
37 °C for 12 hours. The position and orientation of each membrane was 
marked by pushing 3 pins through the membrane into the agar. The 
membranes were blocked (section 2.30.1), incubated with antibody and 
developed as in section 3.32.1. Positive plaques were isolated using 
the sterile blunt end of a Pasteur pipette and the plug eluted in lml 
of SM plus 10 ul of chloroform. After 4 to 5 hours elution the 
putative positive plaques were replated and screened at a density of 
500 pfu per 82mm plates. The positives were rescreened 4 to 5 times 
until pure positive plaques were obtained. Phage DNA of the positive 
plaques was prepared as described in section 2.33.2 and the insert 
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excised using the restriction enzyme EcoRl. The insert was then 
separated from the X arms by agarose gel electrophoresis on a 1% gel 
in TBE buffer. The insert was excised from the gel and purified by 
Gene Cleaning. The fragment was then ligated into the EcoRl site in 
the plasmid pTZ from which large quantitieS of double stranded and 
single stranded DNA could be prepared for restriction analysis, 
probing and sequencing respectively. 
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79 
CHAPTER 3 
The Purification of Carnitine Palaitoyltransferase (CPT) I 
3.1 INTRODUCTION TO THE PURIFICATION OF CPT I 
There has been much speculation regarding the system whereby 
long chain fatty acids enter the mitochondria prior to $ oxidation. 
There are three components involved, carnitine palmitoyltransf erases 
I and II, (CPT I and II), and a darn itine-acylcarnitine translocase. 
The system was originally conceptualised by the pioneering work of 
Fritz and Yue (1963), and Bremer (1963). Since the initial work, the 
system has been refined (Pande, 1975; McGarry and Foster, 1980; 
Murthy and Pande, 1987a), and is currently thought to function as 
shown schematically in Fig. 3.1. Since the late 1970s it has become 
evident that CPT plays a pivotal role in regulation of fatty acid 
oxidation in liver (and probably other tissues) due to the marked 
sensitivity of CPT I to malonyl-00A (McGarry and Foster, 1980). The 
inhibition of CPT I was seen with intact mitochondria, but not with 
solubilised membranes. After treatment of the mitochondria with 
detergents such as Tween 20, the amount of CPT activity in the 
supernatant was almost 50% more than the total CPT activity of intact 
mitochondria. This solubilised CPT activity was no longer malonyl-CoA 
sensitive. The residual membrane however, still showed significant 
CPT activity, and this remaining activity was as sensitive to 
malonyl-00A as the activity of the intact mitochondria. Since these 
discoveries, two main theories have been suggested. One is that CPT I 
and CPT II are in fact identical proteins residing on either side of 
the mitochondrial inner membrane and that the malonyl-CoA sensitivity 
is due to a regulatory subunit associated with CPT I, which is 
dissociated by solubilisation of the membranes (McGarry and Foster, 
1980; Bremer, 1983; Hoppel and Brady, 1985). The second theory is 
that CPT I resides in the outer mitochondrial membrane, (Murthy and 
Pande, 1987b) and is distinct from CPT II (Woeltje et al, 1987; 
Declerq et al, 1987; Zammit et al, 1989; Murthy and Pande, 1990). In 
either case many of the questions regarding the relationship between 
the two enzymes could only be answered by purification of either or 
both of the proteins, followed by cloning of the gene or genes 
concerned. 
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Pig. 3.1 Two theories as to the location of carnitin. 
palaitoyltransf.ras. I in rat liver aitochondrial membranes 
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3.2 PURIFICATION OF RAT LIVER MITOCHONDRIAL OUTER 
MEMBRANES 
Rat liver mitochondrial outer membranes were purified as 
detailed in section 2.11. Since the two CPT activities cannot readily 
be differentiated from each other, assays of marker proteins unique 
to either outer or inner mitochondrial membrane were used to 
determine the degree of purification of the enzymes. Monoamine 
oxidase activity (MAO; section 2.12.2) and cytochrome C oxidase 
activity (section 2.12.1), were used as markers for outer and inner 
membranes respectively; The ratios of these activities before, during 
and after purification along with the CPT activities (radiolabelled 
assay, section 2.12.4) were used to determine the degree of 
purification of the outer membrane preparation. The purification of 
the outer membranes from mitochondria resulted in a 96.9% loss of MAO 
activity (the outer membrane marker); a 99.9% loss of cytochrome c 
oxidase activity (the inner membrane marker); and a 75.2% loss of CPT 
activity (Table 3.1). However after purification there was a 13 fold 
increase and a 20 fold decrease in the specific activities of MAO and 
cytochrome c oxidase, respectively (Table 3.2) as would be expected 
when enriching for outer membranes. The increase in the specific 
activity of MAO was accompanied by a 20 fold enrichment of CPT 
activity (Table 3.2). The purification profile was altered when the 
last activated-sepharose step was replaced by solubilisation of the 
membranes with Tween 20 (Tables 3.3 & 3.4). Although the specific 
activity of CPT purified by Tween 20 solubilisation was slightly less 
than that of a sepharose treated membrane preparation, the 
reproducibility of purification was greatly improved, and the amount 
of malonyl-00A insensitive enzyme activity decreased. This was 
demonstrated by measuring malonyl-00A sensitive CPT activity before 
and after solubilisation of both fractions. Table 3.4 shows that 7-
12% of the CPT activity present in the outer membrane fragments was 
in fact malonyl-CoA insensitive CPT II, therefore the CPT activity 
within the outer membranes is predominantly due to malonyl-00A 
sensitive CPT I. Preparations of mitochondrial outer membranes were 
used to study the effect of inhibitors on the activity of CPT I and 
also served as a good starting point in the purification of CPT I. 
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Table 3.1. Measurement of the total activity of the enzymes in a 
preparation of purified outer membranes 
% loss of 
- KPi Final Activity 
CPT (nmol/min) 4982 1233 75.2 
MAO (nmol/min) 5760 178 96.9 
Cyt c oxidase (units) 	142200 44 99.9 
Table 3.2. 	The specific activity of the enzymes in a preparation of 
purified outer membranes 
Number of Fold 
KPi Final Enrichment 
CPT(fllflol/min/ing) 9.4 272 29 
MAO (nmol/min/mg) 9.4 119 13 
Cyt c oxidase (units /mg) 593 29 0.05 
Table 3.3. 	The specific activity of the enzymes after final Stage 
purification by Tween 20 extraction 
Number of Fold 
KPi Final Enrichment 
CPT (nmol/min/mg) 7.7 170 22 
MAO (nmol/min/mg) 2.9 73 25 
Cyt c oxidase (units /mg) 178 93 0.5 
Table 	3.4. 	Malonyl-00A sensitive CPT activity 	before 	and 	after 


















KC1 	% inhibition 
100 	 63 
4 	 0 
95 	 76 
19 	 0 
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3.3 INHIBITION OF CPT I BY 2-BROZ4OPALNITOYL-COA 
2-Bromopalmitoyl-00A (BrP-00A) is known to be a slowly 
reversible inhibitor of CPT activity (Grantham and Zammit, 1986). It 
competes competitively for the same CPT I binding site as palmitoyl-
00A. The inhibitor action was studied by comparing the activity of 
highly purified membranes before and after incubation with BrP-00A 
(section 2.15.1). The maximum inhibition of CPT activity (90%) was 
obtained when the membranes were incubated with 5 p11 BrP-00A in the 
presence of 1.25 mM carnitine. After the incubation with BrP-00A and 
carnitine the membranes were washed extensively to remove the cold 
carnitine which otherwise could affect the radioactive assay for CPT 
by diluting the ( 3H]-carnitine substrate. The quality of the purified 
outer membranes also affected the extent of the inhibitory effect of 
BrP-00A on CPT so that only in the purest preparations was inhibition 
at a maximum. 
3.4 BINDING OF TRITIATED CARNITINE BY OUTER MEMBRANES 
IN THE PRESENCE OF BRP-COA 
The binding of ( 3H]-carnitine by highly purified membranes was 
measured in the presence and absence of BrP-CoA. The incubations were 
carried out as described in section 2.15.3. The samples were then 
washed in albumin (3 mg/10 ml of 500mM KCl), until negligible counts 
were observed in the washings. It was apparent from the assays (Table 
3.5), that membranes bound 50% more carnitine in the presence of S AM 
BrP-00A, than in controls (7.6 nmol of CPT active protein in rat 
liver outer membrane fragments bound 43 pmol of carnitine in the 
presence of BrP-CoA, and 31 pmol of carnitine in the absence of BrP-
C0A). This suggests that BrP-CoA does not compete with carnitine or 
inhibit its binding, but inhibits the formation of the ester bond 
between the palmitate and the carnitine probably through steric 
interference by the bromide group. 
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Table 3.5. The effect of bromopalmitoyl-CoA (BrP-CoA) on the binding 
of [ 3H]-carnitine by highly purified outer membranes 
control (dpm) BrP-00A(dpm) 
Wash 1 
Wash 2 67760 56261 
Wash 3 1313 1726 
Wash 4 633 919 
Wash 5 797 746 
pellet 6485 10107 
ratio 	of [ 3H)-carnitine 
bound 	in presence 	and 1 1.5 
absence of BrP-00A 
Mitochondrial outer membrane fragments were adjusted to a 
protein concentration of 2.5-3.0 mg/ml with 500 mM KC1. Incubation of 
the membranes with [ 3H)-carnitine in the presence of 10 AM BrP-00A 
was performed as described in section 2.15.3. All experiments were 
carried out with outer membranes prepared from 48 hour starved rats. 
The washes were carried out by resuspension of the pellet in a 
solution of albumin. (3 mg/lOml of 500. mM KC1), followed 'by 
centrifugation at 100000 X g (Beckman Air-fuge). Opti-fluor 12 
scintillant was then added to the supernatants and the final pellet. 
The samples were counted in a scintillation counter. This is a 
typical example of many similar experiments in which the increase of 
bound [ 3H]-carnitine caused by BrP-00A ranged from 45% to 60% giving 
an average of 50%. 
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3.5 INHIBITION OF CPT I BY MALONYL-COA 
Highly purified membranes were treated with 100 p14 malonyl-00A 
and used for measuring CPT activity as described in section 2.15.2. 
100 p14 Malonyl-00A inhibited the highly purified outer membrane CPT 
activity by 67% when compared to untreated membranes (Table 3.6). 
When the membranes were solubilised with Tween 20 the malonyl-00A 
inhibited the CPT activity in the remaining membrane pellet by 86%. 
The enzyme activity in the supernatant was not inhibited. In the 
comparison between the Tween 20 treated membranes and distilled water 
treated membranes, there was no notable difference in the results. It 
was noted that if the rats, from which the membranes had been 
prepared, had been starved for 48 hours, the maximum binding of the 
malonyl-00A was increased, (Kolodziej and Zamznit, 1990a) but the 
inhibitory effect of malonyl-00A was reduced by 40% (Table 3.7). 
3.6  EFFECTS OF DETERGENTS ON CPT I ACTIVITY 
The following detergents were all tested to determine their 
inhibitory effects on the activity of CPT I as described in section 
2.14.1. These tests were performed as preliminary work before 
solubilisations were performed. If the detergents showed adverse 
effects on the activity of CPT I then, regardless of their 
solubilisation properties, they would be useless in the purification 
of the enzyme. Tween 20, octyl glucoside and Mega 8 produced 
relatively low levels of inhibition of CPT I activity at all 
concentrations with 40 mM Tween 20 producing negligible inhibition. 
CHAPS almost totally inhibited the CPT I activity even at the lowest 
concentration which was tested (10 mM). Mega 10 also caused total 
inhibition, but was only semi-soluble in low ionic strength buffers 
such as KC1 and KPi (Table 3.8). 
3.7 SOLUBILISATION OF CPT I BY DETERGENTS 
Having established the inhibitory profile of the detergents the 
next stage was to determine whether the detergents had solubilised 
CPT I from the membranes. This was carried out as described in 
section 2.14.2. 
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Table 3 • 6. Inhibition of CPT activity in Twoen 20 treated rat liver 
mitochondrjal outer membranes by 100 AN malony]-CoA 
control 	+malonyl-00A 	% inhibition 
supernatant 	 25 	 26 	 0 
pellet 	 78 	 11 	 86 
Mitochondrial outer membrane fragments were prepared from fed 
rats as described in section 2.11 and assayed for malonyl-00A 
inhibition of CPT activity (Section 2.15.2). Tween 20 solubilisation 
of the membranes (Section 2.14.2), was carried out inorder to extract 
all CPT II activity which is malonyl-CoA insensitive (McGarry and 
Foster, 1980). The results shown here are an average of three 
experiments where the variance of malonyl-00A inhibition was no more 
than 8%. 
Table 3.7 Inhibition of CPT activity in Tween 20 treated rat liver 
mitochondrial outer membranes, prepared from 48 hour starved rats, by 
100 LM malonyl-CoA 
control 	+malonyl-CoA 	% inhibition 
supernatant 	 7 	 8 	 0 
pellet 	 85 	 49 	 42 
Mitochondrial outer membrane fragments were prepared from 
starved rats as described in section 2.11 and assayed for malonyl-CoA 
inhibition of CPT activity (Section 2.15.2). Tween 20 solubilisation 
of the membranes (Section 2.14.2), was carried out inorder to extract 
all CPT II activity which is malonyl-00A insensitive (McGarry and 
Foster, 1980). The results shown here are an average of three 
experiments where the variance of malonyl-CoA inhibition was no more 
than 6%. 
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Table 3.8 The Effect of Detergents on CPT I Activity as reported by 
dpm of sample and percentage inhibition from control 
Blank 129 dpm 	Control : 6610 dpm 
OG CHAPS MEGA 8 MEGA 10 Tween 20 
Conc dpm % dpm 	% dpm % dpm % dpm % 
(MM) 
40 296 95 140 	98 3575 46 721 89 5948 8 
20 4148 37 90 	98 5473 17 295 95 5125 20 
10 5858 11 65 	99 3877 41 712 89 5563 14 
These results are typical of five experiments to determine the effect on CPT activity of the 
presence of detergents. 
Table 3.9 Solabilisatjon of CPT I by Detergents as Determined by 
Activity (dpm) 
Control 	Supernatant : 	244 dpm 
Pellet : 	5303 dpm 
OG CHAPS 	 MEGA 8 Tween 20 
Conc 	sup. 	pel. sup. 	pel. 	sup. pel. sup. pel. 
(MM) 
40 	171 	123 213 	180 	532 	2584 171 	4832 
.20 	1026 	484 194 	169 	179 	5107 109 	4789 
10 	511 	1023 304 	458 	153 	5509 98 	4874 
These results are typical of numerous experiments to determine the solubilisation effect of 
the detergents on CPT I from rat liver mitochondrial outer membranes. 
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From Table 3.9 it can be seen that Tween 20 and Mega 8 had 
little solubiliaation effect on CPT I at any of the concentrations 
used. CHAPS (20 and 40 inN) however solubilised the enzyme but caused 
a total loss of activity in the supernatants. Octyl glucoside (20 and 
40 mM) solubilised the enzyme and supernatants produced after 
treatment with 20 mM octyl glucoside contained some enzyme activity. 
The concentration of octyl glucoside was varied and it was found that 
35 mM octyl glucoside in 500 mM KC1 was the concentration which 
caused optimal solubilisation, while still retaining CPT I activity 
in the supernatant (Fig. 3.2). It was also noticed that there was a 
reproducible loss of total CPT activity in octyl glucoside treated 
outer membranes (i.e. supernatant plus the respective pellet) 
irrespective of octyl glucoside concentration. This inhibition was 
in the order of 62% when compared to the control, which in turn was 
only 42% of the original membranes before treatment. Using the [ 3H]-
carnitine to detect solubilisation it was found that under the 
conditions described by Murthy & Pande (1987b), 35 mM octyl glucoside 
in 500 mM KC1, 60% solubilisation could be obtained. 
3.8 PURIFICATION OF CPT I FROM OUTER MEMBRANES 
The aim of this experiment was to identify and locate CPT I by 
following the radioactivity in a complex with a labelled ligand on a 
non-denaturing polyacrylamide gel, made with trimethyl sulphone 
(sulphalane) (Vecchio et al ; 1984). The relative mobility of the 
complex (Rf) could be calculated and the appropriate band cut from an 
identical acrylamide gel. This protein could then be run on a SDS 
polyacrylamide gel along with molecular weight standards giving an 
estimate of the molecular weight of CPT I. An outer membrane 
preparation was solubilised in Tween 20 to remove any residual CPT II 
activity. It was then mixed with BrP-00A and 12.5 AM L-carnitine (± 
100 Aci [ 3H]-carnitine) before being solubilised twice with 35 mM 
octyl glucoside in KC1 (500 mM). Polyethylene glycol (PEG) was added 
to the combined supernatants to a final concentration of 20%. This 
was stored on ice for 20 minutes before centrifugation at 100000 x g 
for 1 hour (Beckman Air-fuge). The protein pellet was then 
resuspended in 50% suiphalane to give an approximate protein 
concentration of 1 mg/mi. 
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Fig 3.2 	CPT I activity in the supernatant of octyl glucoside 








25 	- 	30 	 35 	 40 
Octyl Glucoside conc. (mM) 
Membranes, devoid of CPT II activity (Section 3.2), were 
solubilised as in section 2.14.2. The membranes were then centrifuged 
at 100000 X g in a Beckman Air-fuge and the supernatants assayed for 
CPT activity (Section 2.12.4). The protein concentration of the 
membranes was 2 mg/ml and the highest concentration of octyl 
glucoside that caused solubilisation while retaining significant CPT 
activity was 35 mM. 
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This sulphalane suspension was then centrifuged at 8000 x g for 
2 minutes (Beckman Air-fuge) to remove any particulate matter still 
present. The sulphalane suspension was then divided into two and run 
on a 5% sulphalane polyacrylamide gel (25 V for 8 hours at 4 0C). The 
gel and its buffers were prepared as normal, (section 2.28) but 
sulphalane was substituted for SDS. After electrophoresis the gel 
was cut into two halves, one of which was stained for protein (Fig 
3.3). The other half was cut into 120 slices each 2 mm wide. The 
slices were dissolved in 200 Al of soluene, then placed in 10 ml of 
toluene and the amount of bound ( 3H)-carnitine in each slice was 
measured in,a scintillation counter (Table 3.10). 
3.9 DIALYSIS OF SOLUBILISED MEMBRANES TO ENSURE THAT SOLUBILISED CPT 
IS STILL BINDING ( 3HJ-CARNITINE 
During the solubilisation of CPT I with octyl glucoside it was 
noted that most of the [ 3H]-carnitine was being released from the 
enzyme. This was probably due to denaturation of CPT I. ( 14C)-Glucose 
was introduced to the assay mixture in order to confirm that the CPT 
I was binding the BrP-00A and [ 3}I]-carnitine. Glucose was used since 
it is of similar size to carnitine but should not be bound 
specifically to the membrane and will therefore give a control rate 
of dialysis of non-bound substrate. The membranes were then dialysed 
as described in section 2.16. The rates of dialysis of the two 
labelled compounds were measured. The results showed that a large 
proportion of the carnitine was in fact non-specifically associated 
with the membrane because the [ 3M]-carnitine dialysed off the 
membranes at the same rate as the ( 14CJ-glucose (Fig. 3.4). Therefore 
carnitine did not remain specifically bound to CPT I during 
solubilisat ion. 
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Fig 3.3 Optical densitometer scan of non denaturing polyacrylamide 
gel 
' 
50 	60 	70 	60 	30 	100 	110 	120 	130 	140 	130 	160170 
IC (IM) 
Mitochondrial outer membrane fragments from starved rat livers 
(Section 2.11), incubated with BrP-CoA and 12.5 jiM L-carnitine (± 100 zCi [ 3H]-
camitine) (Section 2.15.3) were solubilised twice with 35 mM octyl glucoside in KC1 (500 MM) 
(Section 2. 14.2). Polyethylene glycol (PEG) was added to the combined supernatants to a 
final concentration of 20%. This was stored on ice for 20 minutes before centrifugation at 100000 x 
g for 1 hour (Beckman Air-fuge). The protein pellet was then resuspended in 50% sulphalane to give 
an approximate protein concentration of 1 mg/mi. This suiphalane suspension was then centrifuged 
at 8000 x g for 2 minutes (Beckman Air-fuge). The sulphalane suspension was then devided into two 
and separated on a 5% sulphalane polyacrylamide gel. The gel and its buffers were prepared as 
normal, (section 2.28) but sulphalane was substituted for SDS. The gel was cut into two halves, one 
of which was stained for protein with page blue and scanned on an optical 
dens itorniter. 
The other half was cut into 120 slices each 2 mm wide. The slices were dissolved in 200 jl 
of soluene, then placed in 10 ml of tolulene and the amount of bound [ 3H]-camitine in each slice was 
measured in a scintillation counter (Table 3.10). The radioactive peaks from Table 
3.10 (1 to 6) have been superimposed onto the scan (right hand dprn 
scale) 
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Table 3.10 Rf values of gel slices with dpa significantly abOve 
control 
Rf 	value. dpm 
1 	0.92 151 
2 0.80 446 
3 	0.75 215 
4 0.68 241 
5 	0.57 244 
6 0.52 148 
The results reported here are from one experiment which was 
unreproducible. The dpnw reported are above background, but not 
significant enough to represent large quantities of [ 3H]-carnitine 
bound by CPT I protein. For superimposition over the protein gel see 
Fig. 3.3. 
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Fig. 3.4 Rates of dialysis of both [ 3H]-carnitine and [ 14C-.glucose 
from bromo-palmitoyl-coA treated rat liver aitochondrial outer 
membranes 
dpm X103 (of dialysed sample) 
Time dialysed (minutes) 
Mitochondrial outer membrane fragments from starved rat livers 
(Section 2.11) were incubated with bromo-palmitoyl-00A (BrP-00A) and [3 H]-
carnitine (Section 2.15.3), along with [ 14C]-glucose (Section 3.9). The membranes (100 ,il) 
were then dialysed using a micro dialyser (section 2.16). Samples 
were taken after periods of dialysis, counted in a scintillation 
counter and graphed as above. The total volume was measured at each 
sample time, allowing the total number of counts to be calculated for 
the sample. 
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3. 10 DIGESTION AND N-TERMINAL AMINO ACID SEQUENCING OF PEPTIDES 
IDENTIFIED BY THE COVALENT MARKER 2-TETRADECYLGLYCIDYL-COA (TDG-COA) 
(Carried out in collaboration with Marian Koldziej, Hannah Research 
Institute, Ayr). 
Kiorpes et al (1984), identified 2-tetradecylglycidyl-00A (TDG-
C0A) as an irreversible inhibitor of CPT I. It was later shown to 
also inhibit malonyl-00A binding (Declerq et al, 1987). The authors 
therefore suggested that TDG-00A bound to the same CPT I regulatory 
site as malonyl-00A. If, therefore, the malonyl-CoA binding site for 
CPT'I regulation, resides on CPT I itself, then protein purification 
from outer mitochondrial membrane fragments labelled with TDG-CoA 
could allow the purification of CPT I. 
Using this principle Kolodziej et al (1992), partially purified 
an 84 kDa TDG-00A binding protein. They raised antibodies to this 
protein and reported that they could immunoprecipitate CPT activity 
with the sera and therefore suggested that the protein was CPT I. 
The TDG-00A binding, protein was subjected to N-terminal amino 
acid sequencing by Bryan Dunbar (Aberdeen University, Mariechal 
College, Aberdeen). The N-terminal sequencing of the partially 
purified protein was unsuccessful because the protein was N-
terminally blocked. This is a common problem in protein sequencing 
and is usually caused during the purification of the protein. Known 
blocking agents such as spectrophotometrically impure acrylamide can 
be avoided, but, other blocking agents are more specific to the 
protein being purified. Attempts to sequence the TDG-00A bound 
protein were not reproducible and on occasions appeared to be derived 
from albumin which had been added during the purification (Table 
3.11). 
Attempts were made to digest the TDG-00A binding protein with 
an endoproteinase (section 2.13.2.1). Care had to be taken during the 
digestion of the TDG-00A binding protein with the endoproteinase 
because it was unstable and prone to rapid degradation. The digests 
of the TDG-00A binding protein were carried out by N. Kolodziej, 
(Hannah Research Institute, Ayr) and myself. The enzymes used were, 
endoproteinase Asp-N (Pseudomonas fragi mutant) and endoproteinase 
Glu-C (Staphylococcus aureus V8). 
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Table 3.11 Sequences obtained from N-terminal amino acid sequencing 
of a 84 kDa TDG-00A binding protein 
Cycle A B 
1 Thr lie/Lye 
2 - Val 
3 Lye Glu 
4 Ser lie 
5 Glu Ala 
6 lie Leu 
7 Ala Asp 
8 Ala Phe 
9 Phe Lye 
10 Lye Gly 
ii - Leu 
12 Leu Giy 
13 - Glu 











Table 3.12 The N-terminal amino acid sequences of peptides produced 
from an 84 kDa TDG-00A binding protein after digestion with 


























Table 3.13 Sequences obtained by N-terminal amino acid sequencing of 







A Val * 
A Ala * 
A Phe * 
£ Gin * 
A Phe * 
A Thr * 
A Val * 


























































V Gin • 
V Gin 
V Met • 













































Digests of the TDG-00A binding protein with Asp-N were carried out at 
temperatures between 22 °C and 37 °C (Noreau and Drapeau, 1979; 
Drapeau, 1980). These yielded peptides that were only just readable 
above background on the amino acid sequencer. The derived amino acid 
sequences were not reproducible on repeat experiments (Table 3.12). 
The only enzyme that proved to be successful in the production 
of peptides suitable for sequencing was V-8 endoproteinase, using the 
method reported by Cleveland at al (1977), (N. Kolodziej, Hannah 
Research Institute, Ayr). The optimum recommended incubation 
temperature of V8 endoprotease is 37 °C. Successful incubations with 
V8 eridoproteinase were carried out at 0 °C for 1, 5, 10, 20 and 40 
minutes. The digestion products were separated by electrophoresis 
using a 15% polyacrylamide gel. The peptides were transferred to 
nitrocellulose, lightly stained with amido black, excised and used 
for N-terminal amino acid sequencing. Although there were many 
different sized fragments generated, only 5 different amino acid 
sequences were obtained by the sequencer (Table 3.13). 
3.11 POLYMERASE CHAIN REACTION 
(Section 2.22.4) 
Using the peptides marked by (*) and (°) in Table 3.13, 
oligonucleotidea (of both sense and anti-sense orientations) were 
generated incorporating total codon degeneracy. Non-degenerate 
'gueesmer' oligonucleotides (section 2.8) were also made from the 
sequences marked (ii) and (V) in Table 3.13, using known rat liver 
codon usage. 
A = adenine; T = thymine; C = cytosine; G = guanine; 
R = purine (A or G); 	Y = Pyrimidine (C or T); 
N = A,G,C, or T. 
Degenerate oligonucleotides (*) & (•): 
sense 	a: 	5' "GTNGCNTTYCARTTYACNGT" 3' 
anti-sense a: 	5' "ACNGTRAAYTGRAANGCNAC" 3' 
sense 	b: 	5' "CARCARATGCARCARAT" 3' 
anti-sense b: 	5' "ATYTGYTGCATYTGYTG" 3' 
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Non-codon degenerate olignucleotides () & (V): 
sense 	C: 5' "CAGCAGGCTGTGGCTTTTCAGTTTACcGTGACCCCA" 3' 
anti-sense C: 
5' "GCCATCTGGGGTCACGGTAAACTGAAAAGCCACAGCCTGCTG 3' 
sense 	d: 5' MCAGCAGATGCAGCAGATCCTGGATGATCCA" 3' 
anti-sense d: 5' "TGGATCATCCAGGATCTGCTGCATCTGCTG" 3' 
The templates used were from the following sources; rat liver 
cDNA libraries in XgtlO and Xgtll; rat liver mRNA; rat liver cDNA; 
and rat liver RNA/DNA duplex. Although mRNA is not itself considered 
as a template for PCR, it has been shown that PCR of mRNA is very 
successful (Tee and Forget, 1990). This method is very effective, 
even when subnanogram amounts of total cellular RNA are used, and is 
thought to be possible because of reverse transcriptase activity of 
Taq polymerase. 
All the PCR products which were obtained by the above methods, 
were excised and purified from a 2% agarose gel. They were then 
phosphorylated, blunt-ended and cloned into pTZ19 or pTZ18. Single 
stranded DNA was then prepared and sequenced using the universal 
reverse sequencing primer. 
A total of 24 clones was isolated in this way none of which had 
sequences corresponding to fragments of the malonyl-CoA binding 
protein (section 3.10). Positive identification can be made only when 
predicted amino acid sequence of the PCR product is identical to the 
amino acid sequence of the malonyl-00A binding protein, beyond the 
sequence to which the oligonucleotide primer was generated. 
When the X cDNA was used, all of the PCR products were 
identified as stretches of out of phase X DNA. In the other cases the 
clones were not necessarily identified (sequences unidentified by 
known sequences in data banks) but were not the malonyl-CoA binding 
protein. Fresh preparations of rat liver mRNA were prepared from 48 
hour starved animals in order to increase the level of expression of 
CPT I and the malonyl-00A binding protein. New clones were generated 
but were positively identified as non CPT I clones. 
The conditions of the PCR reactions were also varied for all 
the different templates used. The temperature of annealing was varied 
between 32 °C and 60 °C as a control for non-specific binding, but this 
did not affect the number of false positives being amplified simply 
because the primers, being heterogeneous, were binding to 100% 
complementary stretches of DNA, and therefore would not dissociate 
before true positives. Abundance of the target cDNA and distance 
between the two primers would then play a significant role in 
determining which products would be amplified. In this case the large 
abundance of multiple products from the primers swamped any true 
clones being amplified. 
Extension time was also varied as the distance between the 
primers was unknown. The limit of Taq polymerase is known to be 
around 2 kb of DNA per 2 min extension time. This, however, is an 
optimum figure achieved in ideal conditions and does not include ramp 
times (the time taken for the temperature control unit to reach the 
desired temperature, in this case 72 °C). It was found in control 
experiments using primers to amplify a 1.5 kb DNA fragment that the 
yield could effectively be doubled by increasing the extension time 
from 2 minutes to 5 minutes. For this reason extension times of 2-10 
minutes were used. The magnesium ion concentration was varied from 
0.5-3.0 mM. The magnesium ion concentration is fundamental to the 
specificity of the Taq polymerase and although at higher 
concentrations it can increase the amount of amplification 
dramatically, it can also increase the amount of non-specific 
amplification to the detriment of primer directed extension. These 
alterations of conditions still did not give rise to any sequence 
related to the malonyl-00A binding protein. The presence and absence 
of gelatin in the reaction mixture was also a factor which was 
varied. This did increase the yield of primer-directed amplification 
but did not give rise to a positive clone. This suggested that either 
the degree of promiscuity portrayed by the oligonucleotide primers 
was too great to successfully amplify a fragment encoding the 
malonyl-00A binding protein or the distance between the primers used 
was too great for Tag polymerase to effectively amplify. 
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3 • 12 IMMUNOGENIC STUDIES ON THE TDG-COA REACTIVE 
PROTEIN 
Aliquots of concentrated protein, eluted from gels similar to 
those used to perform the amino acid sequencing, were injected into a 
sheep. After 3 inoculations at 3 week intervals, immune serum was 
collected and IgG prepared (Kolodziej et al 1992). 
Following affinity purification 	(section 2.31.3), 	the 
antibodies were checked for cross reactivity with rat liver 
mitochondrial outer membrane proteins. The affinity-purified antibody 
reacted strongly with an 88 kDa protein. There was also a weaker 
reaction with a 79 kDa protein (Fig. 3.5). The immune serum was 
checked for cross reactivity with rat liver mitochondrial inner 
membrane proteins, total rat liver mitochondrial proteins, rat liver 
peroxisomal proteins, yeast mitochondrial proteins and total yeast 
proteins. Only in total rat liver mitochondrial proteins was there an 
immunogenic reaction seen with an 84 kDa protein (Fig. 3.6). Cross 
reactivity was also checked against sera raised to the rat liver 
peroxisomal carnitine octanoyltransf erase (COT), (gift from Dr R.R. 
Ramsay, Department of Biochemistry and Biophysics, University of 
California, San Francisco). There was no cross reaction of this serum 
with outer membrane proteins. 
3.13 IMMUNOGENIC SCREENING OF A RAT LIVER CDNA LIBRARY IN XGT11, WITH 
SERUM RAISED TO AN 88 KDA TDG-COA BINDING PROTEIN 
The affinity purified serum raised to the TDG-00A binding 
protein was used to screen a Xgtl]. library (obtained from Clontech) 
as described in section 2.33.5. The positives, found from a primary 
screen at near confluent lysis, were picked with the large end of a 
sterile pasteur pipette. The plug was eluted in 1 ml of SM with 10 Al 
of chloroform, for 5-8 hours. The eluted phage were then plated out 
as before at a density of 10,000 pfu per 82 mm plates, and 
rescreened. This procedure was repeated 5 times until pure positives 
were obtained (Fig. 3.7). 
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Fig. 3.5 Immunological detection of 84 kDa protein from rat liver 
Ritochondrial proteins, using affinity purified antibodies raised to 




Rat liver mitochondria, prepared from starved rats, were 
solubilised in 35 mM octyl glucoside (Section 2.14.2). Solubilised 
proteins (30 gig) were then separated by 10% PAGE (Section 2.28). The 
proteins were then transferred to a nitrocelulose membrane by western 
blotting (Section 2.29), blocked with 2% albumin (Section 2.30.1) and 
detected using horse radish peroxidase and dianisidine (Section 
2.32.1). It can be seen that there are two reactions on the western 
blot. The strongest is around 84 kDa and is assumed to be either CPT 
I or its regulatory malonyl-coA binding protein. The second reaction, 
although much weaker, is around 79 kDa. 
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Pig 3.7 Plaque purified Xgtll clone, detected by the affinity 
purified antibody raised to the 84 kDa Ralonyl-CoA binding protein 
fron rat liver citochondrial outer Rebranes 
Plaque purification was carried out as described in section 
2.33. The membranes shown are from a fifth round screen of two out of 
three identical clones. The titre of plaque forming units (pfu) were 
adjusted to fall between 50 and 150 pfu per 82 mm plate. The positive 
plaques are visible as darker circles on the nitrocellulose 
membranes. Plaques were picked as areas in primary screens and then 
as single colonies in later screens until, as depicted above, all 
plaques on the plates reacted positively with the antibody. 
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3.14 INDUCTION OF -OALACTOSIDASE FUSION PROTEIN 
In order to prove that the insert encoded the protein 
responsible for the adsorption of the antibody, a method of induction 
had to be developed. This can be done by proving that the protein 
that is reacting with the serum is a fusion protein with - 
galactosidase, the protein in whose gene the foreign DNA is inserted. 
This can be done by showing that the immunogenic protein can be 
induced for by isopropylthiogalactoside (IPTG), a non-metabolizable 
inducer of the lactose operon. This is usually done by inducing lysis 
of cultures infected with the Xgtll clone in the presence and absence 
of IPTG. Due to the sickly nature of the Xgtll clone, lysed cultures 
were unobtainable by normal procedures. Creation of a high frequency 
lysogen in E.coli strain Y1030 was also unsuccessful. Over 5,000 
colonies were induced for lysogeny but all were negative. False high 
frequency lysogens were avoided by incubating the cells with a 
secondary X, namely X clear. This X is deficient for the cl gene, 
which encodes the X repressor protein. This means that A clear always 
acts as a lysing agent unless another A is also present which does 
contain an active cl gene. This would mean that on a large infection 
of A clear only bacteria also containing the Xgtll clone already 
producing the A repressor would be able to grow without lysing. Still 
no lysogens were produced. Therefore another method of induced and 
non-induced protein extraction had to be developed. 
Plates were prepared for confluence as before but were not 
overlaid with nitrocellulose. Instead they were induced by spreading 
20 mM IPTG (100 jd) over them carefully after a 4 hour incubation at 
42 °C. The plates were then incubated overnight at 37 °C, before being 
extracted with protein loading buffer at 25 °C for 4 hours on a 
rotating platform. The loading buffer was then drained, and aliguoted 
into microcentrifuge tubes. Samples of each aliquot were boiled for 5 
minutes, spun in a microfuge (5 minutes, 15000 x g), and then the 
supernatants were run on a 10% polyacrylamide gel. The separated 
proteins were then transferred to a nitrocellulose membrane by 
western blotting, and tested for cross reactivity with both the 
screening serum and ant i-f3-galactosidase serum (Fig. 3.8). As seen 
from the western blots, the imrnunoreactive protein was induced by 
IPTG, and was visibly larger than the 1-galactosidase protein. 
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Pig. 3.8 Isopropyithiogalactoside (IPTO) induction of both f-
galactosidase from wild type ).gtll and -galacto.idase fusion 
protein in the .gt11 clone 
Affinity purified antibody raised to rat liver mitochondrial 
outer membrane aalonyl-CoA binding protein (84 kDa) 
Antiserum raised to E. coli f3-galactosidase 
a 	
b 
1 2 3 4 5 6 7 8 9 10 







1, 9 & 10 	 Xgtil clone induced 
3 & 8 	 Xgtli clone not induced 
2, 5 & 7 	 Wild type Xgtl]. induced 
4 & 6 	 Wild type Xgtil not induced 
This western blot shows clearly the reaction between the affinity 
purified antibody and the induced Xgtll clones. Non-induced plates 
are devoid of detectable fusion protein. 
The second western blot shows the reaction of 
antibodies, which react strongly with wild type Xgtll and faintly 
with the fusion protein on induced plates only. 
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This proved beyond doubt that the Xgtll clone contained a 
galactosidase fusion protein that reacted imunogenically with the 
affinity purified antibody raised to the malonyl-CoA binding protein. 
3.15 CLONING OF THE DNA INSERT FROM THE XGT11 CLONE 
Xgtll cDNA libraries are constructed by cloning cDNA inserts 
into a unique EcoRl restriction site in the /3-galactosidase gene. 
Therefore, when DNA is prepared from the X clone, the inserts can be 
cut from the X genome by digestion with EcoRl, and separated out on 
an agarose gel. The insert excised in this case, was estimated to be 
about 2.5 kb (Fig 3.9). This was then purified from the gel by Gene-
clean®, and cloned into the EcoRl site in pTZ19 and pTZ18 to ensure 
that both orientations could be sequenced. 
Single stranded DNA was made from pTZ19 by utilising the Fl 
origin of replication on the plasmid, along with M13K07 helper phage. 
Single stranded pTZ19 DNA was hence incorporated into M13 phage 
heads. Single stranded DNA was then prepared as described in section 
2.20.2). 
3.16 SEQUENCING OF THE DNA INSERT FROM THE XOT11 CI.OHE 
The single stranded pTZ19 DNA incorporating the Xgtll clone DNA 
insert, was sequenced using the reverse primer (section 2.23), 
situated at a site on the pTZ19 plasmid just behind the multiple 
cloning site. The insert was initially sequenced over the first 500 
bp from both orientations (Fig. 3.10 and Fig. 3.11). This sequence 
was checked for similarity against known DNA sequence data bases. The 
result of this check was an identical match with the sequence 
encoding long chain acyl-00A synthase, a gene from rat liver which 
had recently been cloned by Suzuk et al, (1990). 
3.17 ANALYSIS OF RAT LONG CHAIN ACYL-COA SYNTHASE 
In order to determine how best to sequence the cDNA clone, it 
was subjected to restriction endonuclease mapping (Fig. 3.12). 
Once the true identity of the clone was discovered, no further 
sequencing was undertaken. 
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Fig. 3.9 EcoRl digestion of DNA prepared from the Xgtll clone, 
obtained by isolation with the affinity purified antibodies raised to 
the alonyl-CoA binding protein from rat liver mitochondrial outer 
membranes 
A 	 B 








A; EcoR I digested Agt 11 clone DNA 
B ; kHind Ill markers 
XDNA was prepared (Section 2.33.2) from recombinant Xgtll 
clones (Section 3.13) and digested with the restriction enzyme EcoRl. 
The digests were then separated on a 2% agarose gel (section 2.21.1) 
stained with ethidium bromide and visualised under ultra violet 
light. A fragment estimated to be around 2.5 kb was seen under the 
two unresolved Xgtll arms. All the tracks in A were prepared from the 
Xgtll clones and, where visible, gave rise to the same size of 
insert. Track B contains XHind III markers. 
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Fig. 3.10 Sequence data from the cloned 2.5 kb fragment of long chain 
acyl-CoA cynthase 
(TCG A) 
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Sequence (a) shows the first orientation sequenced of the long 
chain acyl-CoA synthase, including the multiple cloning site of the 
pTZ plasmid up to the EcoRl restriction site into which the cDNA was 
cloned. The sequencing was primed from the universal reverse primer. 
Sequence (b) shows both orientations (i and ii) from inside the 
clone sequence which matched identically to the cDNA reported by 


































Fig. 3.11 Alignment of sequence data for. Xgtll clone with either end 





CCAACACAGA ACTATGGAAG TCCACGAATT 
TGACATTCGG CAGTACGTGC GTACCCTTCC 
TGCAGCGCTC ACCACCTTCT GGTATGCCAC 
TCTGTCCATG CAGTCTGTGG AAGTAACGGG 
TGTACGATGG GACAAGCTCT TGCTGTACTA 
CTTCCAGAGG GGGATTCAGG TGTCAAATGA 
CCAGCCATAT GAGTGGATTT CTTACAAACA 
GGCGCTGATC CAGAAGGGTT TCAAACCTTG 
GAACAGACCT GAGTGGGTGA CCATCGAGCA 
TCCGCTCTAT GACACGCTTG GAACCGACGC 
CTCTGTCATT TTTGCTGACA AGCCAGAAAA A 
Termination codon 
CATCAAGATT TAACATGAGG AAGAATCCTT AGAGGAAATG GCGCACCTCC ACAATCCTCC 
TCGTACCAAT GGCCTTTGAG TTGGTAACTC TGCCTGCAGC GAGTGTGGGA AAGGAAATGC 
CATGCTGGAC TTGTGCACAG GGTCTTACCA TAGGGATAGC AGAGGGCACG GAACACTGCC 
TTACAGTCAC CTGTGTTGTA GCCCATGATC CTGGGGATAC ACAGTTTCCA AAACGAGCCT 
TAAACATTGT AAAGGGGA.AC CCATAAAAGT GCTAAGTTAT TTAAGACTTC AACC1ATAAG 
GTGGGTGTTA AAACTTCTGT CTCCTGTTTT TCTAACCAAG GGGTTAGGAC TTACTCTTTC 
TGATACGTCT GCTGCTGGCT GCACACCCTG CAGCCGTCTG CTGCTCTGAA GAGTACAGTA 
CACTGGAGA AAGCTACCCC TTTAAGAGCA ACTGTCCAGG CTGAAGAAAG TCACAGTGGA 




The underlined bases represent the sequenced cDNA from either 
end of the Xgtll clone isolated using the affinity purified antibody 
raised to the TDG-00A binding protein in rat liver mitochondrial 
outer membranes. The sequence matches the long chain acyl-CoA 
synthase sequence identically. The Xgtll clone was not full length 
and lacked 165 bases from the 5' end, which included the initiation 
methionine, and 1065 bp from the 3' untranslated sequence. 
Fig. 3.12 Restriction map of cDNA isolated from Xgtll clone 
subsequently identified as a 2.5 kb fragment of long chain acyl-CoA 
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The cDNA clone was excised from the Xgtll bacteriophage and subjected 
to restriction endonuclease mapping. It should be noted that this map 
differs from the one reported by Suzuki et al (1990) since it is not 
full length. This was performed in order to plan a sequencing 
strategy for the TDG-00A binding protein which was not undertaken 




Most of the described experimental procedures used for the 
purification of CPT I have relied primarily on the purity of the 
outer membrane preparation. Several groups have attempted similar 
work with contradictory results but this can often be attributed to 
contamination due to the presense of microsomes, mitochondrial inner 
membranes, or light mitochondria which are known to be heavily 
contaminated with peroxisomee. The CPT II and COT contamination in 
these respective organelles would swamp all CPT I activity and 
results could be misinterpreted. In the method used here (section 
2.11), extreme care was taken, especially through the first few 
stages, to ensure accurate differential centrifugation of the 
mitochondria. The use of protease inhibitors was found to reduce the 
final yield of outer membrane in the preparation. 
The Sprague-Dawley rats were starved for a period of 48 hours, 
(the legal limit for starvation of rats) in order to increase the 
amount of CPT activity present in the rat liver mitochondrial outer 
membrane. Starvation also had the effect of de-fatting the membrane 
preparation, hence increasing both the quality and the yield of CPT 
rich outer membrane fragments. The Percoll stage was designed to 
ensure the separation of the heavy from light mitochondria thus 
ensuring the absence of peroxisomes which are known to contain COT 
activity (60 kDa protein). COT is identical over some 25-30% of its 
residues with CPT II, and allowing for conservative amino acid 
changes has a homology of 50% (Chatterjee et al, 1988, Woeltje et al, 
1990b). 
The final stage in which the cytochrome C sepharose was prepared 
proved to be very variable and was vital in the quality of the final 
preparation. The only indication as to the quality of the activated 
sepharose was indicated by the purification results of the outer 
membranes. At all stages, in the purification of the outer membranes, 
samples were taken and assays performed to evaluate the degree of 
purification at each stage. Tables 3.1 - 3.4 outline the varying 
stages of purification. A bad batch of activated sepharose could 
result in a 30 to 60% loss in reactive protein and an irretrievable 
loss in quality. At this stage there is no further purification of 
CPT I from CPT II and therefore it could conceivably be left out 
without any marked effect on the purification of the preparation. 
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Such membrane preparations could be treated with Tween 20, in order 
to remove any CPT II protein, and then could be used for CPT I 
specific work. This method proved to be very successful and was used 
routinely after comparisons showed no significant difference from the 
activated sepharose method, apart from a marked increase in 
reliability. 
The effect on CPT I, by starvation of the rats, was reported by 
Kolodziej and Zanvnit (1990a). They found as reported in Tables 36 
and 3.7 that starvation diminished the sensitivity of CPT I to 
malonyl-00A. The number of malonyl-00A high affinity binding sites 
however increased almost 2 fold. This increase was very similar to 
that observed for specific CPT activity in outer membranes. In outer 
membrane preparations from starved rats, the maximum inhibition was 
60%, as opposed to outer membrane preparations from fed rats which 
gave a maximum inhibition of 90%. No further increase in malonyl-CoA 
concentration could result in any further 1088 in CPT I activity. 
From this they postulated that there were other factors governing the 
activity of CPT I such as membrane fluidity. Membrane fluidity would 
be altered dramatically as the fatty acid content of the membrane 
decreased, or by changes in its cholesterol content. The fluidity was 
altered by using benzyl alcohol, isoamyl alcohol and 2-(2-
methoxyethoxy)ethyl-8-(cis-2-n-octylpropyl)octanoate. All of these 
were shown by Kolodziej and Zammit (1990b), to have the affect of 
causing a decrease in malonyl-CoA inhibition of CPT I. They also 
suggested that the effect of increasing membrane fluidity on the 
malonyl-00A sensitivity of CPT I may occur independently from other 
effects which act more directly with the active site. 
In rat liver mitochondrial outer membrane preparations, the 
purity of CPT I with respect to CPT II was vitally important for the 
radiation inactivation studies performed by Zammit et al (1988); 
Zammit et al (1989). This method relied on the difference in CPT 
activity before and after irradiation for an estimation of the 
molecular size of the protein. These results can be linked to size 
since the larger the protein is, the more likely it is to be hit and 
inactivated by radiation. If CPT II was present (69 kDa protein), the 
activity after irradiation would be artificially higher than if all 
the CPT activity were due to CPT I (estimated 84 kDa protein). This 
would cause the weight of CPT I to appear considerably lower than it 
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actually is. The initial work performed on CPT I suggested an 
apparent molecular weight of 96 kDa, (Zanmit et al 1988). In later 
studies however this was corrected to be approximately 84 kDa (Zanimit 
at al 1989). The initial anomaly was most probably due to other 
impurities in the preparation of the outer membranes, hence as the 
purity of the preparations increased the accuracy of the estimation 
also increased. This method can be very accurate for some proteins 
but inaccurate for others. Zammit at al, (1988) also reported that 
radiation inactivation of CPT II gave an estimated molecular weight 
of 69 kDa. This size has been confirmed by sequence determination 
(Woeltje at al, 1990b). 
In order to purify CPT I a method of detecting the protein had 
to be developed. CPT I is an integral membrane protein and is likely 
to be a very hydrophobic protein. It may even rely on specific 
phospholipid groups for activity (Sire at al, 1983). This would 
explain why extracting CPT I from the membrane resulted in a major 
loss of activity. The use of mild, non-ionic detergents was 
considered the obvious next choice. If CPT I could be extracted from 
the membrane without being denatured then perhaps activity, or at 
least some activity could be retained. The detergents were first 
tested for any inhibitory effects. The only detergent to show both a 
high degree of solubilisation while still retaining activity was 
octyl glucoside. The amount of activity retained was concentration 
dependent and a very fine balance had to be achieved (2 mg protein 
and 35 mM octyl glucoside in 500 mM KC1). It was also noted that once 
solubilised the activity was lost very quickly. Almost total loss of 
activity occurred after 8 hours at 4 °C. Lund (1987), reported that 
two CPT activities could be separated by solubilisation. He used 
Triton X-lOO (5% w/v), to solubilise a malonyl-CoA insensitive CPT, 
and then 30mM octyl glucoside to solubilise a malonyl-CoA sensitive 
CPT. In order to detect malonyl-00A sensitive CPT activity, all 
detergents had to be removed. Even then activity was lost rapidly in 
its solubilised form. He also reported that activity could be 
partially protected by adding large quantities of glycerol but not to 
the extent that would allow further purification. For these reasons 
further purification of CPT I was very limited. Similar results were 
reported by Murthy and Pande (1987b), although they claimed that 
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activity could be restored after reconstitution in liposOmes. 
During the acylation of the carnitine by CPT I, 2-bromo-
palmitoyl-00A and carnitine can be tightly bound (non-cova lent ly) in 
the reactive site of the enzyme. This is presumed to be due to the 
self catalysed formation of the S-carboxy palmitoyl-00A ester of 
carnitine on the active site of the enzyme (Chase and Tubbs, 1972). 
Because of its bi-dentate nature this slowly reversible inhibitor 
binds tightly to CPT I along with carnitine which when labelled with 
( 3H) was shown by dialysis to remain associated with the membranes. 
It was thought that although the protein would lose activity after 
solubilisation even with non-denaturing detergents, perhaps the 
associated inhibitors would give a more sensitive detection system 
and further purification could be achieved. Again the main priority 
was to keep denaturation of CPT to a minimum otherwise the unfolded 
protein would merely release the ligand. Again solubilisation with 
octyl glucoside was initially successful but limited by the short 
time that the ligand remained associated to the protein. It was 
reported by Vecchio et al, (1984) that after initial solubilisation 
with a stronger detergent a more non-denaturing detergent could be 
introduced. The detergent used by Vecchio et al (1984) was thiophene, 
tetrahydro-1, 1-dioxy suiphanoyl (sulphalane) . This detergent 
although not powerful enough to extract integral membrane proteins 
from their hydrophobic environment could, once the proteins had 
already been extracted with octyl glucoside, be used to limit any 
further loss in the activity of the CPT I by forming micelles which 
still favour.protein structure. This method proved to be partially 
successful with CPT I, but detection of protein associated 
radioactivity was lost completely after 12 hours at 0 °C. This 
extraction method did not allow the detection of CPT I as a single 
band on a polyacrylamide gel. Ten proteins were detected on a 
polyacrylamide gel. The protein of interest could be limited to one 
of six labelled proteins by examining the radioactive counts (Fig. 
3.3). Kolodziej et al (1992) tried to solve the problem of 
identification by using a covalently bound radioactive marker, 2-
tetradecylglycidyl-CoA (TDG-00A). This compound is inhibitory and 
binds to the enzyme irreversibly (Declercq et al, 1987). Radio-
labelling with TDG-00A followed by PAGE were used by Kolodziej et 
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al, (1992) to 	identify outer membrane proteins which react with 
malony].-coA. One of these proteins was estimated to have a molecular 
mass of 84 kDa. It was therefore thought that this protein could be 
CPT I since the radiation inactivation size analysis suggested that 
this was the size of CPT I (Zammit et al, 1989). The full protein, 
along with partial digests of the protein, were then N-terminally 
sequenced (section 3.10), and also used to generate polyclonal 
antibodies (section 3.12). Sequences of the fragments were used to 
generate heterogeneous and guessmer DNA probes, the latter of which 
were elucidated from known rat liver codon usage. These sequences 
were used to screen XgtlO and Xgtli libraries but no true positives 
were found. 
Polymerase chain reactions were also performed under many 
different conditions, but all sequences found, although clearly 
derived from the added primer, did not encode the CPT I peptides 
beyond the primer sequence. Out of a total of 24 bands purified, sub 
cloned into pTZ18 or pTZ19 and sequenced, none were found that 
resembled the TDG-CoA binding protein fragments. Initially the PCR 
was carried out on DNA prepared from the cDNA X libraries, but due to 
the heterogeneity of the oligonucleotide all PCR products cloned were 
different and often contained X DNA sequences. RNA, RNA/DNA duplex 
and Clontech cDNA were all used as templates for PCR, but no 
sequences resembling the peptides were found. 
The immunogenic studies with the sera raised from the TDG-00A 
binding protein suggested that there is no cross reactivity with CPT 
II, or the peroxisomal equivalent. Using an antibody against the 
peroxisomal COT (section 3.12) no cross reactivity was seen with the 
outer membrane preparations. Kolodziej et al (1992), reported that 
the anti-TDG-CoA binding protein sera, when checked against heart, 
skeletal muscle, foetal liver, adult liver, kidney, white adipose 
tissue, brown adipose tissue, mammary gland and brain, strongly cross 
reacted with a 84 kDa protein in foetal liver, adult liver and kidney 
cortex. Faint adsorptions were also seen in heart, skeletal muscle 
and brain all with a 84 kDa protein showing what the authors 
described as a slight degree of immunogenic similarity between the 
CPT I of these tissues. Similar results were reported by Esser et al 
(1993a). Reports of CPT I active malonyl-CoA binding proteins in 
these tissues suggests that the proteins are of different molecular 
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size, (Woeltje et al, 1987), different kinetic characteristics for Km 
of their reaction with carnitine, (McGarry et al, 1983), and 
different malonyl-CoA inhibitions, (Saggerson and Carpenter, 1981). 
Kolodziej et al (1992), however, did not comment on a 79 kDa protein 
which reacted strongly with rat proteins from white adipose tissue, 
brown adipose tissue, mammary gland and adult liver, and to a lesser 
extent with heart, skeletal muscle and foetal liver. This cross 
reaction is of great importance when it is taken into consideration 
that the molecular weight of the protein encoded for by the cDNA 
insert purified from the Xgt11 clone is 78 kDa. This protein, long 
chain acyl-00A synthase, was isolated from the Xgtll library by the 
same affinity purified antibody which was used for the previous 
western blots (section 3.12). Long chain acyl-00A synthase has been 
shown to be localised in the microsomes (Konberg and Pricer, 1953); 
outer mitochondrial membrane (Norum et al, 1966; Garland et al, 1970) 
and peroxisomal membrane (Shindo and Hashimoto, 1978; Krisans et al, 
1980). This would suggest that the protein was present in the 
original purified outer membrane fragments, but would not explain the 
cross reaction with the affinity purified antibody from the 88 kDa 
protein assumed either to be CPT I or its regulatory subunit. In 
either case the antibody was generated against a malonyl-00A binding 
protein which, if it is CPT I, may also bind long chain fatty acids. 
The long chain acyl-CoA synthase is as its name suggests, a long 
chain acyl-00A binding protein and so perhaps would display some 
identity at the active site. But for such a strong reaction as that 
demonstrated in Fig 3.5, the long chain acyl-00A synthase must have a 
far greater similarity to the malonyl-00A binding protein than 
expected. Purified rat liver long chain acyl-CoA synthase from 
microsomes, mitochondria (Tanaka et al, 1979), and the peroxisomal 
fraction (Miyamoto et al, 1981), are identical with respect to 
molecular and catalytic properties. They have the same molecular 
weights, amino acid composition, substrate specificities and kinetic 
properties. Suzuk et al, (1990) reported that the cDNA for long chain 
acyl-CoA synthase lacked a classical N-terminal targeting sequence 
for either endoplasmic reticulum or mitochondria. They also reported 
that in vitro, the initial translation product had the same molecular 
mass as the purified enzymes. The authors concluded from this that 
the primary structure of the protein was devoid of any signal 
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sequence. There is also no apparent peroxisomal targeting sequence 
visible at the C-terminus. This protein, being more widespread and 
abundant that CPT I, would obviously be more abundantly expressed in 
a rat liver cDNA library, which if the cross reactivity was caused by 
a true protein similarity, would hinder further attempts to isolate 
CPT I in this manner. The possibility that long chain acyl-00A 
synthase was in fact CPT I can be ruled out since the peptide 
sequences (Table 3.13) taken from the same protein from which the 
serum was raised, are not encoded for by the cDNA which encodes long 
chain acyl-CoA synthase. 
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CHAPTER 4 




Purification and Cloning of Carnitine PaiRitoyltransferase (CPT) II 
4.1 INTRODUCTION TO THE PURIFICATION AND CLONING OF CARNITINE 
PALNITOYLTRANS?ERASE II 
It was originally thought, and indeed is still adhered to by 
some (Kerner and Bieber, 1990; Woldergiorgis et al, 1992), that CPT I 
and CPT II are identical polypeptides but that the former has 
associated with it a regulatory component to which inhibitors bind 
and cause allosteric inactivation of the enzyme. Implicit in this 
formulation is the assumption that detergents (as described in 
chapter 3) disrupt the link between the catalytic and regulatory 
components of CPT I allowing co-purification of active CPT I and CPT 
II as a single protein of 69 kDa. In some cases it is also thought 
that both CPT I and CPT II reside on either side of the mitochondrial 
inner membrane (Brady et al, 1986) explaining the lack of cross 
reactivity between serum raised to the 69 kDa CPT active protein and 
proteins resident in the mitochondrial outer membrane. The regulatory 
subunit, is however suggested by Woldergiorgis et al, (1992), to be 
the 87 kDa protein identified by Kolodziej et al, (1992). The 87 kDa 
protein is thought to reside in the mitochondrial outer membrane as 
an integral membrane protein, in close proximity to CPT I perhaps via 
a contact site. As described in section 1.11.3, contact sites are 
sites where the inner and outer mitochondrial membranes are in very 
close proximity to each other. They are thought to play a specific 
role in protein translocation across both mitochondrial membranes. 
The membranes are thought to be held in this configuration by 
integral membrane protein complexes between the two membranes. There 
is conflicting evidence for the single identity of CPT (discussed in 
chapter 3). As described in section 3.2, CPT II has already been 
shown to be easily solubilised from mitochondria while still 
retaining activity (Woeltje et al, 1990a), and therefore could be 
purified. This CPT active protein could then be used to clone the 
gene responsible, at least for one of the CPT activities in the 
mitochondria. Subsequent targeting studies could then be used to 
determine which Location (or locations) the immature protein was 
targeted to. 
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4.2 PURIFICATION OF CPT II FROM RAT LIVER MITOCHONDRIA 
The livers from 30 rats were removed and prepared as described 
in section 2.17. The purification was stopped after the heavy 
mitochondria were removed from the Percoli gradients. The heavy 
mitochondria were then pelleted 35000 X g (OTD-Combi), sonicated for 
5 minutes, pelleted again and frozen (-80 °C) overnight. After careful 
thawing the mitochondrial pellet was resuspended in an appropriate 
volume to give a final protein concentration of 10 mg/mi. Tween 20 (2 
Al) was added per mg of protein along with antiproteasea, the final 
concentrations of which were as follows; 100 ig/ml pepstatin; 1 Ag/ml 
of phenylmethyl sulphonyl fluoride (PMSF); 200 ig/ml antipain; 
4 Al/ml leupeptin. The solubilisation mixture was then sonicated on 
ice for 4 x 1 minute, (with 10 minute standing time) with constant 
stirring to disperse heat. It was then spun for 1 hour at 35000 X g 
(OTD Combi). The supernatant was then subjected to two polyethylene 
glycol (PEG) cuts. The percentage of PEG was calculated by trial and 
error techniques on sample volumes of the solubilisation mixture by 
measuring the activity of CPT in both pellet and supernatant in the 
same volume and using the same conditions. The first cut was made at 
15% PEG, with the CPT activity remaining in the supernatent, and the 
second was made on the supernatant from the first cut at 50% PEG. In 
both cases the suspension was spun at 35000 X g 20 minuits (OTD 
Combi). The CPT active pellet, from the second PEG cut, was stored at 
-80 °C overnight. 
The pellet was suspended in an appropriate volume at a 
concentration of 8-9 g/100 ml, and further purified by two ammonium 
sulphate ((NH4) 2 SO4) cuts. The trial and error approach was adopted 
once more to establish the optimal percentages of (NH4)2SO4. The 
first cut was made at 40% and the second (on the supernatant of the 
first cut) at 80%. Both (NH4)2SO4 cuts were separated by 
centrifugation at 20000 X g (OTD Combi). The resultant CPT rich 
pellet was dialysed against 2 litres 500 mM KC1 overnight. 
The dialysed sample was then separated through an ion exchange 
Mono Q column 10/10 by a fast protein liquid chromatography (FPLC) 
(section 2.17.4). The active samples were collected, pooled and 
ultrafiltrated to a final volume of 8 ml in Centricon tubes (Amicon) 
with a 30,000 dalton cut off point. The concentrated sample was then 
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dialysed overnight against 10 mM imidazole pH 7.5 containing 0.5% 
Tween 20. The elution profile of the column can be seen in Fig. 4.1. 
The dialysed samples were concentrated as before, to a final 
volume of 1.2 ml, which was loaded onto a chromatofocusing column 
(mono P), which had been pre-equilabrated to pH 8. The protein was 
eluted from the column with polybuffer 96 adjusted to pH 6 (section 
2.17.5). The column was operated in conjunction with an FPLC system 
which produced an efficient and rapid separation of the sample. The 
activity was eluted as equal peaks at pH 6.2, which were pooled and 
dialysed against 20 mM KPi containing 0.5% Tween 20. The purified 
protein was then stored in aliquots at -80 °C. The elution profile of 
the column can be seen in Fig. 4.2. 
A typical purification table for the purification of CPT II is 
shown in Table 4.1. Although the CPT II activity is very low, when 
analysed by 22% polyacrylamide gel electrophoresis (PAGE), the 
purified sample consisted of a single protein of 69 kDa (Fig. 4.3). 
This CPT activity was not sensitive to malonyl-00A. Reasons for the 
activity being so low are probably due to the denaturation of the 
protein during the column purifications which were carried out at 
room temperature. 
4.3 N-TERMINAL SEQUENCING OF PURIFIED CPT II 
The purified CPT protein described in section 4.2, was 
subjected to SDS-PAGE and transferred to nitrocellulose by western 
blotting. The protein was the stained lightly with amido black, 
excised and subjected to N-terminal amino acid sequencing which was 
performed by Bryan Dunbar using the SERC protein sequencing facility 
in Aberdeen University. The yield of sequence was not large, probably 
due to a high degree of N-terminal blocking of the protein. Some 
sequence was however obtained (Table 4.2) for the first 20 amino 
acids. Although the reading was close to the limits of sensitivity 
for the protein sequencer, it was reproducible on all occasions of 
sequencing. 
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Fig. 4.1 Ilution profile of ion exchange mono Q column, performed on fast protein liquid chromatography (FPLC) 
during the purification of cPT II (Section 2.17.4) 
Full scale deflection= 02 OD (280 nm) 
	
%NaCI (015M) 
100-i 	 i-100 
Salt (NaCl) Gradient 
1 	2 	' 3 	'4 	' 	5 ' 	6 '7 
Sample Number 
8 	9 	10 	11 	12 13 	14 	15 
The trace shown a typical elution profile from the mono Q column, along with the salt gradient used 
in the elution of the proteins. The samples containing CPT activity were 4-8. These along with samples 
of an identical run were pooled, concentrated and measured for protein concentration. 
Pig. 4.2 Ilution profile of chroatofocusing mono P coluan, performed on fast protein liquid chromatography (FPLC), 
during the purification of cpT II (Section 2.17.5) 
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The trace shows a typical elution profile from the mono p column, along with the pH gradient used 
in the elution of the Proteins. The, samples containing CPT activity were 7 and B. These samples 	were 
pooled, 	concentrated, 	measured 	for 	protein contcentration. 
Table 4.1 Purification table of CPT II, purified from 30 non-starved 
rat livers 
Total 
Sample 	 Activity (U) 	Percentage yield 
poet Tween 20 	 3.91  
solubilisation 
15% PEG 2.31 100 
supernatant 
50% PEG 1.84 80 
pellet 
40% ammonium sulphate 1.27 55 
supernatant 
80% ammonium sulphate 0.72 31 
pellet 
post mono Q 0.39 17 
ion exchange 
poet mono P 0.14 6 
chromatofocusing 
Although the final yield is low, both in terms of units 
activity (&mole/min), and percentage of starting activity, a single 
band of 69 kDa was obtained as visualised by polyacrylamide gel 
electrophoresis (Fig. 4.2). Before solubilisation by Tween 20 the 
total amount of mitochondrial protein present from 30 rat livers was 
1 g. The final specific activity of the purified sample was usually 
around 2.5 - 3 tmol/min/mg. When compared to an initial specific 
activity of 0.006 /Lmol/min/mg, the purification was around 500 - 600 
fold. 
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Pig. 4.3 Examination of purified carnitins pal.itoyltransf.ras. II as 
det.rined by polyacrylaidis gel electrophoresis 
A 	 B 	 C 
116 - 
69— 	 69kDa 
- _ 
45 	 MARKERS 
_ 	 - 
29 
14 
ASIC ; markers 
B ; pUrified CPT II 
Approximately 10 Ag of protein was loaded into each well of a 
5% polyacrylamide gel which was electrophoresed as described in 
section 2.28. All the tracks in B are from the final purified sample 
of rat liver mitochondrial CPT II. The gel was stained with page blue 
and the purified CPT II estimated to be approximately 69 kDa. 
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Attempts were made to digest CPT II in order to generate 
peptides which may be used to provide further amino acid sequence 
data. The enzymes used for digestion were clostropain (section 
2.13.2) and V8 endoproteinase, and chemical cleavage was produced by 
cyanogen bromide treatment (section 2.13.3). The digestions were 
carried out at 25, 30 and 37 °C, for time periods of 1 to 30 minutes. 
Many apparent fragments were produced, when visualised by reverse 
phase high pressure liquid chromatography (HPLC). These fragments 
were analysed for amino acid content by Linda Kerr (WeliMet 
sequencing facility, Department of Biochemistry, Edinburgh 
University) before being sequenced, but were found in all cases to be 
entirely devoid of protein. 
4.4 IIOIUNOGENIC STUDIES ON CPT II 
Purified CPT II (section 4.2) was injected into a sheep, and 3 
booster injections were administered at 3 week intervals. Serum was 
collected and IgG prepared as described in section 2.31. The serum 
was then affinity purified (section 2.31.3), and used for immunogenic 
comparisons between CPT II and CPT I. The serum reacted with a single 
protein prepared from rat liver mitochondria which had a molecular 
mass of 69 kDa (Fig 4.4). There was no observed cross reactivity 
between this CPT II antibody and any other mitochondrial proteins. 
There was no cross reactivity between the proteins and sera to the 
TDG-00A binding protein (section 3.12) and the CPT II protein. The 
serum (gift from Dr.R. Ramsay, Department of Biochemistry and 
Biophysics, University of California, San Francisco) raised by Ramsay 
(1988) against rat liver mitochondrial CPT II (Ramsay et al, 1987) 
also reacted with the CPT II protein purified in section 4.2 (Fig. 
4.5). 
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Pig. 4.4 Iunod.t.ction of carnitin. pa1itoy1transf.ras. (CPT) II 
on western blots using antibody prepared h-os purified CPT active 
protein of molecular sass 69 kfla 
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69kDa 
Purified rat liver mitochondria] CPT II 
Rat liver outer mitochondrial membrane proteins 
(2) 	Rat liver mitochondrial proteins 
There is only one immunological reaction with rat liver mitochondrial 
proteins of 69 kDa from mitochondrial inner membranes. From this it 
can be deduced that the 69 kDa CPT II antiserum does not react with 
any other proteins in rat liver mitochondria ie. neith€r an 84 kDa or 
a 69 kDa protein in mitochondrial outer membranes, reacted with the 
serum. 
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Fig. 4.5 confir.ation that carnitin. palaitoyltransf.ras. II 
antisszu, raised by Rassy (1988), cross reacts with the protein 
purifi.d in section 4.1 
12345 
- --69 kDa 
Rat liver mitochondrial outer membrane proteins 
Purified CPT II 
Blank 
& (5) 	Rat liver mitochondrial proteins 
The antibody prepared by Ramsey (1988) reacts with the same CPT 
active 69 kDa protein prepared from rat liver mitochondrial inner 
membranes (section 4.2). It does not however react with any proteins 
in the mitochondrial outer membrane. 
130 
4.5 SCREENING OF XGT1O LIBRARY WITH OLIGONUCLEOTIDES 
Brady et al, (1988) published a paper which reported the N-
terminal sequence of a detergent-labile malonyl-00A-insensitive 
mature CPT enzyme which had a molecular mass of 69 kDa. 
N- "Glu-Lys-Gly-Val-Gln-Thr-Gly-Gln" -c 
This amino acid sequence was used to design degenerate 
oligonucleotides which were made by OSWEL DNA service, Department of 
Chemistry, University of Edinburgh. The oligonucleotides were used to 
screen a cDNA library contained in Xgtll (gift from Brian Burchell, 
Department of Biochemical Medicine, University of Dundee). 
el 	3' ; 	5' " GARAARGGNGTNCARAC 	" 3' 
e2 	S. ; 	5' " GARAARGGNGTNCARACNGGNCAR 	" 3' 
The oligonucleotides were phosphorylated with y-labelled [ 32p)- 
ATP (section 2.24.2.1). After comprehensive screening of this 
library, and 3 other such libraries, (Clontech XgtlO, Clontech X 
gtll, Clontech Xgtll stretch), with no success, efforts were stopped. 
The libraries were checked for both inserts, and the degree of 
size variation between these inserts, by random single plaque 
purification. Twelve randomly purified plaques were amplified, and 
the DNA from them (section 2.33.2) was digested with EcoRl. The 
digests were analysed on a 2% agarose gel and the fragments were 
visualised using a UV transilluminator (Fig 4.6). The libraries were 
found to be of good quality and it was therefore thought that the 
lack of positive results in the screening was due to some other 
problem. 
Northern blot hybridisation (section 2.24.1.2) was carried out 
using the degenerate probe e2 (Fig. 4.7). Although a band was visible 
at the size expected for CPT II mRNA (2.7 kb), many other bands were 
also visible. As the stringency of washing was increased, these bands 
did not disappear any more rapidly than the 2.7 kb band. This is 
probably due to the high degree of codon degeneracy built in to the 
probes. 
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Fig. 4 • 6 Agaros. gal .l.ctropbor.tic separation of Ico1 fragments of 
DNA prepared f roe random single plaque purification of a X9t10 
library 
X Hind 
___ 	 C markers 	A 	- B _________________________-- 
23130 kb N 
9416 kb - 
6557 kb 
4361 kb - 
2322 kb - 
2027 kb 
564 kb - 
A& C ; XHind III markers 
B; EcoR I digested kgtlO DNA 
XgtlO DNA was prepared (Section 2.33.2) from 12 randomly picked 
single plaques, taken from the XgtlO cDNA library (Section 4.5). The 
DNA was then digested with the restriction enzyme EcoRl, separated on 
a 1% agarose gel and stained with ethidiurn bromide. The photograph of 
the gel shows that the insert sizes of XgtlO cDNA library fall 
between 0.5-2.5 kb. All the plaques which were purified contained 
different sized fragments. This indicates that the library would 
appear to be of a good quality. 
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Pig. 4.7 Hybridisation of CPT II oligonucleotide, generated to N-
t.rinal amino acid sequence reported by Brady et al (1988), to a 
Northern blot of rat liver RNA. 
Oligonucleotide sequence: 5 - GARAARGGNGTNCARACNGGNCAR - 3 
N = (A,G,C or T); R = (A or G) 
 
I  
AM W Ww" - 5 kb 
'2 kb 
RNA, prepared from 48 hour starved rat livers (Section 
2.20.3.2), was separated (two identical samples) by agarose gel 
electrophoresis (Section 2.21.4) and Northern blot analysis (Section 
2.24.1.2). At higher stringency of hybridisation and washing, all 
bands disappear at the same point. 
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4.6 CLONING OF CPT II BY POLYMERASE CHAIN REACTION 
(Section 2.22.4) 
The cDNA sequence for CPT II reported by Woeltje at al (1990b), 
was used to design non degenerate oligonucleotidea to either end of 
the cDNA sequence. EcoRl (GAATTC) and HindlIl (AAGCTT) sites were 
incorporated into the two ol igonuc leot idea respectively (section 
2.8). 
f 5' ; 	5' "GATGAATTCATGATGCCGCGCCTGCTGTTTC" 3 
g 3' ; 	5' "GTCAAGCTTCTAAGTTTTGATGGCTTTGCCT 3' 
These oligonucleotides were used in an attempt to amplify the 
cDNA for CPT II. The length of the cDNA for CPT II is just under 2 
kb, which is the longest size of DA that Tag polymerase can cope 
with in optimal conditions. This procedure, however is also reliant 
on a full length template being present in the amplification. The 
templates used varied from cDNA prepared from libraries contained in 
Xgtlo and Xgtll vectors, cDNA purchased from Clontech, cDNA prepared 
from RNA (induced by starvation; section 2.20.3.2) and DNA/RNA duplex 
(prepared in a similar way). Many different conditions were used 
(section 3.11), including significantly longer extension times of 2 
to 10 minutes, where, in the latter case, extra Tag was added after 7 
hours. Although no fragments of the desired size were visualised 
after separation by 2% agarose gel electrophoresis and UV 
illumination, cloning procedures were still attempted. No inserts 
were evident from sequences of the 'cloned' fragments. Other 
oligonucLeotides were therefore made to regions closer to the 3' end 
of the cDNA for CPT II (section 2.8). 
h 	5' ; 	5' "CAGCACATGATGGCTGAGTGTTCCA" 3' 
i 	3' ; 	5' "TACAGCTGCGACCTCACACTACCT" 3' 
This pair of oligonucleotides were used in an attempt to 
amplify a smaller region of the CPT II cDNA at the 3' end of the 
gene. The products obtained from the PCR amplification were numerous 
but were not of the predicted size of the fragment encompassed 
between the two primers (563 bp). 
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The fact that the band was not visible on the gel, and that 
cloning of the total PCR reaction mix still did not yield the desired 
CPT II fragment, did not strictly mean that there was no 
amplification of the product. In order to check this, a second pair 
of ol igonucleot ides was made to generate a fragment from within the 
predicted fragment enclosed between the last pair of 
oligonucleotides. 
j 	5' ; 	5 • "GAAGCAGCGATGGGCCAG" 3' 
k 	3' ; 	5' "TCGAAAATGTCTTCCAAGCA 3' 
After the first amplification was complete the DNA products 
would be purified and re-amplified using the second pair of primers. 
Hopefully this would select for a fragment 284 kb in size. This 
method however was unsuccessful in raising the desired fragment. 
Different combinations of all the CPT II ol igonuc leot ides were 
then used in PCR amplifications. Success was obtained with one of the 
full length oligonucleotides (h), and one of the newer 
oligonucleot ides (g) made from the sequence situated 300 bp from the 
3' end of the cDNA. The oligonucleotides generated a fragment of 300 
bp (Fig 4.8). 
The conditions used for the successful amplification were as 
follows. Denaturation of the duplex at 98 °C for 10 minutes in the 
absence of Taq, followed by 35 to 40 cycles of; 
annealing at 50 °C for 30 seconds 
extension at 72 °C for 2 minutes 
C) 	denaturation at 95 °C for 1 minute 
It is important to note that the only ingredient absent during 
the initial denaturation was the Tag polymerase enzyme. It was vital 
that the dNTPs were present during this stage, because no 
amplification was obtained when they were absent. The reason for this 
is unclear. 
The only template that generated the CPT II fragment, with 
these two primers, was RNA/DNA duplex. This duplex was reverse 
transcribed from RNA prepared from 48 hour starved rat livers. 
This fragment was cloned into pTZ19, from which single stranded 
DNA was prepared and sequenced (section 4.7). 
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Fig. 4.8 300 bp fragment generated by poly.rase chain reaction 
(PcR), using oligonucl.otid.s generated to the C-t.r.inus of 
carnitine palaitoyltransf.ras. II 
)PCR products 
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bp 
5' - CAGCACATGGCTGAGTGTTCCA - 3' 
3' - CCGTTTCGGTAGTTTTGAATCTTCGAACTG - 5' 
A 300 bp fragment was generated by PCR (Section 2.22.4) using 
the above oligos taken from the cDNA reported by Woeltje et al 
(1990b). The fragment was amplified from a template of RNA/DNA duplex 
prepared from 48 hour starved rat livers as described in section 4.6. 
The amplification products were the separated on a 2% agarose gel 
(Section 2.22.2) and stained with ethidium bromide. 
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4.7 SEQUENCING OF THE 300 bp FRAGMENT 
The single stranded DNA prepared from pTZ19 containing the 300 
bp fragment was sequenced using both reverse primer and the two PCR 
primers, as described in section 2.23. When the oligonucleotides were 
used as primers, manganese was added to the sequenase reaction 
mixture in order to allow reading of the DNA sequence as close to the 
primer as possible. The sequences obtained (Fig. 4.9a) were 100% 
identical to the cDNA sequence reported by Woeltje et a1, (1990b). It 
should be noted that in the sequence primed by the reverse primer 
there is also a shadow sequence leading off from the insert, and a 
strange feature of a poly A sequence enclosed by the PCR primers, 
before the CPT reading frame. This was removed by digestion with 
EcoRi. and Hind III followed by religation into pTZ19. However this 
did not get rid of the shadow sequence. Transformation of the plasmid 
DNA and picking of single colonies still did not get rid of the 
shadow sequence. This is confusing since the single transformants are 
caused by absorption of one plasmid by a individual cell, giving rise 
to a ampicillin resistant colony. It is unlikely that all the 
transformants absorbed two plasmids during transformation, but no 
other possibilities can be thought of. The shadow sequence was 
finally removed by PCR amplification of the CPT II fragment using the 
same primers but using the pTZ19 plasmid DNA as a template, followed 
by re-cloning into pTZ19 (Fig. 4.9b). The reason for this shadow 
sequence is unclear since it was not lost during re-transformation of 
the plasmid. Contamination in such a case was unlikely. The loss of 
the shadow sequence on re-amplification could only be due to it being 
amplified by different primers. This feature still remains slightly 
confusing. 
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Fig. 4.9 Sequence data from the cloned 300 bp fragment of carnitin. 
paiRitoyltransferase II (CPT II) 
Tracks read T C GA 
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The autoradiograph shows four sequences obtained from the 300 bp 
fragment, only one of which is identifiable as CPT II. Also visible in 
this sequence is a poly A tail between two of the primert positioned 
directly before the open reading frame of CPT II. There is also a shadow 
sequence visible over the CPT insert, suggesting the presence of a 
contaminating clone. 
Sequence of excised and re-amplified (PCR) 300 bp fragment. This 
sequence is devoid of both a poly A tail and a shadow sequence. 
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4.8 SOUTHERN BLOT ANALYSIS OF THE 300 bp FRAGMENT 
Southern blot hybridisation (section 2.24.1.1) was carried out 
under standard conditions using rat liver DNA digested with EcoRl and 
Hindu. The 300 bp PCR fragment (section 4.6) was used as a probe. It 
was labelled with ( 32P] by either PCR incorporation (section 
2.24.2.3) or by random priming (section 2.24.2.2). Hybridisation was 
carried out at 45 °C and washings at a stringency of 55 °C. The 300 bp 
fragment hybridised to a single band on the tracks containing the rat 
liver DNA digested with EcoRl and Hindu (Fig. 4.10). This suggests 
that the 300 bp fragment is hybridising specifically to one sequence 
only, which will presumably be CPT II. The probe therefore could be 
used effectively to screen cDNA libraries specifically for CPT II 
clones. 
4.9 SCREENING OF A XGT10 LIBRARY WITH THE 300 bp 
FRAGMENT OF CPT II 
(Sections 2.33.3 & 2.33.4) 
The 300 bp fragment of CPT II was used to screen a cDNA library 
contained in XgtlO, Xgtll and Xgtll stretch (Clontech). The fragment 
was labelled using random priming as described in section 2.24.2.2. 
However, screening has to date been unsuccessful, is. positive clones 
of CPT II have not been found. The low expression of CPT II, 
especially when it has not been induced, makes the screening very 
difficult with the mammalian cDNA library. After screening 
approximately 500000 clones from each of the 4 libraries it is almost 
certain that the CPT II gene is not present in these libraries. 
Further success could only be achieved by acquiring another library, 
preferably one which had been prepared from rats which had been 
induced for CPT activity either by drug induced diabetes or 
starvation for 48 hours. 
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Pig. 4. 10 Southern blot analysis, using 300 bp fragunt fros the C-
tsrinus of carnitine pal.itoyltransf.ras. II, to prob. Ecofli and 






1)&2) Control (S. cerevisiae) DNA digested with EcoRl 
3) Rat liver DNA digested with EcoR]. 
Rat liver DNA digested with Hindlil 
DNA was prepared from rat liver as described in section 2.20 
and DNA from S. cerevisiae was obtained from Dr. E. Ellis. 
Restriction endonuclease digestion of the DNA was carried out using 
EcoRl and Hindlil as described in section 2.22.1. Southern blot 
analysis was carried out as in section 2.24.1.1, and hybridised 
(Section 2.24.3) with a random primed (Section 2.24.2.2) 300 bp 
fragment of CPT II. At a stringency of 55 °C washing all bands had 




Since the publication of the N-terminal peptide sequence of rat 
liver mitochondrial CPT by Brady at al (1988), followed by the 
publication of the full length cDNA of rat liver mitochondrial CPT by 
Woeltje at al (1990b), there has been much confusion as to the reason 
for the two different sequences. The peptide described Brady at al 
(1988) was not found by Woeltje at al, (1990b). Brady at al (1991) 
claimed that their sequence was part of the mature protein and was 
further upstream of the N-terminus of the CPT II clone reported by 
Woeltje at al (1990b). This is strange as the cDNA reported by 
Woeltje at al (1990b) does include a classical mitochondrial 
targeting sequence, and it would therefore be unlikely that further 
sequence associated with the active enzyme would be found further up 
stream. 
Brown at al (1991) reported that in vitro studies on the clone 
found by Woeltje at al (1990b), efficiently targeted CPT II to the 
inner membrane of the mitochondria, and in so doing cleaved a leader 
peptide of 25 amino acids. They reported that the cleavage took place 
between leucine and serine which is positioned next to an alanine 
residue. This agrees with the N-terminal sequence of purified 
(mature) CPT II (Table 4.1) where the first identifiable residue is 
alanine. The sequence then agrees with the predicted amino acid 
sequence of Woeltje at al (1990b). There are a few differences that 
are due to amino acid sequencing errors, due the the low quantities 
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The reason the first residue of the mature protein was not seen 
during sequencing, is probably because the N-terminal amino acid of a 
protein is often undetectable in the first cycle of sequencing. In 
view of this it is unlikely that the sequence described by Brady •t 
al (1988) is part of the mature protein. 
Similar results were reported by Finocchiaro at al (1991) on 
their elucidation of the cDNA encoding human CPT II. Since there is a 
high degree of homology between rat liver mitochondrial CPT II and 
human liver mitochondrial CPT II, this would seem to add further 
evidence against the claims made by Brady at al (1991). Another 
oddity about the sequence published by Brady et al (1988), was that 
the sequence was quoted from 3' to 5' and was for the antisense 
strand. No apparent reason or explanation was given for this. 
The results obtained from the immunological studies (section 
4.4) show that the affinity purified antibody reacted solely with a 
69 kDa rat liver mitochondrial inner membrane protein. The protein 
recognised by this antibody was the same protein as that recognised 
by the anti-CPT II serum prepared by Ramsay (1988). Both sera did not 
recognise any proteins from rat mitochondrial outer membranes. 
This evidence is contrary to reports by Ghadiminejad and 
Saggerson (1991) who did find a cross reaction. They reported that 
anti-CPT II serum reacted strongly with a 69 kDa protein in rat liver 
mitochondrial outer membranes. They could not however prove that it 
was a CPT active enzyme. This cross reaction is probably due to some 
mitochondrial inner membrane contamination during their purification 
procedures and not due to a immunological similarity between CPT II 
and CPT I. 
The fact that there was no cross reaction between the anti-CPT 
II serum and any mitochondrial outer membrane proteins suggests that 
there is no immunogenic similarity between CPT I and CPT II. Similar 
results were reported in Chapter 3 for the anti-84 kDa TDG-00A 
binding protein serum, which was believed to be either CPT I or its 
regulatory subunit. 
The 300 bp PCR fragment described in sections 4.6 and 4.7 (Fig. 
4.6), gave rise to more than one sequence (Fig. 4.7a). Out of 12 
sequenced transformants, only one sequence was positively identified 
as CPT II, when compaired with the cDNA sequence reported by Woeltje 
et al (1990b). 
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The 300 bp fragment was shown by Southern blot analysis to 
react with only one sequence in total rat DNA (Fig. 4.10) which would 
suggest that it would be possible to screen for the full length clone 
by screening cDNA libraries held in Xgtlo and Xgtll. 
However, attempts to use the 300 bp fragment to pull out a CPT 
II clone out of vector cDNA libraries proved to be unsuccessful. This 
was probably due to the naturally low expression of CPT II. 
Future work aimed at cloning a full length cDNA of CPT II could 
best be undertaken by the preparation of a cDNA library prepared from 
rats livers which were pre-induced for CPT activity. This could be 
done either by using diabetic rats or 48 hour starved rats. This 
would increase the possibility of the message being present in the 
mRNA which could then be reverse transcribed into cDNA and ligated 
into a XgtlO library. The library could then be screened with the 300 
bp fragment from the C-terminus of CPT II. 
The 300 bp fragment could also be used to prime CPT induced 
mRNA for specific reverse transcriptase. This would result in one 
cDNA message being reverse transcribed only. This could the be 
amplified by PCR yielding a full length clone. The clone would have 
to be checked for sequence homology with the existing sequence for 
CPT II, since Taq polymerase is known to make mistakes (approximately 







The theory that CPT I and CPT II are identical proteins has 
been proposed by Woldergiorgis et al, (1992), Brady et al, (1986), 
and Kerner and Bieber (1990). The latter two groups also suggest that 
the two enzymes reside on either side of the mitochondrial inner 
membrane. If CPT I is identical to CPT II, then cross reactions would 
be expected between the serum raised to CPT II and a 69 kDa protein 
in the outer membrane. This was not observed (Fig. 4.4 and 4.5). 
Ghadizninejad and Saggerson (1991), reported that an antibody raised 
to rat liver mitochondrial inner membrane CPT protein, reacted with a 
69 kDa protein in the outer membrane, but did not show that the 
protein was an active CPT enzyme. They also reported that CPT II 
could be associated with malonyl-00A binding proteins from the outer 
membrane, and suggested that this was due to a high degree of 
similarity in structure between CPT I and CPT II. As described 
before, no evidence was found to substantiate the existence of an 
outer membrane 69 kDa protein of either immunogenic similarity to CPT 
II (section 4.4) or containing CPT activity (Zammit et al, 1989). 
This perhaps would strengthen the theory that CPT I resides on the 
outside of the inner mitochondrial membrane and was indistinguishable 
from CPT II upon detergent extraction (Woldergiorgis et al, 1992). 
The malonyl-00A sensitivity of CPT I could therefore be induced by a 
regulatory subunit contained in the outer membrane but in close 
proximity to CPT I via a contact site. However, this purification 
procedure was used to isolate mitochondrial outer membranes which 
contained malonyl-00A sensitive CPT activity, and furthermore did not 
contain a 69 kDa protein which could react with anti CPT II serum. So 
the work presented in Chapter 3 would tend to suggest that malonyl-
00A sensitive CPT activity in rat liver mitochondria was localised in 
the outer membranes only, which is strengthened by the immunological 
studies of Chapter 4. 
The association of CPT II with malonyl-CoA binding proteins 
could be due to its similarity with the peroxisomal carnitine 
octanoyltransferase (COT) (section 3.18), which has been shown to be 
malonyl-CoA sensitive (Derrick and Ramsay, 1989) and has a molecular 
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weight of 60 kDa. So the association of CPT II with malonyl-00A 
binding proteins in rat liver mitochondrial outer membranes could be 
due to a relationship with its peroxisomal counterpart rather than 
any similarity to CPT I. The COT was reported by Derrick and Ramsay 
(1989) to be inhibited by up to 90% by less than 10 i14 malonyl-00A. 
They also reported that malonyl-CoA sensitivity was lost after 
solubilisation, probably due to the dissociation of a malonyl-00A 
sensitive regulatory subunit, and that a similar system was in 
operation in the case of rat liver mitochondrial CPT I. Skornin et si 
(1992) reported that COT was inhibited by both malonyl-00A and its 
analogue TDG-00A, but during such inhibition peroxisomal oxidation 
increased by 40% as measured by catalase activity. They suggested 
from this that the inhibition of COT decreased the amount of medium 
chain fatty acids being shuttled out of the peroxisomes therefore 
increasing the 3-oxidation within the peroxisome. Although the COT 
was inhibited by the TDG-00A, carnitine acetyltransf erase (CAT) 
activity was seen to be increased by 40% (Skornin et al, 1992). The 
connection between CPT I inhibitors and peroxisomal oxidation of 
medium to long chain fatty acids is perhaps through production of 
acyl-carnitine for uptake into the mitochondria. 
The specificities of CPT and COT are overlapping to some 
degree, but in general the preferred fatty acyl substrates of the two 
organelles are C100, C120 and C140 for the peroxisome and C160 to 
C18.0 for the mitochondria. C 160 and C180 are mostly oxidised in 
the mitochondria, which could perhaps in part explain why peroxisomal 
activity is increased when COT is inhibited by TDG-00A. In other 
words the inhibition of the enzyme decreases the amount of activated 
long chain length fatty acid carnitine being transported to the 
mitochondrion, by inhibiting the shuttling of long chain fatty acids 
from the peroxisome to the mitochondrion. It does however, not affect 
overall peroxisomal oxidation. 
The peroxisomal system is perhaps similar to the system 
observed in yeast where the mitochondria are devoid of CPT activity 
(Kohlhaw and Tan-Wilson, 1977). The activity of the fatty acid 13-
oxidation system has been detected exclusively in the peroxisomes 
(Kawamoto et al, 1978), but malate dehydrogenase, citrate synthase 
and aconitase, which are common to the tricarboxylic acid and 
glyoxylate cycles are localised in the mitochondria (Kawamoto et al, 
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1977). These results strongly suggest that acetyl-00A necessary for 
the citrate synthase reaction in mitochondria could be supplied from 
the peroxisomes by a transport system for acetyl unite. Several 
transport systems can be suggested: direct transport of acetyl-CoA; 
transport of acetate after hydrolysis of acetyl-00A; and transport 
via the acetyl-carnitine shuttle mediated by carnitine 
acetyltransferase (CAT). 
It was reported by Ueda et al, (1982) that since acetyl-00A 
could not permeate the mitochondrial inner membrane and the activity 
required to hydrolyse acetyl-00A could not been detected in yeast 
peroxisomes, the carnitine acetyltransf erase shuttle system was the 
most likely candidate for the acetyl-00A transport. They reported 
that the level of carnitine acetyltranaferase in the cells was 
greatly enhanced when yeast were grown on alkanes. 
The assumption that an acetyl-carnitine shuttle may play an 
indispensable role in the transport of acetyl units between the 
peroxisomes and the mitochondria is strengthened by reports by 
Kawamoto et al, (1978). They reported that CAT can be isolated from 
both peroxisomes and mitochondria in alkane grown yeast. The 
suggested shuttle system is shown in Fig. 5.1. 
Recently a cDNA sequence was published which allegedly encoded 
S. cerevisiae mitochondrial CAT (Kispal et al, 1993). The predicted 
amino acid sequence showed highly homologous regions with choline and 
carnitine acetyltransf erases, including rat and human mitochondrial 
CPT II and rat COT. The authors proposed that the CAT was possibly 
the evolutionary ancestral protein of all the acyltransferases. 
The evolutionary role may be taken one stage further. The 
biological importance of peroxisomes in some of the higher eukaryotes 
is still unknown. In yeast however, one function of peroxisomes is to 
perform I-oxidation of medium to long chain fatty acids. This 
function can not be undertaken by yeast mitochondria since they are 
devoid of CPT. The peroxisomes then shuttle shorter chain fatty acids 
across to the mitochondria for entry into the Krebs cycle, a 
metabolic pathway that does not exist in the peroxisomes. Perhaps 
during evolution, the CPT system was developed in higher eukaryotes, 
enabling the mitochondria to oxidise medium to long chain fatty 
acids. The peroxisomes in the higher eukaryotes, although still 
capable of oxidising fatty acids, would no longer be exclusively 
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Pig 5.1 Possible mechanism for the complete oxidation of long chain fatty acids via a peroxi some /mitochondrion 
carnitin. dependent shuttle system in yeast. 
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required to do so. They would still operate as usual but would also 
supply the mitochondria with multi-chain length acyl-carnitine, via 
the carnitine shuttle system for both $3-oxidation and entry into the 
Krebs cycle. This would make the physiological importance of 
peroxisomal 13-oxidation redundant in higher eukaryotes. 
From the binding studies of the different inhibitors and 
labelled substrates it can be seen that malonyl-00A inhibits CPT I 
activity (section 3.5). The maximum binding of malonyl-CoA however, 
is unaffected by the binding of either carnitine or palmitoyl-00A as 
reported by Kolodziej and Zammit, (1990a). The reasons for this have 
been much discussed in the literature to date. The binding site for 
malonyl-00A could either reside on a separate binding site on CPT I, 
close to the active site of the enzyme, or on a entirely different 
protein. This protein would presumably act as a regulatory subunit of 
the active protein/phospholipid complex. This would however suggest 
that the protein that was labelled with the malonyl-CoA analogue TDG-
CoA was a regulatory subunit and not CPT I. This would open further 
discussion as to the actual size of CPT I and whether in fact it is 
different from CPT II. 
Kolodziej and Zammit (1990a) reported that the number of high 
affinity binding sites on outer membranes for malonyl-00A was in the 
same order as the number of CPT I catalytic sites. During starvation, 
Kolodziej and Zammit (1990a), observed a co-ordinated rise in both 
the number of malonyl-CoA binding sites and CPT I active protein. 
They postulated that this was in order with a two fold increase in 
CPT I activity. It seems unlikely that a regulatory subunit would be 
co-ordinately induced during starvation, at the same time as CPT I 
was being desensitised to malonyl-00A inhibition (section 3.5). So, 
when this starvation induced co-ordinated increase of binding is 
taken into consideration, it suggests that malonyl-00A binds to CPT I 
and not a regulatory subunit. 
Woldergiorgis et al (1992), reported that malonyl-CoA binding 
proteins, from rat liver mitochondrial outer membranes, could be 
purified and then reconstituted by dialysis in a liposome system. The 
authors reported that when these proteins were reconstituted along 
with detergent labile CPT II, reconstituted CPT activity could then 
be inhibited by up to 50% by 100iM malonyl-CoA. Hence claiming that 
CPT I and CPT II are identical proteins. They suggested that one of 
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the malonyl-CoA binding proteins that they purified, was the same as 
the 84 kDa protein purified by Kolodziej et al (1992). They also 
suggested that co-ordinated inducement of the malonyl-00A regulatory 
subunit during starvation, was to enable the rapid inhibition of the 
CPT system once the starvation period was over. 
Although the system described by Woldergiorgis et al (1992) is 
attractive, they made no attempt to reconstitute the malonyl-00A 
binding proteins without the detergent solubilised CPT. This would 
have been useful in order to test the malonyl-00A binding proteins 
for CPT activity. 
Schemes for the two possibilities were suggested by McGarry et 
al 1991 (Fig. 5.2 & 5.3). These systems both work on the concept that 
rat liver CPT I is a mitochondrial outer membrane protein, as 
described in section 3.2, but show CPT I both as its own malonyl-CoA 
regulator (Fig. 5.3), and as an identical protein to CPT II, with a 
malonyl-00A sensitive regulatory subunit (Fig. 5.2). 
Murthy and Pande (1987b), reported that malonyl-00A 
sensitivity of CPT I activity was restored from octyl glucoside 
solubilised outer membranes. These membranes had previously been 
depleted of all CPT II contamination by solubilisation with Triton X-
100. Murthy and Pande (1990), also reported that two CPT activity 
peaks could be separated from total mitochondria on a hydroxyapatite 
column, hence strengthening the theory that CPT I and CPT II are 
distinct proteins. 
An interesting addition to the conceptualisation of CPT I was 
reported by Murthy and Pande (1987a). They reported that when out-
side out vesicles, containing reconstituted malonyl-CoA sensitive CPT 
active protein, were treated with proteases (nargase, papain, pronase 
and trypsin), malonyl-00A binding was greatly inhibited. CPT activity 
however was not affected. The CPT I activity was degraded when the 
treatment with the protease was preceded by sonication of out-side 
out vesicles, which had been resistant up until then. They suggested 
from these findings that the malonyl-00A binding site, on rat liver 
mitochondria, was on the outer side of the mitochondrial outer 
membrane, but the carnitine and palmitoyl-CoA binding site was on the 
inner side of the mitochondrial outer membrane. 
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Fig. 5.2 Diagram depicting ealonyl-Cok regulation of CPT I through a 
e.parate regulatory subunit in rat liver aitochondria 








Fig. 5.3 Diagram depicting .alonyl-CoA regulation of CPT I through a 
alonyl-CoA binding site on CPT I in rat liver mitochondria 
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McGarry et al, 	(1992) reported that the differential 
sensitivity of the two binding sites was not due to membrane topology 
but to the tertiary structure of the protein which responded to 
malonyl-CoA by inducing a conformational change. Esser et az, 
(1993a) reported that CPT I activity in mitochondrial outer membrane 
fragments could be protected from protease activity by the addition 
of malonyl-00A. They showed, by polyacrylamide gel electrophoresis, 
that the CPT I protein was cleaved from 90 kDa to 82 kDa. The authors 
claimed that this 8 kDa cleaved portion of CPT I was unnecessary for 
catalytic activity. They also claimed that the protection of CPT I by 
malonyl-00A from protease action strengthened the hypothesis that CPT 
I was the malonyl-CoA binding protein. 
Further elucidation of the CPT system was reported by Esser et 
al, (1993b). Four fragments were obtained by carrying out partial 
chymotryptic and tryptic digests of CPT I while still in its membrane 
environment. The fragments were then purified and N-terminally 
sequenced. Oligonucleotidea were generated to these amino acid 
sequences, and used to isolate a cDNA clone for CPT I (Esser et al, 
1993b). The clone consisted of 102-nucleotide 5 untranslated region, 
a single open reading frame of 2319 bases, a 3 untranslated segment 
of 1957 nucleotides and a poly A tail. The authors reported that a 
fragment of the cDNA clone recognised a single mRNA of 4.7 kb in 
size. The predicted amino acid sequence of such a cDNA gave rise to 
773 amino acids (Mr = 88150). The cDNA reported does contain the five 
peptides that were described in Table 3.13, indicating that the 
enzyme purified by the TDG-00A (malonyl-00A analogue) was CPT I, 
hence confirming that CPT I contains the binding site for regulation 
by malonyl-00A. 
Interestingly, one of the fragments reported in section 3.10, 
appears four amino acids from the N-terminus of the predicted 
translation product of the cDNA. 
Gin-Ala-Val-Al a-Phe-Gln-Phe-Val-Thr-Pro-Asp-Gly-I le-Asp- 
It can therefore be assumed that the mature protein does not 
under go any proteolytic cleavage during its translocation into its 
final position in the mitochondrial outer membrane. This is very 
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common in known nuclear encoded mitochondrial outer membrane 
proteins. 
It however disagrees with the prediction of the authors that a 
region (55 - 61 amino acids from the N-terminus) consisting of "-Pro-
Ala-Aen-Pro-Ser-Ser-" was probably part of a cleavable mitochondrial 
import sequence, and that the existence of a cleavable mitochondrial 
targeting sequence was still to be established. 
An interesting observation of the N-terminal sequence of the 
cDNA is that it is devoid of a classical mitochondrial targeting 
sequence. In order to clarify this situation, the full length clone 
of Esser et al (1993b) was examined for possible mistakes. From Fig. 
5.4 it can be seen that in order for a classical mitochondrial 
targeting sequence to be included on the cDNA sequence errors would 
have to have been made. A number of scenarios exist for such errors. 
The first could be the deletion of a thymine (T) between the 
adenine (A), at position 103, and the T at position 104. Inclusion of 
this T would alter the initiation methionine reported by Esser et al 
(1993b) to leucine, and would also alter the reading frame, before 
this point, from 'a' to 'b' (Fig. 5.4). The second error, would be 
the deletion of another T between the A at position 54 and the 
guanosine (G) at position 55. The inclusion of this second T would 
introduce a new inframe initiation methionine. These mistakes would 
add a further 50 bp on to the N-terminus of the open reading frame of 
CPT I. The predicted amino acid sequence of this new N-terminus would 
now include three hydroxylated amino acids (*) and three basic amino 
acids (V), which is more similar to a classical mitochondrial 
targeting. sequence. This sequence still includes two acidic amino 
acids (-), which are normally absent from mitochondrial sequences. 
The new N-terminal sequence would read; 
- 	* 	 * 
Met-Asp-Ser-Ala-Cys-Ser-Gly-Glu-Cys-
V 	 V * V 
Arg-Ala-Ile-Gly-Pro-His-Ser-Arg-leu- - - 
Another possibility would be that the T at position 64 was 
replaced by an A introducing a second initiation methionine in the 
same frame as the open reading frame (a) (Fig. 5.4). This would add a 
further 39 nucleotides to the open reading frame, and give a 13 amino 
acid extension to the predicted N-terminus. This leader peptide would 
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Fig. 5.4 N-terminus of the cDNA encoding CPT I (Esser et al, 1993) 
showing all three reading frames 
AGTcGGTcGACTCcGAGCTCAGTGAGGACCTAAAGCAGAGGACTGTGGTGcGGAGGACAG 
1 ---------+---------+---------+---------+---------+--------- + 60 
TCAGCCAGCTGAGGCTcGAGTCACTCCTGGATTTcGTCTCCTGACACCAcGCCTCCTGTC 
a 	SR ST PS S V R T * SR CL W CC G Q - 
b V G R L R A Q * C P K A ED C GA ED S - 
c 	 S 	D SE L SE D L X Q R TV V R R TV - 
TGCTTGCTCcGGGGAGTGCAGAGCAATAGGTCCCCACTCAAGATGGCAGAGGCTCACCA 
61 ---------+---------+---------+---------+---------+---------+ 120 
ACGAACGAGGCCCCTCACGTCTCGTTATCCAGGGGTGAGTTCTACCGTCTCCGAGTGGTT  
a 	CL L R G V Q S 	R S P L KA E A H Q - 
b A C S GE CRAIG PH SR W Q R L T K - 
c 	 LA P C S A S Q * V P T Q D C R C S P S- 
GCTGTGGCCTTCCAGTTCACCGTCACCCCCGATGGCATTGACCTCCGCCTGAGCCAGAA 
121 ---------+---------+---------+---------+---------+---------+ 180 
CGACACCGGAAGGTCAAGTGGCAGTGGGGGCTACCGTAACTGGAGGCGGACTGGTGCTT 
a 	A V A F Q F TV T PD G ID L R L SHE - 
b LW PS S S PS PPM ALT S A * AT K - 
C 	 C G L P V H R H P R W H * p p p E P R S- 
 
- 
The reading frame encoding the predicted amino acid sequence of 
CPT I is a. The initiation codon starts at nucleotide position 102. 
Unlike classical mitochondrial targeting sequences, the predicted N-
terminal sequence contains very few basic or hydroxylated amino acids. 
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contain no acidic residues, three basic amino acids (*) and two 
hydroxylated amino acids (V). This is also more similar to a 
mitochondrial targeting sequence and importantly contains no acidic 
residues; 
	
* 	 V 	* V 	* 
)4et-Leu-Arg-Gly-Val -G 1 n-Ser-Aan-Arg-Ser-Pro-Lys-Met- 
Incorporation of the third reading frame (C) (Fig. 5.4) would 
involve at least three sequence alterations. One to shift frames 
(deletion of Guanine (G) at position 101), another to introduce a new 
initiation methionine (substitution of cytosine (C) at position 60 
with a A) and a third to delete the amber stop codon starting at 
position 87 (TAG) (substitution of T to A, altering the codon to code 
for Lysine). The predicted N-terminal amino acid sequence would 
contain one acidic amino acid (-), two hydroxylated amino acids (V) 
and one basic amino acid (*). This would seem the less likely of the 
three possibilities because of the number of changes involved along 
with the inclusion of the acid amino acidic. 
Met-Ala-Pro-Gly-Ser-Ala-Glu-Gln-Lys-Val-Pro-Thr-Gln- 
There are many other possibilities involving other possible 
sequence errors in the cDNA reported by Esser et al (1993b). Such 
errors, although possible, are not common and therefore unlikely. 
The identity of the N-terminus of CPT I could easily be checked 
by PCR of the extreme 5 end of the cDNA clone. This could be 
done using primers generated to sequences either side of the reported 
N-terminus (Fig. 5.4). The amplified product could then be checked by 
DNA sequencing. Since the PCR amplification product would be from the 
5 end of the template, a very high quality cDNA or mRNA would have 
to be used to ensure that most the messages present were full length. 
If reverse transcription was initiated from oligonucleotide dT, then 
the cDNA would have to include the large untranslated 3' sequence 
(1957 nucleotides). In order to alleviate this problem reverse 
transcription of the mRNA could be primed using an oligonucleotide 
generated to the 3' end of the reading frame. This could help in two 
ways, it would specifically generate RNA/DNA duplex for the CPT I 
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clone, and would shorten the length of the cDNA required to contain 
the N-terminus of the clone. It would also be important that the rat 
livers from which the mRNA or cDNA was prepared, were pre-induced for 
CPT I. 
From the cDNA reported by Esser at al (1993b), there are 2 
hydrophobic domains in CPT I. The more N-terminal of the 2 
hydrophobic domains (residues 48-73), has 5 positively charged amino 
acid residues flanking its N-terminal aide, and 3 positively charged 
amino acids on its C-terminal side. Applying the rules for membrane 
topology, described by Hartman at al (1989) and Parks and Lamb (1991) 
(discussed in section 1.11), a net positive charge of plus 3 is 
obtained in favour of its N-terminal side. This suggests that CPT I 
has an orientation where its N-terminus is exposed to the cytoplasm 
and its C-terminus is exposed tu tre intermembrane apace (Nc ytCin ). 
It was suggested that the second hydrophobic domain also 
traversed the membrane (Esser at al, 1993b). However, when there is 
more than one tranamembrane sequence, the orientation of them all is 
determined by the most N-terminal one (Hartmann et al, 1989). 
Therefore it seems more likely that the second hydrophobic region 
loops round through the membrane leaving the C-terminus still exposed 
to the intermembrane space. 
CPT I, when compared to the other known acyltransferases, shows 
a similar degree of homology over much of its amino acid sequence. 
Allowing for conservative changes, the similarity in amino acid 
sequence is 50%. CPT I is significantly larger than the other 
recently analysed rat tissue acyltransf erases. The main confirmed 
difference between CPT I and the other acyltranaferases is that CPT I 
has an extra binding site for regulation via malonyl-CoA. Comparison 
of the known acyltransferase cDNA sequences suggests that there is 
least homology between the N-terminus of CPT I and the other acyl-
transferases. It is therefore not unreasonable to predict that the N-
terminal domain of CPT I will be responsible for malonyl-CoA binding. 
The predicted N-terminal sequence protuding into the cytosol is 
only 48 residues in length. It is impossible to say whether or not 
this is large enough to act as a malonyl-00A binding site. 
An interesting picture is developed when this information is 
combined with both the protease studies of Murthy and Pande (1987a), 
and the predicted CPT I membrane topology described above. The 
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hydrophobic domains of CPT I are situated just after the predicted N-
terminal domain and are therefore positioned perfectly to separate 
the two catalytic binding sites by spanning the outer membrane. The 
resultant picture of the CPT system would therefore resemble the 
diagram depicted in Fig. 5.5. 
The translocation of such proteins has, to date, been little 
studied. The translocation of CPT I could possibly occur as follows; 
CPT I must be targeted to the mitochondrial outer membrane, probably 
to a receptor initiated by its N-terminus (devoid of a classical 
targeting sequence). This would normally be followed by insertion of 
the N-terminus into the outer membrane. Translocation of the N-
terminus would then proceed up until the first hydrophobic sequence. 
This would then act as a stop transfer signal. The first hydrophobic 
sequence would then 'flip round, because of the charge differential 
on the flanking regions (N-terminal flanking region being more 
positive). This would leave the N-terminus on the cytosolic side of 
the membrane. Translocation of the C-terminus however would continue, 
probably facilitated through unknown translocation machinery. 
Another possibility is that the N-terminus aligns itself with 
the outer membrane bringing some other part of the protein in close 
proximity to the membrane. Translocation of the protein is then 
initiated through this second structure and not the N-terminus, which 
remains cytosolic at all times. Whether some other mitochondrial 
targeting system exists has yet to be discovered. 
From the findings of this study along with careful examination 
of the recent publications, it is now apparent that rat liver CPT I 
and CPT II are distinct proteins, encoded by distinct genes. The 
proteins reside on the outer and inner mitochondrial membranes 
respectively. Their relationship to each other is no more close than 
that of all the acyltransf erases, probably through an ancestral CAT. 
The targeting of CPT II to the inner mitochondrial membrane is 
facilitated through a classical N-terminal leader peptide of 26 amino 
acids, possibly through known translocation machinery. The method of 
targeting of CPT I to the outer mitochondrial membrane will be a 
subject of great discussion. It could be through traditional 
targeting sequences, or by another unknown method. The translocation 
of CPT I to its functional position in the outer membrane is also a 
matter for debate and can really only be elucidated once the 
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Fig 5.5 A possible schematic representation of CPT system in rat liver mitochondria as suggested by the evidence 
reported in this thesis along with other current opinions. 
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